[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 700
6. Lotan TL, Epstein JI: Clinical implications of changing definitions within the Gleason grading system. Nat Rev Urol; 2010 Mar;7(3):136-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The changing definitions of Gleason pattern 3 and 4 prostatic adenocarcinoma have tended to narrow the scope of pattern 3 carcinoma and widen the scope of pattern 4 carcinoma.
  • [MeSH-major] Prostatic Neoplasms / classification. Prostatic Neoplasms / diagnosis. Severity of Illness Index

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20157302.001).
  • [ISSN] 1759-4820
  • [Journal-full-title] Nature reviews. Urology
  • [ISO-abbreviation] Nat Rev Urol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 32
  •  go-up   go-down


7. Reid BJ, Li X, Galipeau PC, Vaughan TL: Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer; 2010 Feb;10(2):87-101
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
  • The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma.
  • The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past four decades in many regions of the Western world, and there are indications that the incidence of this disease is on the rise in Asian populations in which it has been rare.
  • Much has been learned of host and environmental risk factors that affect the incidence of oesophageal adenocarcinoma, and data indicate that patients with Barrett's oesophagus rarely develop oesophageal adenocarcinoma.
  • Given that 95% of oesophageal adenocarcinomas arise in individuals without a prior diagnosis of Barrett's oesophagus, what strategies can be used to reduce late diagnosis of oesophageal adenocarcinoma?

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Cancer Res. 2009 May 15;15(10):3305-14 [19417022.001]
  • [Cites] N Engl J Med. 2009 May 28;360(22):2277-88 [19474425.001]
  • [Cites] Am J Gastroenterol. 2009 Jun;104(6):1356-62 [19491849.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2079-89 [19567501.001]
  • [Cites] Histopathology. 2009 Jun;54(7):814-9 [19635100.001]
  • [Cites] Am J Gastroenterol. 2009 Sep;104(9):2153-60 [19584833.001]
  • [Cites] BMC Fam Pract. 2009;10:59 [19706198.001]
  • [Cites] Nat Rev Cancer. 2009 Oct;9(10):701-13 [19693097.001]
  • [Cites] Gut. 2009 Nov;58(11):1451-9 [19651633.001]
  • [Cites] Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304 [19523538.001]
  • [Cites] Dis Esophagus. 2009;22(8):676-81 [19222529.001]
  • [Cites] Biomarkers. 2006 Nov-Dec;11(6):547-61 [17056474.001]
  • [Cites] Am J Gastroenterol. 2006 Nov;101(11):2619-28 [16952280.001]
  • [Cites] Gut. 2006 Dec;55(12):1810-20 [17124160.001]
  • [Cites] Semin Radiat Oncol. 2007 Jan;17(1):2-9 [17185192.001]
  • [Cites] Scand J Gastroenterol. 2007 Jan;42(1):23-7 [17190758.001]
  • [Cites] Am J Gastroenterol. 2007 Jan;102(1):10-20 [17266684.001]
  • [Cites] PLoS Med. 2007 Feb;4(2):e67 [17326708.001]
  • [Cites] Am J Gastroenterol. 2007 Mar;102(3):483-93; quiz 694 [17338734.001]
  • [Cites] J Natl Cancer Inst. 2007 Apr 4;99(7):545-57 [17405999.001]
  • [Cites] World J Gastroenterol. 2007 Mar 14;13(10):1585-94 [17461453.001]
  • [Cites] Cancer Causes Control. 2007 Nov;18(9):1039-46 [17665311.001]
  • [Cites] Cancer Detect Prev. 2007;31(3):233-6 [17646057.001]
  • [Cites] Int J Cancer. 2007 Oct 15;121(8):1643-58 [17674367.001]
  • [Cites] Gastrointest Endosc. 2007 Sep;66(3):460-8 [17643436.001]
  • [Cites] Int J Pediatr Obes. 2006;1(2):109-13 [17907323.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2090-6 [17890521.001]
  • [Cites] Am J Gastroenterol. 2007 Nov;102(11):2373-9 [17581270.001]
  • [Cites] Aliment Pharmacol Ther. 2007 Dec;26(11-12):1465-77 [17900269.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2007 Dec;293(6):G1106-13 [17932229.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2637-40 [18086768.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2649-55 [18086770.001]
  • [Cites] Gut. 2008 Feb;57(2):173-80 [17932103.001]
  • [Cites] Int J Cancer. 2008 Jul 1;123(1):174-80 [18386788.001]
  • [Cites] Am J Gastroenterol. 2008 May;103(5):1079-89 [18445097.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1169-78 [18483339.001]
  • [Cites] Cancer Res. 2008 Jun 1;68(11):4163-72 [18519675.001]
  • [Cites] Arch Iran Med. 2008 Jul;11(4):364-70 [18588366.001]
  • [Cites] Gut. 2008 Aug;57(8):1041-8 [18305067.001]
  • [Cites] Am J Epidemiol. 2008 Aug 1;168(3):237-49 [18550563.001]
  • [Cites] J Clin Gastroenterol. 2008 Aug;42(7):806-9 [18385604.001]
  • [Cites] Hum Pathol. 2008 Aug;39(8):1128-35 [18602665.001]
  • [Cites] Jpn J Clin Oncol. 2008 Jul;38(7):464-8 [18664481.001]
  • [Cites] Am J Gastroenterol. 2008 Jul;103(7):1614-23; quiz 1624 [18494834.001]
  • [Cites] J Natl Cancer Inst. 2008 Aug 20;100(16):1184-7 [18695138.001]
  • [Cites] Genome Res. 2008 Sep;18(9):1518-29 [18577705.001]
  • [Cites] Mutagenesis. 2008 Sep;23(5):399-405 [18515815.001]
  • [Cites] BMC Genomics. 2008;9:394 [18717985.001]
  • [Cites] Gut. 2008 Oct;57(10):1354-9 [18424568.001]
  • [Cites] J Gastrointest Surg. 2008 Oct;12(10):1627-36; discussion 1636-7 [18704598.001]
  • [Cites] Dis Esophagus. 2008;21(6):529-38 [18840137.001]
  • [Cites] Mol Cancer. 2008;7:75 [18831746.001]
  • [Cites] Gastroenterology. 2008 Oct;135(4):1392-1413, 1413.e1-5 [18801365.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):659-69 [18971125.001]
  • [Cites] Clin Cancer Res. 2008 Nov 1;14(21):6988-95 [18980994.001]
  • [Cites] Gastrointest Endosc. 2008 Nov;68(5):849-55 [18547567.001]
  • [Cites] Contemp Clin Trials. 2009 Jan;30(1):2-7 [19013259.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Dec;23(12):1785-93 [19120871.001]
  • [Cites] Cancer Prev Res (Phila). 2008 Oct;1(5):308-11 [19138974.001]
  • [Cites] Cancer Prev Res (Phila). 2008 Oct;1(5):329-38 [19138977.001]
  • [Cites] Cancer Prev Res (Phila). 2008 Nov;1(6):413-23 [19138988.001]
  • [Cites] Nat Genet. 2009 Feb;41(2):178-86 [19151715.001]
  • [Cites] Br J Cancer. 2009 Feb 10;100(3):551-7 [19156150.001]
  • [Cites] Am J Clin Nutr. 2009 Mar;89(3):890-6 [19144726.001]
  • [Cites] Cancer Causes Control. 2009 Apr;20(3):279-88 [18839322.001]
  • [Cites] Cancer Res. 2004 Oct 15;64(20):7629-33 [15492292.001]
  • [Cites] Nature. 1975 May 15;255(5505):197-200 [1143315.001]
  • [Cites] J Thorac Cardiovasc Surg. 1975 Nov;70(5):826-35 [1186274.001]
  • [Cites] Science. 1976 Oct 1;194(4260):23-8 [959840.001]
  • [Cites] Hum Pathol. 1988 Feb;19(2):166-78 [3343032.001]
  • [Cites] Gastroenterology. 1989 Feb;96(2 Pt 1):355-67 [2910757.001]
  • [Cites] Stat Med. 1989 Apr;8(4):431-40 [2727467.001]
  • [Cites] J Thorac Cardiovasc Surg. 1993 Mar;105(3):383-7; discussion 387-8 [8445916.001]
  • [Cites] Stat Med. 1994 May 15;13(9):955-68 [8047747.001]
  • [Cites] J Thorac Cardiovasc Surg. 1994 Nov;108(5):813-21; discussion 821-2 [7967662.001]
  • [Cites] Cancer Causes Control. 2009 Apr;20(3):303-11 [18853262.001]
  • [Cites] Gastroenterology. 2009 Mar;136(3):799-805 [19162028.001]
  • [Cites] Cell Cycle. 2009 Mar 15;8(6):809-17 [19229128.001]
  • [Cites] Gastroenterology. 2009 Apr;136(4):1215-24, e1-2 [19250648.001]
  • [Cites] Am J Gastroenterol. 2009 Apr;104(4):834-42 [19319131.001]
  • [Cites] Lancet. 2009 Apr 11;373(9671):1301-9 [19328542.001]
  • [Cites] Cancer Biomark. 2009;5(3):143-58 [19407369.001]
  • [Cites] Cancer Prev Res (Phila). 2009 May;2(5):459-65 [19401529.001]
  • [Cites] Histopathology. 2009 May;54(6):699-712 [19438745.001]
  • [Cites] Cancer Res. 2009 May 15;69(10):4112-5 [19435894.001]
  • [Cites] Am J Gastroenterol. 1999 Jan;94(1):86-91 [9934736.001]
  • [Cites] N Engl J Med. 1999 Mar 18;340(11):825-31 [10080844.001]
  • [Cites] Gut. 1998 Aug;43(2):216-22 [10189847.001]
  • [Cites] Cancer Res. 1999 Apr 15;59(8):1837-9 [10213488.001]
  • [Cites] Nat Genet. 1999 May;22(1):106-9 [10319873.001]
  • [Cites] Gastroenterology. 1999 Aug;117(2):327-35 [10419913.001]
  • [Cites] Br J Surg. 1950 Oct;38(150):175-82 [14791960.001]
  • [Cites] Thorax. 1953 Jun;8(2):87-101 [13077502.001]
  • [Cites] Am J Gastroenterol. 2004 Nov;99(11):2107-14 [15554988.001]
  • [Cites] Semin Cancer Biol. 2005 Feb;15(1):51-60 [15613288.001]
  • [Cites] J Infect Dis. 2005 Mar 1;191(5):761-7 [15688293.001]
  • [Cites] Scand J Gastroenterol. 2004 Dec;39(12):1175-9 [15742992.001]
  • [Cites] Gastroenterology. 2005 Mar;128(3):771-8 [15765412.001]
  • [Cites] Am J Gastroenterol. 2005 Apr;100(4):775-83 [15784018.001]
  • [Cites] Clin Cancer Res. 2005 Apr 1;11(7):2478-85 [15814623.001]
  • [Cites] J Gastroenterol Hepatol. 2005 Apr;20(4):633-6 [15836715.001]
  • [Cites] JAMA. 2005 May 4;293(17):2095-101 [15870412.001]
  • [Cites] Cancer Causes Control. 2005 Apr;16(3):285-94 [15947880.001]
  • [Cites] Clin Gastroenterol Hepatol. 2005 Jun;3(6):529-37 [15952094.001]
  • [Cites] J Gastroenterol Hepatol. 2005 Jul;20(7):995-1001 [15955205.001]
  • [Cites] Ann Intern Med. 2005 Aug 2;143(3):199-211 [16061918.001]
  • [Cites] Int J Cancer. 2006 May 15;118(10):2628-31 [16353151.001]
  • [Cites] Aliment Pharmacol Ther. 2006 Mar 15;23(6):727-33 [16556174.001]
  • [Cites] Gastrointest Endosc. 2006 Apr;63(4):570-80 [16564854.001]
  • [Cites] Nat Genet. 2006 Apr;38(4):468-73 [16565718.001]
  • [Cites] JAMA. 2006 Apr 5;295(13):1549-55 [16595758.001]
  • [Cites] Cancer Res. 2006 May 1;66(9):4975-82 [16651456.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 May;4(5):566-72 [16630761.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):872-8 [16702363.001]
  • [Cites] J Natl Cancer Inst. 2006 Jun 7;98(11):748-56 [16757699.001]
  • [Cites] J Nutr. 2006 Jul;136(7 Suppl):1935S-1939S [16772463.001]
  • [Cites] Clin Cancer Res. 2006 Jun 15;12(12):3661-97 [16778094.001]
  • [Cites] BMJ. 2006 Jun 24;332(7556):1512 [16793832.001]
  • [Cites] Scand J Gastroenterol. 2006 Aug;41(8):887-91 [16803686.001]
  • [Cites] Cancer Causes Control. 2006 Sep;17(7):901-9 [16841257.001]
  • [Cites] Cancer Causes Control. 2006 Sep;17(7):971-81 [16841264.001]
  • [Cites] Am J Gastroenterol. 2006 Jul;101(7):1430-6 [16863543.001]
  • [Cites] Aging Cell. 2006 Aug;5(4):325-30 [16913878.001]
  • [Cites] Carcinogenesis. 2006 Sep;27(9):1835-41 [16571649.001]
  • [Cites] Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943 [16928254.001]
  • [Cites] Anal Chem. 2006 Sep 1;78(17):5977-86 [16944874.001]
  • [Cites] Gut. 2006 Oct;55(10):1390-7 [16682429.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1668-73 [16985029.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1935-40 [17035402.001]
  • [Cites] Br J Surg. 2002 Jul;89(7):824-37 [12081731.001]
  • [Cites] Trends Biochem Sci. 2002 Jul;27(7):339-44 [12114022.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):745-52 [12163328.001]
  • [Cites] Gut. 2002 Sep;51(3):323-8 [12171951.001]
  • [Cites] Int J Cancer. 2002 Dec 20;102(6):551-5 [12447994.001]
  • [Cites] Gastroenterology. 2003 Jan;124(1):47-56 [12512029.001]
  • [Cites] Int J Cancer. 2003 May 20;105(1):98-100 [12672037.001]
  • [Cites] Gastroenterology. 2003 May;124(5):1193-201 [12730860.001]
  • [Cites] Clin Cancer Res. 2003 Jul;9(7):2560-6 [12855631.001]
  • [Cites] Lancet. 2005 Aug 20-26;366(9486):662-4 [16112303.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Jun;46(6):532-42 [17330261.001]
  • [Cites] Carcinogenesis. 2007 Jun;28(6):1323-8 [17277236.001]
  • [Cites] Mol Cell Proteomics. 2007 Jun;6(6):987-99 [16829691.001]
  • [Cites] Genet Med. 2007 Jun;9(6):341-7 [17575500.001]
  • [Cites] Cancer Causes Control. 2007 Sep;18(7):713-22 [17562192.001]
  • [Cites] Transl Res. 2007 Jul;150(1):3-17 [17585859.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G264-70 [17431220.001]
  • [Cites] Gastroenterology. 2007 Jul;133(1):34-41; quiz 311 [17631128.001]
  • [Cites] J Mol Med (Berl). 2007 Jul;85(7):733-43 [17415542.001]
  • [Cites] Gastroenterology. 2007 Aug;133(2):403-11 [17681161.001]
  • [Cites] Carcinogenesis. 2005 Sep;26(9):1536-41 [15878910.001]
  • [Cites] Am J Gastroenterol. 2005 Oct;100(10):2151-6 [16181362.001]
  • [Cites] Gastrointest Endosc. 2005 Oct;62(4):488-98 [16185958.001]
  • [Cites] Scand J Gastroenterol. 2005 Sep;40(9):1127-8 [16211720.001]
  • [Cites] Gastroenterology. 2005 Oct;129(4):1274-81 [16230080.001]
  • [Cites] Lancet Oncol. 2005 Dec;6(12):945-52 [16321762.001]
  • [Cites] Am J Gastroenterol. 2005 Dec;100(12):2616-21 [16393209.001]
  • [Cites] J Urol. 2006 Feb;175(2):425-31 [16406965.001]
  • [Cites] Cancer Causes Control. 2000 Mar;11(3):231-8 [10782657.001]
  • [Cites] Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:3-9 [10807397.001]
  • [Cites] Am J Gastroenterol. 2000 Jul;95(7):1669-76 [10925966.001]
  • [Cites] J Natl Cancer Inst. 2000 Aug 16;92(16):1316-21 [10944553.001]
  • [Cites] Am J Gastroenterol. 2000 Oct;95(10):2946-52 [11051373.001]
  • [Cites] Gut. 2001 Mar;48(3):304-9 [11171817.001]
  • [Cites] Ann Surg. 2001 Mar;233(3):322-37 [11224619.001]
  • [Cites] Hum Pathol. 2001 Apr;32(4):368-78 [11331953.001]
  • [Cites] Am J Gastroenterol. 2001 May;96(5):1355-62 [11374668.001]
  • [Cites] Gastroenterology. 2001 Jun;120(7):1607-19 [11375943.001]
  • [Cites] Gastroenterology. 2001 Jun;120(7):1630-9 [11375945.001]
  • [Cites] Cancer. 2001 Aug 1;92(3):549-55 [11505399.001]
  • [Cites] Cancer Causes Control. 2001 Oct;12(8):721-32 [11562112.001]
  • [Cites] Am J Gastroenterol. 2001 Sep;96(9):2575-83 [11569678.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1055-62 [11588131.001]
  • [Cites] Gastroenterology. 2002 Jan;122(1):26-33 [11781277.001]
  • [Cites] Gastroenterology. 2002 Jan;122(1):55-9 [11781280.001]
  • [Cites] Gastroenterology. 2002 Mar;122(3):633-40 [11874995.001]
  • [Cites] Neoplasia. 2002 Mar-Apr;4(2):121-8 [11896567.001]
  • [Cites] Gastroenterology. 2002 Apr;122(4):1101-12 [11910360.001]
  • [Cites] JAMA. 2002 Apr 17;287(15):1972-81 [11960540.001]
  • [Cites] Surg Endosc. 2002 Feb;16(2):263-6 [11967675.001]
  • [Cites] J Gastrointest Surg. 2002 Jan-Feb;6(1):29-35; discussion 36 [11986015.001]
  • [Cites] J Mol Diagn. 2008 Jan;10(1):67-77 [18083688.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):126-34 [18187391.001]
  • [Cites] Aliment Pharmacol Ther. 2008 Feb 15;27(4):316-20 [18062791.001]
  • [Cites] Cell Oncol. 2008;30(1):63-75 [18219111.001]
  • [Cites] Int J Cancer. 2008 Mar 15;122(6):1303-10 [18000824.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):352-8 [18268119.001]
  • [Cites] Gut. 2008 Apr;57(4):448-54 [18178609.001]
  • [Cites] Am J Gastroenterol. 2008 Mar;103(3):788-97 [18341497.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):727-31 [18349295.001]
  • [Cites] Gut. 2003 Aug;52(8):1081-4 [12865262.001]
  • [Cites] Gut. 2003 Aug;52(8):1085-9 [12865263.001]
  • [Cites] Cancer. 2003 Sep 1;98(5):940-8 [12942560.001]
  • [Cites] Nat Rev Cancer. 2003 Sep;3(9):695-701 [12951588.001]
  • [Cites] J Med Genet. 2003 Sep;40(9):651-6 [12960209.001]
  • [Cites] J Natl Cancer Inst. 2003 Sep 17;95(18):1404-13 [13130116.001]
  • [Cites] Am J Gastroenterol. 2003 Sep;98(9):1931-9 [14499768.001]
  • [Cites] Nature. 2004 Feb 26;427(6977):787 [14985739.001]
  • [Cites] Cancer Res. 2004 May 15;64(10):3414-27 [15150093.001]
  • [Cites] Gastroenterology. 2004 Jul;127(1):310-30 [15236196.001]
  • [Cites] Cancer Cell. 2004 Jul;6(1):11-6 [15261138.001]
  • [Cites] Br J Surg. 2004 Aug;91(8):997-1003 [15286961.001]
  • [Cites] Nat Rev Cancer. 2004 Aug;4(8):579-91 [15286738.001]
  • [Cites] Cancer Causes Control. 2004 Oct;15(8):837-43 [15456997.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):85-92 [7742727.001]
  • [Cites] Am J Gastroenterol. 1996 Sep;91(9):1855-6 [8792715.001]
  • [Cites] Am J Gastroenterol. 1997 Apr;92(4):586-91 [9128304.001]
  • [Cites] J Natl Cancer Inst. 1997 Sep 3;89(17):1277-84 [9293918.001]
  • [Cites] Gastroenterology. 1997 Nov;113(5):1449-56 [9352846.001]
  • [Cites] Gut. 1997 Sep;41(3):303-7 [9378382.001]
  • [Cites] J Natl Cancer Inst. 1998 Jan 21;90(2):150-5 [9450576.001]
  • [Cites] Cancer Res. 1998 Feb 15;58(4):588-90 [9485003.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):97-102 [9488582.001]
  • [Cites] Am J Gastroenterol. 1998 Jul;93(7):1028-32 [9672324.001]
  • (PMID = 20094044.001).
  • [ISSN] 1474-1768
  • [Journal-full-title] Nature reviews. Cancer
  • [ISO-abbreviation] Nat. Rev. Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA124911-02; United States / NCI NIH HHS / CA / K05 CA124911; United States / NCI NIH HHS / CA / P01 CA091955; United States / NCI NIH HHS / CA / P01 CA091955-08; United States / NCI NIH HHS / CA / K05 CA124911-02
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 218
  • [Other-IDs] NLM/ NIHMS200752; NLM/ PMC2879265
  •  go-up   go-down


8. Holder-Murray J, Fichera A: Anal transition zone in the surgical management of ulcerative colitis. World J Gastroenterol; 2009 Feb 21;15(7):769-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anal transition zone in the surgical management of ulcerative colitis.
  • Preservation of the anal transition zone has long been a significant source of controversy in the surgical management of ulcerative colitis.
  • The two techniques for restorative proctocolectomy and ileal pouch anal anastomosis (RPC IPAA) in common practice are a stapled anastomosis and a handsewn anastomosis; these techniques differ in the amount of remaining rectal mucosa and therefore the presence of the anal transition zone following surgery.
  • [MeSH-major] Anal Canal / anatomy & histology. Anal Canal / surgery. Colitis, Ulcerative / surgery. Colonic Pouches. Proctocolectomy, Restorative / methods
  • [MeSH-minor] Adenocarcinoma / surgery. Anastomosis, Surgical / methods. Humans. Inflammation. Postoperative Complications / prevention & control. Rectal Neoplasms / surgery. Sepsis / prevention & control. Sutures. Treatment Outcome

  • Genetic Alliance. consumer health - Ulcerative Colitis.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Today. 2000;30(3):223-7 [10752773.001]
  • [Cites] Surgery. 2008 Oct;144(4):533-7; discussion 537-9 [18847636.001]
  • [Cites] Dis Colon Rectum. 2001 Nov;44(11):1590-6 [11711729.001]
  • [Cites] Dis Colon Rectum. 2003 Jan;46(1):6-13 [12544515.001]
  • [Cites] Ann Surg. 2003 Sep;238(3):433-41; discussion 442-5 [14501509.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1979 Sep;87A(5):379-86 [93398.001]
  • [Cites] Br J Surg. 1982 Oct;69(10):599-604 [7127042.001]
  • [Cites] Dis Colon Rectum. 1983 Dec;26(12):768-71 [6641457.001]
  • [Cites] Br J Surg. 1986 Jun;73(6):469-73 [3719274.001]
  • [Cites] Dis Colon Rectum. 1987 Jan;30(1):1-5 [3803100.001]
  • [Cites] Br J Surg. 1987 Jun;74(6):511-5 [3607414.001]
  • [Cites] Br J Surg. 1987 Oct;74(10):940-4 [3664227.001]
  • [Cites] Int J Colorectal Dis. 1989;4(1):45-9 [2708882.001]
  • [Cites] Dis Colon Rectum. 1990 May;33(5):414-8 [2328630.001]
  • [Cites] Am J Surg. 1991 Jan;161(1):90-5; discussion 95-6 [1987862.001]
  • [Cites] Br J Surg. 1991 Jan;78(1):67-70 [1998869.001]
  • [Cites] Br J Surg. 1991 Apr;78(4):430-4 [2032101.001]
  • [Cites] Gastroenterology. 1992 Aug;103(2):431-8 [1634062.001]
  • [Cites] Arch Surg. 1993 Apr;128(4):437-40 [8384435.001]
  • [Cites] Dis Colon Rectum. 1994 Dec;37(12):1281-5 [7995159.001]
  • [Cites] Ann Surg Oncol. 1994 Nov;1(6):512-5 [7850557.001]
  • [Cites] Dis Colon Rectum. 1995 Aug;38(8):803-6 [7634974.001]
  • [Cites] Am J Surg. 1996 Mar;171(3):320-3 [8615465.001]
  • [Cites] Dis Colon Rectum. 1997 Mar;40(3):257-62 [9118737.001]
  • [Cites] Ann Surg. 1997 Jun;225(6):666-76; discussion 676-7 [9230807.001]
  • [Cites] Br J Surg. 1998 Nov;85(11):1517-21 [9823914.001]
  • [Cites] Colorectal Dis. 2004 Nov;6(6):494-8 [15521942.001]
  • [Cites] Br J Surg. 1960 May;47:585-95 [13818898.001]
  • [Cites] Colorectal Dis. 2005 Nov;7(6):591-7 [16232241.001]
  • [Cites] Ann Surg. 2006 Jul;244(1):18-26 [16794385.001]
  • [Cites] J Gastrointest Surg. 2007 Dec;11(12):1647-52; discussion 1652-3 [17906906.001]
  • [Cites] Surg Today. 2000;30(7):575-81 [10930221.001]
  • (PMID = 19230038.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Editorial
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2653377
  •  go-up   go-down


9. Kim KH, Kim YB, Lee JK, Kim YJ, Jung TY: Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer. Korean J Urol; 2010 Jun;51(6):398-402
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: The incidence of adenocarcinoma on a subsequent biopsy following a diagnosis of atypical small acinar proliferation (ASAP) ranges from 34% to 60%.
  • MATERIALS AND METHODS: From January 2007 to December 2008, a total of 118 patients who had been diagnosed with adenocarcinoma on prostate needle biopsy underwent RP.
  • RESULTS: Thirty-six of the 46 patients (78%) were diagnosed as having adenocarcinoma at sites of ASAP on the initial prostate needle biopsies.
  • CONCLUSIONS: Most ASAP on initial prostate needle biopsy was a true pathological entity, in other words, prostatic adenocarcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Urol. 2009 Oct;27(5):587-92 [19373471.001]
  • [Cites] J Urol. 2001 May;165(5):1409-14 [11342887.001]
  • [Cites] Eur Urol. 2008 Dec;54(6):1306-13 [18083294.001]
  • [Cites] BJU Int. 2007 Apr;99(4):780-5 [17378841.001]
  • [Cites] BJU Int. 2007 Jan;99(1):49-52 [17227491.001]
  • [Cites] Eur Urol. 2006 Oct;50(4):666-74 [16930809.001]
  • [Cites] Arch Pathol Lab Med. 2006 Jun;130(6):835-43 [16740037.001]
  • [Cites] Anal Quant Cytol Histol. 2006 Apr;28(2):104-10 [16637513.001]
  • [Cites] Eur Urol. 2006 Jan;49(1):49-53; discussion 53 [16314035.001]
  • [Cites] Am J Surg Pathol. 2005 Sep;29(9):1201-7 [16096410.001]
  • [Cites] Int J Urol. 2005 Apr;12(4):353-60 [15948721.001]
  • [Cites] Am J Clin Pathol. 2005 Feb;123(2):231-6 [15842047.001]
  • [Cites] Urology. 1999 Feb;53(2):351-5 [9933053.001]
  • [Cites] Urology. 1998 May;51(5):749-57; discussion 757-8 [9610588.001]
  • [Cites] Virchows Arch. 1997 Jan;430(1):1-16 [9037309.001]
  • [Cites] Hum Pathol. 1993 Aug;24(8):819-32 [8375853.001]
  • [Cites] J Urol. 1989 Jul;142(1):71-4; discussion 74-5 [2659827.001]
  • [Cites] J Urol. 2004 Sep;172(3):906-8; discussion 908-9 [15310995.001]
  • [Cites] Arch Pathol Lab Med. 2004 May;128(5):557-60 [15086303.001]
  • [Cites] Am J Surg Pathol. 2004 Feb;28(2):239-43 [15043314.001]
  • [Cites] J Urol. 2003 Aug;170(2 Pt 1):370-2 [12853777.001]
  • [Cites] Int J Urol. 2003 Feb;10(2):68-71 [12588600.001]
  • [Cites] Urology. 2002 Nov;60(5):851-4 [12429314.001]
  • [Cites] J Urol. 2001 Aug;166(2):402-10 [11458037.001]
  • [Cites] BJU Int. 2001 Jul;88(2):147-57 [11446873.001]
  • [Cites] Urol Oncol. 2009 Sep-Oct;27(5):509-13 [18625570.001]
  • (PMID = 20577606.001).
  • [ISSN] 2005-6745
  • [Journal-full-title] Korean journal of urology
  • [ISO-abbreviation] Korean J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2890056
  • [Keywords] NOTNLM ; Needle biopsy / Prostatectomy / Prostatic neoplasms / Surgical pathology
  •  go-up   go-down


10. Andres AH, Walk CB, Meywirth E, Milkereit E: [Awareness under remifentanil-propofol anaesthesia]. Anaesthesist; 2005 Oct;54(10):1000-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report on a 49-year-old female patient suffering from recurrent carcinoma of the rectum, who underwent a palliative Hartmann operation for an anus praeter reconstruction.
  • [MeSH-minor] Adenocarcinoma / surgery. Anal Canal / surgery. Female. Hemodynamics / physiology. Humans. Middle Aged. Pain, Postoperative / psychology. Reconstructive Surgical Procedures. Rectal Neoplasms / surgery

  • Hazardous Substances Data Bank. PROPOFOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Anaesthesiol Scand. 1997 Sep;41(8):978-84 [9311394.001]
  • [Cites] Curr Opin Anaesthesiol. 2000 Apr;13(2):161-5 [17016296.001]
  • [Cites] Anesth Analg. 1999 Aug;89(2):529-30 [10439780.001]
  • [Cites] Anesthesiology. 1992 Jul;77(1):207-9 [1609996.001]
  • [Cites] Anaesthesist. 2004 Jun;53(6):581-92; quiz 593-4 [15241526.001]
  • [Cites] Anesthesiology. 2000 Feb;92(2):597-602 [10691248.001]
  • [Cites] Anaesthesia. 1998 Mar;53(3):308 [9613280.001]
  • [Cites] Anaesthesia. 1999 Aug;54(8):745-52 [10460526.001]
  • [Cites] Br J Anaesth. 1993 Dec;71(6):782-7 [8280538.001]
  • [Cites] Anaesthesia. 1990 Feb;45(2):153-5 [2321720.001]
  • [Cites] Lancet. 2004 May 29;363(9423):1757-63 [15172773.001]
  • [Cites] Masui. 2001 Aug;50(8):886-9 [11554023.001]
  • [Cites] Trends Neurosci. 1998 Jul;21(7):294-9 [9683321.001]
  • [Cites] Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Feb;38(2):75-84 [12557119.001]
  • [Cites] Anaesthesia. 1998 Apr;53 Suppl 1:61-7 [9640119.001]
  • [Cites] Anesthesiology. 2001 Feb;94(2):322-32 [11176098.001]
  • [Cites] Lancet. 2000 Feb 26;355(9205):707-11 [10703802.001]
  • (PMID = 15999266.001).
  • [ISSN] 0003-2417
  • [Journal-full-title] Der Anaesthesist
  • [ISO-abbreviation] Anaesthesist
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anesthetics, Intravenous; 0 / Piperidines; P10582JYYK / remifentanil; YI7VU623SF / Propofol
  •  go-up   go-down


11. Chatelain D, Mokrani N, Fléjou JF: [Anal and anal margin tumors]. Ann Pathol; 2007 Dec;27(6):459-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Anal and anal margin tumors].
  • Tumors of the anal canal and anal margin are rare.
  • [MeSH-major] Anus Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. Endocrine Gland Neoplasms / epidemiology. Endocrine Gland Neoplasms / pathology. France / epidemiology. Humans. Incidence. Leiomyosarcoma / pathology. Lymphoma / pathology. Melanoma / epidemiology. Melanoma / pathology. Papilloma / pathology. Sarcoma, Kaposi / pathology

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18554556.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 110
  •  go-up   go-down


12. Ribeiro da Rocha JJ, Féres O: A new proctoscope for transanal endoscopic operations. Tech Coloproctol; 2008 Sep;12(3):241-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The end inserted into the anus has a bevelled aspect and rounded borders, allowing correct exposure of the anal lesion.
  • The rectoscope is fixed to the anal border with surgical thread through perforations in the external end.
  • Part of the equipment is a guide which is positioned inside the rectoscope on insertion into the anus.
  • [MeSH-major] Adenocarcinoma / surgery. Adenoma / surgery. Proctoscopes. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Colorectal Cancer. 2005 Nov;5(4):268-73 [16356304.001]
  • [Cites] Br J Surg. 1996 Feb;83(2):207-10 [8689164.001]
  • [Cites] Anticancer Res. 2004 Mar-Apr;24(2C):1167-72 [15154642.001]
  • [Cites] Surg Laparosc Endosc. 1998 Apr;8(2):117-9 [9566564.001]
  • [Cites] Isr Med Assoc J. 2005 Jul;7(7):435-8 [16011058.001]
  • [Cites] Chirurg. 1996 Feb;67(2):121-8 [8881207.001]
  • [Cites] Endoscopy. 1987 Nov;19 Suppl 1:38-42 [3428240.001]
  • [Cites] World J Surg. 2001 Jul;25(7):870-5 [11572026.001]
  • [Cites] Eur J Cancer. 1995 Jul-Aug;31A(7-8):1233-7 [7577029.001]
  • [Cites] Surg Oncol Clin N Am. 1996 Jul;5(3):723-34 [8829329.001]
  • [Cites] Surg Endosc. 2003 Aug;17(8):1283-7 [12739119.001]
  • [Cites] Praxis (Bern 1994). 1998 Aug 12;87(33):1014-8 [9747130.001]
  • [Cites] Recent Results Cancer Res. 2005;165:120-35 [15865027.001]
  • [Cites] Surg Endosc. 2003 Sep;17(9):1461-3 [12739115.001]
  • [Cites] Proc R Soc Med. 1970;63 Suppl:91-4 [4947872.001]
  • [Cites] Colorectal Dis. 2000 Jan;2(1):13-7 [23577928.001]
  • [Cites] Colorectal Dis. 2005 Mar;7(2):133-7 [15720349.001]
  • [Cites] Surg Oncol Clin N Am. 2001 Jul;10(3):709-31, xi [11685937.001]
  • [Cites] Dig Surg. 2005;22(3):182-9; discussion 189-90 [16137996.001]
  • [Cites] J Surg Oncol. 2000 Jun;74(2):158-62 [10914828.001]
  • [Cites] ANZ J Surg. 2002 Dec;72(12):854-6 [12485218.001]
  • [Cites] Surg Endosc. 1996 Jul;10(7):736-41 [8662430.001]
  • [Cites] World J Surg. 2003 Feb;27(2):197-202 [12616436.001]
  • [Cites] Surg Endosc. 1998 Feb;12(2):151-3 [9479731.001]
  • [Cites] Surg Endosc. 1988;2(4):245-50 [3071872.001]
  • [Cites] Surg Endosc. 1999 Jul;13(7):710-2 [10384080.001]
  • [Cites] Chirurg. 1996 Feb;67(2):139-44 [8881210.001]
  • [Cites] Semin Surg Oncol. 2000 Dec;19(4):367-75 [11241919.001]
  • [Cites] Colorectal Dis. 2004 Sep;6(5):350-5 [15335369.001]
  • [Cites] Colorectal Dis. 2002 Nov;4(6):467-72 [12790922.001]
  • [Cites] Dis Colon Rectum. 1986 Jun;29(6):374-7 [3709314.001]
  • [Cites] Hong Kong Med J. 2004 Aug;10(4):239-43 [15299168.001]
  • [Cites] Am J Surg. 1997 May;173(5):383-5 [9168071.001]
  • [Cites] Schweiz Med Wochenschr. 1994 Oct 15;124(41):1800-6 [7973506.001]
  • [Cites] Br J Surg. 2002 Jun;89(6):769-74 [12027989.001]
  • [Cites] Colorectal Dis. 2000 Apr;2(2):73-6 [23577988.001]
  • [Cites] Semin Laparosc Surg. 2004 Mar;11(1):45-51 [15094978.001]
  • [Cites] Dis Colon Rectum. 1995 Nov;38(11):1193-9 [7587763.001]
  • [Cites] Surg Endosc. 1988;2(1):24-7 [3175831.001]
  • [Cites] Colorectal Dis. 2003 Mar;5(2):159-63 [12780906.001]
  • [Cites] Dig Surg. 2005;22(1-2):6-15 [15761225.001]
  • [Cites] CA Cancer J Clin. 1997 Mar-Apr;47(2):113-28 [9074489.001]
  • (PMID = 18679568.001).
  • [ISSN] 1123-6337
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


13. Egawa T, Nagashima A, Kitano M, Doi M, Hayashi S, Sekine K, Ito Y, Shimizu M, Yoshii H: [An elderly patient with recurrent rectal cancer successfully responded to S-1 combined with CPT-11]. Gan To Kagaku Ryoho; 2007 Nov;34(12):2053-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An 80-year-old female visited our hospital with a chief complaint of anal pain and bleeding.
  • The pathological findings were poorly differentiated adenocarcinoma with pMP and pN2.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18219896.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; 7673326042 / irinotecan; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


1
Advertisement
4. Billis A, Meirelles L, Freitas LL: Mergence of partial and complete atrophy in prostate needle biopsies: a morphologic and immunohistochemical study. Virchows Arch; 2010 Jun;456(6):689-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Partial atrophy is the most common benign lesion that causes difficulty in the differential diagnosis with adenocarcinoma of the prostate.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lab Invest. 1986 Apr;54(4):442-56 [2421104.001]
  • [Cites] Mod Pathol. 1998 Jan;11(1):47-54 [9556422.001]
  • [Cites] Am J Surg Pathol. 2005 Jul;29(7):874-80 [15958851.001]
  • [Cites] Am J Surg Pathol. 2008 Jan;32(1):58-64 [18162771.001]
  • [Cites] Am J Surg Pathol. 1995 Sep;19(9):1068-76 [7544958.001]
  • [Cites] Blood. 1990 Aug 15;76(4):655-63 [2200535.001]
  • [Cites] Anal Quant Cytol Histol. 2009 Dec;31(6):424-31 [20698359.001]
  • [Cites] Am J Surg Pathol. 1998 Sep;22(9):1073-7 [9737239.001]
  • [Cites] Am J Pathol. 2003 May;162(5):1529-37 [12707036.001]
  • [Cites] Am J Surg Pathol. 2008 Jun;32(6):851-7 [18408595.001]
  • [Cites] Urology. 2005 Apr;65(4):745-9 [15833520.001]
  • [Cites] Am J Pathol. 1999 Dec;155(6):1985-92 [10595928.001]
  • [Cites] Am J Surg Pathol. 1998 Apr;22(4):440-5 [9537471.001]
  • [Cites] Eur Urol. 2007 Jan;51(1):98-103; discussion 103-4 [16824675.001]
  • (PMID = 20361207.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. Tajiri M, Kameda Y, Nakayama H, Sakamoto K: Prognosis and morphometrical features of non-bronchioloalveolar cell adenocarcinoma: an assessment of the non-alveolar replacing area and high grade atypical area. J Clin Pathol; 2006 Mar;59(3):269-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognosis and morphometrical features of non-bronchioloalveolar cell adenocarcinoma: an assessment of the non-alveolar replacing area and high grade atypical area.
  • AIM: It has become obvious that the prognosis of bronchioloalveolar cell carcinoma (BAC) in small peripheral adenocarcinoma of the lung is good, but most cases actually treated as pulmonary adenocarcinoma in hospitals tend to be non-bronchioloalveolar cell carcinoma (non-BAC).
  • [MeSH-major] Adenocarcinoma / pathology. Bronchial Neoplasms / pathology. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Adenocarcinoma, Bronchiolo-Alveolar / pathology. Aged. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Proportional Hazards Models. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Thorac Surg. 1999 Dec;68(6):2069-73 [10616979.001]
  • [Cites] Ann Thorac Surg. 2000 Mar;69(3):893-7 [10750779.001]
  • [Cites] Lung Cancer. 2000 Sep;29(3):179-88 [10996420.001]
  • [Cites] Cancer Res. 2001 Nov 1;61(21):7950-4 [11691817.001]
  • [Cites] Am J Surg Pathol. 2003 Jul;27(7):937-51 [12826886.001]
  • [Cites] Am J Clin Pathol. 1999 May;111(5):610-22 [10230351.001]
  • [Cites] Anal Quant Cytol. 1982 Sep;4(3):225-32 [7149488.001]
  • [Cites] Mod Pathol. 1990 May;3(3):314-20 [2362938.001]
  • [Cites] Am J Surg Pathol. 1990 Oct;14(10):904-12 [2403196.001]
  • [Cites] Cancer. 1995 Jun 15;75(12):2844-52 [7773933.001]
  • [Cites] Am J Surg Pathol. 1996 May;20(5):553-62 [8619420.001]
  • [Cites] Am J Surg Pathol. 2004 Feb;28(2):198-206 [15043309.001]
  • (PMID = 16505277.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1860342
  •  go-up   go-down


16. Shinoda M, Hatano S, Kawakubo H, Kakefuda T, Omori T, Ishii S: Adult cecoanal intussusception caused by cecum cancer: report of a case. Surg Today; 2007;37(9):802-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The patient presented to our hospital with a mass protruding from the anus.
  • The pathological finding was submucosal adenocarcinoma in adenoma.
  • [MeSH-major] Anal Canal / pathology. Cecal Neoplasms / complications. Cecum / pathology. Intussusception / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 1988 Aug;31(8):629-31 [3402288.001]
  • [Cites] Anticancer Res. 2000 Nov-Dec;20(6C):4697-700 [11205203.001]
  • [Cites] Am J Surg. 1997 Feb;173(2):88-94 [9074370.001]
  • [Cites] Ann Surg. 1970 Aug;172(2):306-10 [5433296.001]
  • [Cites] Hepatogastroenterology. 2004 Jul-Aug;51(58):998-1000 [15239233.001]
  • [Cites] World J Gastroenterol. 2006 Jan 7;12(1):146-9 [16440436.001]
  • [Cites] Ann Surg. 1997 Aug;226(2):134-8 [9296505.001]
  • [Cites] Dis Colon Rectum. 2002 Feb;45(2):200-6 [11852333.001]
  • [Cites] Am J Surg. 1976 Jun;131(6):758-61 [937658.001]
  • (PMID = 17713738.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


17. Iguchi T, Sugita S, Wang CY, Newman NB, Nakatani T, Haas GP: MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status. In Vivo; 2009 Jan-Feb;23(1):7-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status.
  • BACKGROUND: Cigarette smoke contains carcinogenic aromatic and heterocyclic amines that are metabolized by N-acetyltransferase (NAT).
  • These carcinogens also produce reactive oxygen species that are metabolized by manganese superoxide dismutase (MnSOD).
  • The association between prostate cancer (PCA) and the polymorphism of MnSOD and NAT, and cigarette smoking was investigated.
  • PATIENTS AND METHODS: DNA samples from 187 PCA patients and 175 age-matched controls were genotyped for MnSOD, NAT1 and NAT2 by PCR restriction fragment length polymorphism analysis and DNA sequencing.
  • RESULTS: MnSOD AA genotype, as compared to MnSOD VV and VA, was associated with PCA (odds ratio, 1.65; 95% confidence interval, 1.03-2.66.
  • There was no association of PCA with NAT or smoking.
  • Results of exploratory analyses of the data suggest that the association of PCA and MnSOD exists only in the subpopulation of rapid NAT1 genotypes and smokers.
  • CONCLUSION: The present study demonstrates the association of PCA and MnSOD.
  • Oxidative stress and cigarette smoking may play an important role in the carcinogenesis of the prostate in those who have MnSOD AA and rapid NAT1 genotypes.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1115-20 [17548672.001]
  • [Cites] J Natl Cancer Inst. 1999 Dec 1;91(23):2038-44 [10580030.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42 [10667461.001]
  • [Cites] Carcinogenesis. 2000 Mar;21(3):361-70 [10688856.001]
  • [Cites] N Engl J Med. 2000 Jul 13;343(2):78-85 [10891514.001]
  • [Cites] Carcinogenesis. 2001 May;22(5):827-9 [11323405.001]
  • [Cites] Toxicology. 2002 Nov 15;180(2):121-37 [12324189.001]
  • [Cites] Environ Mol Mutagen. 2002;40(3):161-7 [12355549.001]
  • [Cites] Nature. 2002 Dec 19-26;420(6917):860-7 [12490959.001]
  • [Cites] Pharmacogenetics. 2003 Mar;13(3):145-57 [12618592.001]
  • [Cites] Int J Urol. 2003 Mar;10(3):167-73 [12622714.001]
  • [Cites] FASEB J. 2003 Jul;17(10):1195-214 [12832285.001]
  • [Cites] Cancer Causes Control. 2003 Aug;14(6):513-8 [12948282.001]
  • [Cites] Curr Med Chem. 2003 Dec;10(23):2495-505 [14529465.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):989-96 [15184255.001]
  • [Cites] Urology. 2008 Aug;72(2):238-41; discussion 241-2 [18571701.001]
  • [Cites] Anticancer Res. 2008 Sep-Oct;28(5B):3007-10 [19031947.001]
  • [Cites] Biochim Biophys Acta. 1995 May 24;1271(1):67-74 [7599228.001]
  • [Cites] J Biol Chem. 1985 Aug 25;260(18):10099-104 [2991275.001]
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • [Cites] Chem Biol Interact. 2006 Mar 10;160(1):1-40 [16430879.001]
  • [Cites] DNA Repair (Amst). 2006 Feb 3;5(2):145-52 [15878696.001]
  • [Cites] J Biochem. 1990 Jul;108(1):9-16 [2229015.001]
  • [Cites] Annu Rev Biochem. 1995;64:97-112 [7574505.001]
  • [Cites] Biochem Biophys Res Commun. 1996 Sep 13;226(2):561-5 [8806673.001]
  • [Cites] Mutat Res. 1997 May 12;376(1-2):61-70 [9202739.001]
  • [Cites] CA Cancer J Clin. 1997 Sep-Oct;47(5):273-87 [9314822.001]
  • [Cites] Anal Biochem. 1997 Nov 15;253(2):219-24 [9367506.001]
  • [Cites] Cancer Lett. 1999 Feb 8;136(1):83-7 [10211944.001]
  • [Cites] Carcinogenesis. 1999 Aug;20(8):1591-5 [10426812.001]
  • [Cites] Pharmacogenetics. 1999 Jun;9(3):333-40 [10471065.001]
  • [Cites] Cancer Res. 2005 Feb 1;65(3):1105-11 [15705913.001]
  • [Cites] Cancer Res. 2005 Mar 15;65(6):2498-504 [15781667.001]
  • [Cites] Carcinogenesis. 2005 Jul;26(7):1170-81 [15498784.001]
  • [Cites] Prostate. 2005 Aug 1;64(3):246-52 [15717312.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2005 Nov 11;54(44):1124-7 [16280970.001]
  • (PMID = 19368118.001).
  • [ISSN] 0258-851X
  • [Journal-full-title] In vivo (Athens, Greece)
  • [ISO-abbreviation] In Vivo
  • [Language] ENG
  • [Grant] United States / NIA NIH HHS / AG / R01 AG021389-03; United States / NCI NIH HHS / CA / CA097751-01; United States / NCI NIH HHS / CA / CA097751; United States / NIA NIH HHS / AG / R01 AG021389; United States / NCI NIH HHS / CA / R03 CA097751-01; United States / NIA NIH HHS / AG / AG021389-03; United States / NIA NIH HHS / AG / AG021389
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Isoenzymes; EC 1.15.1.1 / Superoxide Dismutase; EC 2.3.1.5 / Arylamine N-Acetyltransferase; EC 2.3.1.5 / N-acetyltransferase 1; EC 2.3.1.5 / NAT2 protein, human
  • [Other-IDs] NLM/ NIHMS96809; NLM/ PMC2670457
  •  go-up   go-down


18. Izawa M, Inoue M, Osaki M, Ito H, Harada T, Terakawa N, Ikeguchi M: Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer. Gastric Cancer; 2008;11(2):103-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / genetics. Aromatase / genetics. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. ESTRADIOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1994 Mar 15;54(6):1580-6 [7511047.001]
  • [Cites] Endocr Relat Cancer. 1999 Jun;6(2):315-24 [10731125.001]
  • [Cites] Jpn J Exp Med. 1978 Feb;48(1):61-8 [209229.001]
  • [Cites] Cancer. 1986 Apr 1;57(7):1376-9 [3948119.001]
  • [Cites] N Engl J Med. 1991 Jan 31;324(5):317-22 [1986290.001]
  • [Cites] J Clin Endocrinol Metab. 1981 Aug;53(2):412-7 [7251819.001]
  • [Cites] Cancer Res. 1991 Jan 1;51(1):381-6 [1846312.001]
  • [Cites] Breast Cancer Res. 2007;9(3):R37 [17555561.001]
  • [Cites] Endocrinology. 2002 Aug;143(8):3162-70 [12130582.001]
  • [Cites] Apoptosis. 1999 Oct;4(5):321-5 [14634335.001]
  • [Cites] Fertil Steril. 2008 May;89(5 Suppl):1390-6 [17662285.001]
  • [Cites] Eur J Surg Oncol. 2007 Mar;33(2):195-201 [17046193.001]
  • [Cites] J Endocrinol. 2002 Jan;172(1):21-30 [11786371.001]
  • [Cites] World J Gastroenterol. 2003 Apr;9(4):665-9 [12679906.001]
  • [Cites] Pathol Res Pract. 1992 Feb;188(1-2):53-60 [1594500.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Dec;85(12):4889-99 [11134158.001]
  • [Cites] Biol Reprod. 1996 Feb;54(2):287-93 [8788178.001]
  • [Cites] J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):81-96 [17590327.001]
  • [Cites] Circ Res. 1999 Jun 11;84(11):1285-91 [10364566.001]
  • [Cites] Brain Res Brain Res Rev. 1996 Jun;22(1):1-26 [8871783.001]
  • [Cites] Cell. 2001 Mar 9;104(5):719-30 [11257226.001]
  • [Cites] J Cancer Res Clin Oncol. 2002 Jun;128(6):319-24 [12073050.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Apoptosis. 2001 Oct;6(5):353-8 [11483859.001]
  • (PMID = 18595017.001).
  • [ISSN] 1436-3291
  • [Journal-full-title] Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
  • [ISO-abbreviation] Gastric Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / RNA, Messenger; 4TI98Z838E / Estradiol; EC 1.14.14.1 / Aromatase
  •  go-up   go-down


19. Redlak MJ, Power JJ, Miller TA: Aspirin-induced apoptosis in human gastric cancer epithelial cells: relationship with protein kinase C signaling. Dig Dis Sci; 2007 Mar;52(3):810-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / physiopathology. Signal Transduction / physiology. Stomach Neoplasms / physiopathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. ACETYLSALICYLIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FASEB J. 1998 Jan;12(1):35-42 [9438408.001]
  • [Cites] N Engl J Med. 1992 Sep 10;327(11):749-54 [1501650.001]
  • [Cites] Mol Pathol. 1997 Jun;50(3):124-31 [9292146.001]
  • [Cites] Cell Death Differ. 2002 Jan;9(1):40-52 [11803373.001]
  • [Cites] J Exp Med. 1996 Dec 1;184(6):2399-404 [8976194.001]
  • [Cites] J Chronic Dis. 1978;31(11):691-6 [730824.001]
  • [Cites] N Engl J Med. 1990 May 3;322(18):1277-89 [2271017.001]
  • [Cites] J Cell Sci. 1992 Dec;103 ( Pt 4):881-7 [1487501.001]
  • [Cites] Biochemistry. 1984 Oct 9;23 (21):5036-41 [6238627.001]
  • [Cites] J Biol Chem. 1997 Aug 15;272(33):20317-20 [9252332.001]
  • [Cites] Biochem Biophys Res Commun. 1990 Nov 15;172(3):993-9 [2244923.001]
  • [Cites] N Engl J Med. 1967 Jun 8;276(23):1307-12 [6024894.001]
  • [Cites] EMBO J. 1995 Dec 15;14(24):6148-56 [8557034.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G731-8 [15976387.001]
  • [Cites] J Biol Chem. 1991 Aug 25;266(24):15771-81 [1874734.001]
  • [Cites] Dig Dis Sci. 2004 Sep;49(9):1518-25 [15481331.001]
  • [Cites] Biochem Biophys Res Commun. 1991 Apr 15;176(1):288-93 [1708246.001]
  • [Cites] Gastroenterology. 2000 Mar;118(3):507-14 [10702201.001]
  • [Cites] Med Clin North Am. 1995 Mar;79(2):231-46 [7877388.001]
  • [Cites] Semin Arthritis Rheum. 2000 Dec;30(3):167-79 [11124281.001]
  • [Cites] J Physiol Pharmacol. 2000 Mar;51(1):3-15 [10768847.001]
  • [Cites] Gastroenterology. 2000 Aug;119(2):521-35 [10930388.001]
  • [Cites] Proc Soc Exp Biol Med. 2000 Jun;224(2):102-8 [10806417.001]
  • [Cites] Eur J Biochem. 1997 Nov 15;250(1):7-18 [9431985.001]
  • [Cites] Sci Am. 1972 Jan;226(1):87-93 [4550480.001]
  • [Cites] J Natl Cancer Inst. 1993 Feb 17;85(4):307-11 [8426374.001]
  • [Cites] Dig Dis Sci. 2006 May;51(5):834-43 [16773430.001]
  • [Cites] N Engl J Med. 1999 Jun 17;340(24):1888-99 [10369853.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Oct;281(4):G1092-100 [11557530.001]
  • [Cites] J Biol Chem. 1999 Apr 16;274(16):10765-70 [10196149.001]
  • [Cites] Br J Cancer. 1999 Feb;79(3-4):393-400 [10027304.001]
  • [Cites] Eur J Pharmacol. 1998 Nov 6;360(2-3):273-80 [9851595.001]
  • [Cites] Arch Toxicol. 1991;65(6):437-44 [1929863.001]
  • (PMID = 17253132.001).
  • [ISSN] 0163-2116
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / DK25838
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; EC 2.7.11.13 / Protein Kinase C; EC 3.4.22.- / Caspases; R16CO5Y76E / Aspirin
  •  go-up   go-down


20. Pickard MR, Green AR, Ellis IO, Caldas C, Hedge VL, Mourtada-Maarabouni M, Williams GT: Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer. Breast Cancer Res; 2009;11(4):R60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.
  • INTRODUCTION: Programmed cell death through apoptosis plays an essential role in the hormone-regulated physiological turnover of mammary tissue.
  • Failure of this active gene-dependent process is central both to the development of breast cancer and to the appearance of the therapy-resistant cancer cells that produce clinical relapse.
  • Functional expression cloning in two independent laboratories has identified Finkel-Biskis-Reilly murine sarcoma virus-associated ubiquitously expressed gene (Fau) as a novel apoptosis regulator and candidate tumour suppressor.
  • Fau modifies apoptosis-controller Bcl-G, which is also a key target for candidate oncoprotein maternal embryonic leucine zipper kinase (MELK).
  • METHODS: We have used RNA interference to downregulate Fau and Bcl-G expression, both simultaneously and independently, in breast cancer cells in vitro to determine the importance of their roles in apoptosis.
  • Expression of Fau, Bcl-G and MELK was measured by quantitative RT-PCR in breast cancer tissue and in matched breast epithelial tissue from the same patients.
  • Expression data of these genes obtained using microarrays from a separate group of patients were related to patient survival in Kaplan-Meier analyses.
  • RESULTS: siRNA-mediated downregulation of either Fau or Bcl-G expression inhibited apoptosis, and the inhibition produced by combining the two siRNAs was consistent with control of Bcl-G by Fau.
  • Fau expression is significantly reduced in breast cancer tissue and this reduction is associated with poor patient survival, as predicted for a candidate breast cancer tumour suppressor.
  • In addition, MELK expression is increased in breast cancer tissue and this increase is also associated with poor patient survival, as predicted for a candidate oncogene.
  • Bcl-G expression is reduced in breast cancer tissue but decreased Bcl-G expression showed no correlation with survival, indicating that the most important factors controlling Bcl-G activity are post-translational modification (by Fau and MELK) rather than the rate of transcription of Bcl-G itself.
  • CONCLUSIONS: The combination of in vitro functional studies with the analysis of gene expression in clinical breast cancer samples indicates that three functionally interconnected genes, Fau, Bcl-G and MELK, are crucially important in breast cancer and identifies them as attractive targets for improvements in breast cancer risk prediction, prognosis and therapy.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • SciCrunch. ArrayExpress: Data: Microarray .
  • The Lens. Cited by Patents in .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1754-9 [10677530.001]
  • [Cites] Carcinogenesis. 1999 Feb;20(2):311-6 [10069470.001]
  • [Cites] J Biol Chem. 2000 Dec 15;275(50):38953-6 [11038347.001]
  • [Cites] J Biol Chem. 2001 Jan 26;276(4):2780-5 [11054413.001]
  • [Cites] Cell Death Differ. 2003 Sep;10(9):1016-24 [12934076.001]
  • [Cites] Eur J Biochem. 2003 Oct;270(20):4052-8 [14519116.001]
  • [Cites] Oncogene. 2003 Nov 24;22(53):8590-607 [14634621.001]
  • [Cites] Breast Cancer Res. 2004;6(5):R499-513 [15318932.001]
  • [Cites] Biochemistry. 1979 Nov 27;18(24):5294-9 [518835.001]
  • [Cites] Cell. 1991 Jun 28;65(7):1097-8 [1648446.001]
  • [Cites] Anal Biochem. 1992 Jun;203(2):352-6 [1384388.001]
  • [Cites] J Natl Cancer Inst. 1993 Sep 1;85(17):1412-8 [8350365.001]
  • [Cites] Oncogene. 1993 Sep;8(9):2537-46 [8395683.001]
  • [Cites] J Cell Sci. 1999 Jun;112 ( Pt 11):1771-83 [10318769.001]
  • [Cites] Oncogene. 2004 Dec 16;23(58):9419-26 [15543234.001]
  • [Cites] J Natl Cancer Inst. 2005 May 4;97(9):643-55 [15870435.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1727-41 [15894099.001]
  • [Cites] Cancer Res. 2005 Nov 1;65(21):9751-61 [16266996.001]
  • [Cites] J Clin Oncol. 2006 Jan 1;24(1):16-24 [16330672.001]
  • [Cites] Nat Rev Cancer. 2006 Oct;6(10):776-88 [16990855.001]
  • [Cites] Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S15-24 [17259554.001]
  • [Cites] Oncogene. 2007 Feb 26;26(9):1324-37 [17322918.001]
  • [Cites] Oncogene. 2007 Mar 1;26(10):1507-16 [16936776.001]
  • [Cites] Breast Cancer Res. 2007;9(1):R17 [17280616.001]
  • [Cites] Oncogene. 2007 May 28;26(25):3637-43 [17530017.001]
  • [Cites] Nat Rev Cancer. 2008 Feb;8(2):121-32 [18202696.001]
  • [Cites] J Cell Sci. 2008 Apr 1;121(Pt 7):939-46 [18354083.001]
  • [Cites] N Engl J Med. 2008 Jun 26;358(26):2796-803 [18579814.001]
  • [Cites] Oncogene. 2009 Jan 15;28(2):195-208 [18836484.001]
  • [Cites] Nat Med. 1996 Jul;2(7):811-4 [8673929.001]
  • [Cites] Nature. 1997 Nov 13;390(6656):180-4 [9367156.001]
  • [Cites] Oncogene. 2000 Aug 3;19(33):3774-81 [10949932.001]
  • (PMID = 19671159.001).
  • [ISSN] 1465-542X
  • [Journal-full-title] Breast cancer research : BCR
  • [ISO-abbreviation] Breast Cancer Res.
  • [Language] ENG
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / ; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / BCL2L14 protein, human; 0 / Neoplasm Proteins; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / RNA, Small Interfering; 0 / Ribosomal Proteins; 148266-62-0 / FAU protein, human; EC 2.7.1.- / MELK protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  • [Other-IDs] NLM/ PMC2750122
  •  go-up   go-down


21. Mansilla F, da Costa KA, Wang S, Kruhøffer M, Lewin TM, Orntoft TF, Coleman RA, Birkenkamp-Demtröder K: Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl); 2009 Jan;87(1):85-97
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] 1-Acylglycerophosphocholine O-Acyltransferase / biosynthesis. Adenocarcinoma / metabolism. Colorectal Neoplasms / metabolism. Gene Expression Regulation, Enzymologic. Gene Expression Regulation, Neoplastic. Neoplasm Proteins / biosynthesis

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • Genetic Alliance. consumer health - Colorectal cancer 1.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CHOLINE CHLORIDE .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2007 Jun 18;96(12):1896-903 [17519897.001]
  • [Cites] J Endocrinol. 2007 Jun;193(3):445-57 [17535882.001]
  • [Cites] J Cancer Res Ther. 2005 Jul-Sep;1(3):180-6 [17998650.001]
  • [Cites] Cell Mol Biol Lett. 2001;6(2A):255-63 [11598644.001]
  • [Cites] J Biol Chem. 2001 Nov 16;276(46):43182-8 [11557771.001]
  • [Cites] Cancer Res. 2002 Aug 1;62(15):4352-63 [12154040.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Aug 23;296(3):580-3 [12176020.001]
  • [Cites] Anal Chem. 2002 Sep 15;74(18):4734-40 [12349977.001]
  • [Cites] J Cell Biochem. 2003 Oct 15;90(3):525-33 [14523987.001]
  • [Cites] EMBO Rep. 2003 Oct;4(10):948-52 [14528265.001]
  • [Cites] Biochem Cell Biol. 2004 Feb;82(1):113-28 [15052332.001]
  • [Cites] Cancer Res. 2004 Jun 15;64(12):4270-6 [15205341.001]
  • [Cites] Annu Rev Cell Biol. 1988;4:579-610 [3058167.001]
  • [Cites] J Biol Chem. 1994 Feb 25;269(8):5742-9 [8119913.001]
  • [Cites] Mol Cell Biochem. 1996 Sep 20;162(2):97-103 [8905631.001]
  • [Cites] J Biol Chem. 1998 May 29;273(22):14022-9 [9593753.001]
  • [Cites] Cancer Res. 1999 Jan 1;59(1):80-4 [9892190.001]
  • [Cites] J Biol Chem. 1999 Apr 2;274(14):9400-8 [10092620.001]
  • [Cites] Biochemistry. 1999 May 4;38(18):5764-71 [10231527.001]
  • [Cites] Jpn J Cancer Res. 1999 Apr;90(4):419-24 [10363580.001]
  • [Cites] Can J Biochem Physiol. 1959 Aug;37(8):911-7 [13671378.001]
  • [Cites] Gut. 2005 Mar;54(3):374-84 [15710986.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):534-44 [15671042.001]
  • [Cites] Br J Cancer. 2005 Jun 20;92(12):2240-8 [15956967.001]
  • [Cites] Mol Cell Biochem. 2005 Aug;276(1-2):113-9 [16132692.001]
  • [Cites] J Biol Chem. 2006 Jul 21;281(29):20140-7 [16704971.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11724-9 [16864775.001]
  • [Cites] Neoplasia. 2006 Sep;8(9):758-71 [16984733.001]
  • [Cites] Arch Biochem Biophys. 2007 Mar 1;459(1):98-106 [17222386.001]
  • (PMID = 18974965.001).
  • [ISSN] 0946-2716
  • [Journal-full-title] Journal of molecular medicine (Berlin, Germany)
  • [ISO-abbreviation] J. Mol. Med.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK056350-08; United States / NIDDK NIH HHS / DK / DK59935; United States / NIDDK NIH HHS / DK / R01 DK059935-07; United States / NIDDK NIH HHS / DK / P30 DK056350-050001; United States / NIDDK NIH HHS / DK / R01 DK056598; United States / NHLBI NIH HHS / HL / HL081554; United States / NIDDK NIH HHS / DK / P30-DK56350; United States / NHLBI NIH HHS / HL / R21 HL081554-02; United States / NIDDK NIH HHS / DK / P30 DK056350; United States / NIDDK NIH HHS / DK / R01 DK059935; United States / NIDDK NIH HHS / DK / R01 DK056598-25; United States / NIDDK NIH HHS / DK / R01 DK056598-23; United States / NIDDK NIH HHS / DK / DK56598
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Neoplasm Proteins; EC 2.3.1.23 / 1-Acylglycerophosphocholine O-Acyltransferase; EC 2.3.1.23 / Lpcat1 protein, human; N91BDP6H0X / Choline
  • [Other-IDs] NLM/ NIHMS83533; NLM/ PMC2614561
  •  go-up   go-down


22. Li LR, Wan DS, Pan ZZ, Zhou ZW, Chen G, Wu XJ, Lu ZH, Ding PR: [Clinical features and treatment of 49 patients with anal canal adenocarcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep;9(5):402-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical features and treatment of 49 patients with anal canal adenocarcinoma].
  • OBJECTIVE: To investigate the clinical features and treatment of anal canal adenocarcinoma.
  • METHODS: Clinical data of 49 patients with anal canal adenocarcinoma treated in our hospital from January 1965 to March 2002 were analyzed retrospectively.
  • Anal bleeding, tapering stool and anal lump were the most common symptoms.
  • CONCLUSIONS: Anal canal adenocarcinoma is a rare and fatal malignancy.
  • [MeSH-major] Adenocarcinoma / therapy. Anus Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anal Canal / pathology. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Survival Rate. Young Adult

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17043960.001).
  • [ISSN] 1671-0274
  • [Journal-full-title] Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • [ISO-abbreviation] Zhonghua Wei Chang Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


23. Gao Y, Xiao Q, Ma H, Li L, Liu J, Feng Y, Fang Z, Wu J, Han X, Zhang J, Sun Y, Wu G, Padera R, Chen H, Wong KK, Ge G, Ji H: LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci U S A; 2010 Nov 2;107(44):18892-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / enzymology. Extracellular Matrix / metabolism. Extracellular Matrix Proteins / metabolism. Lung Neoplasms / enzymology. Lung Neoplasms / metabolism. Protein-Lysine 6-Oxidase / metabolism. Protein-Serine-Threonine Kinases / metabolism


24. Galamb O, Sipos F, Dinya E, Spisak S, Tulassay Z, Molnar B: mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray. World J Gastroenterol; 2006 Nov 21;12(43):6998-7006
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / genetics. Adenocarcinoma / metabolism. Aged. Aged, 80 and over. Analysis of Variance. Biopsy. Cluster Analysis. Colorectal Neoplasms / diagnosis. Colorectal Neoplasms / genetics. Colorectal Neoplasms / metabolism. DNA / genetics. DNA, Neoplasm / genetics. Female. Genetic Markers. Humans. Male. Middle Aged. Multivariate Analysis. Reproducibility of Results


25. Lee SH, Ahn BK, Chang HK, Baek SU: Adenocarcinoma in ileal pouch after proctocolectomy for familial adenomatous polyposis: report of a case. J Korean Med Sci; 2009 Oct;24(5):985-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma in ileal pouch after proctocolectomy for familial adenomatous polyposis: report of a case.
  • Restorative proctocolectomy with ileal pouch-anal anastomosis is one of the surgical treatments of choice for patients with familial adenomatous polyposis.
  • Although the risk of cancer developing in an ileal pouch is not yet clear, a few cases of adenocarcinoma arising in an ileal pouch have been reported.
  • We report a case of adenocarcinoma in ileal pouch after proctocolectomy with ileal pouch-anal anastomosis.
  • Six years later, she underwent completion-proctectomy with ileal J pouch-anal anastomosis including anorectal mucosectomy for rectal cancer.
  • After 7 yr, she presented with anal spotting.
  • Endoscopic biopsies revealed adenocarcinoma at the ileal pouch.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenomatous Polyposis Coli / surgery. Colonic Pouches / pathology. Colorectal Neoplasms / diagnosis. Proctocolectomy, Restorative

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • Genetic Alliance. consumer health - Familial Polyposis.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gut. 2000 Nov;47(5):732-4 [11034594.001]
  • [Cites] Med Princ Pract. 2006;15(1):83-6 [16340235.001]
  • [Cites] Dis Colon Rectum. 2001 Apr;44(4):487-99 [11330575.001]
  • [Cites] Gastroenterology. 2001 Aug;121(2):275-81 [11487537.001]
  • [Cites] Dis Colon Rectum. 2001 Nov;44(11):1714-5 [11711749.001]
  • [Cites] Int J Colorectal Dis. 2002 Mar;17(2):92-7 [12014427.001]
  • [Cites] Dis Colon Rectum. 2003 Jan;46(1):6-13 [12544515.001]
  • [Cites] Dis Colon Rectum. 2003 Feb;46(2):156-9 [12576887.001]
  • [Cites] Dis Colon Rectum. 2003 Oct;46(10):1418-23; discussion 1422-3 [14530685.001]
  • [Cites] Colorectal Dis. 2003 Nov;5(6):592-4 [14617250.001]
  • [Cites] Dis Colon Rectum. 2004 Apr;47(4):530-4 [14978621.001]
  • [Cites] Dis Colon Rectum. 1983 Dec;26(12):768-71 [6641457.001]
  • [Cites] Ann Surg. 1989 Sep;210(3):268-71; discussion 272-3 [2549890.001]
  • [Cites] Am J Surg. 1991 Jan;161(1):90-5; discussion 95-6 [1987862.001]
  • [Cites] Dis Colon Rectum. 1994 Aug;37(8):824-8 [8055729.001]
  • [Cites] Dis Colon Rectum. 1994 Dec;37(12):1281-5 [7995159.001]
  • [Cites] Gut. 1994 Dec;35(12):1721-7 [7829009.001]
  • [Cites] Gastroenterology. 1995 Oct;109(4):1090-7 [7557073.001]
  • [Cites] Br J Surg. 1996 Apr;83(4):506 [8665242.001]
  • [Cites] Am J Surg Pathol. 1996 Aug;20(8):995-9 [8712299.001]
  • [Cites] Gastroenterology. 1997 May;112(5):1487-92 [9136826.001]
  • [Cites] Indian J Cancer. 1997 Mar;34(1):16-9 [9491657.001]
  • [Cites] Int J Colorectal Dis. 1998;13(5-6):196-207 [9870162.001]
  • [Cites] J Gastrointest Surg. 2005 May-Jun;9(5):695-702 [15862266.001]
  • [Cites] Dis Colon Rectum. 2005 Apr;48(4):816-23 [15747076.001]
  • [Cites] Ann Surg. 2001 Mar;233(3):360-4 [11224623.001]
  • (PMID = 19795007.001).
  • [ISSN] 1598-6357
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2752792
  • [Keywords] NOTNLM ; Adenocarcinoma / Adenomatous Polyposis Coli / Ileal Pouches
  •  go-up   go-down


26. Timmermann B, Kerick M, Roehr C, Fischer A, Isau M, Boerno ST, Wunderlich A, Barmeyer C, Seemann P, Koenig J, Lappe M, Kuss AW, Garshasbi M, Bertram L, Trappe K, Werber M, Herrmann BG, Zatloukal K, Lehrach H, Schweiger MR: Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS One; 2010;5(12):e15661
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Extensive research is ongoing to decipher the underlying genetic patterns with the hope to improve early cancer diagnosis and treatment.
  • [MeSH-minor] Adenocarcinoma / genetics. Aged. Colonic Neoplasms / genetics. Computational Biology / methods. DNA Mutational Analysis. Genomics. Humans. Male. Middle Aged. Mutation

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Mutat. 2001 May;17(5):389-96 [11317354.001]
  • [Cites] Science. 1998 May 15;280(5366):1086-8 [9582123.001]
  • [Cites] Cancer Res. 2003 Sep 15;63(18):5738-44 [14522894.001]
  • [Cites] Nucleic Acids Res. 2004 Jan 1;32(Database issue):D217-22 [14681398.001]
  • [Cites] J Med Genet. 2004 Jul;41(7):484-91 [15235019.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10065-9 [1359533.001]
  • [Cites] Science. 1993 May 7;260(5109):812-6 [8484121.001]
  • [Cites] Science. 1993 May 7;260(5109):816-9 [8484122.001]
  • [Cites] Nature. 1993 Jun 10;363(6429):558-61 [8505985.001]
  • [Cites] Science. 1995 Jun 2;268(5215):1336-8 [7761852.001]
  • [Cites] Science. 1996 Jan 19;271(5247):350-3 [8553070.001]
  • [Cites] J Biol Chem. 1998 Aug 14;273(33):21145-52 [9694870.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6 [10411935.001]
  • [Cites] J Hum Genet. 2006;51(5):391-6 [16596323.001]
  • [Cites] Anal Biochem. 2006 Sep 1;356(1):94-9 [16750160.001]
  • [Cites] Science. 2006 Oct 13;314(5797):268-74 [16959974.001]
  • [Cites] Gastroenterology. 2007 Jan;132(1):127-38 [17087942.001]
  • [Cites] Nature. 2007 Mar 8;446(7132):153-8 [17344846.001]
  • [Cites] Bioinformatics. 2007 Mar 15;23(6):657-63 [17234643.001]
  • [Cites] Science. 2007 Nov 16;318(5853):1108-13 [17932254.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18654-9 [18003927.001]
  • [Cites] Science. 2008 Sep 26;321(5897):1801-6 [18772397.001]
  • [Cites] Nature. 2008 Oct 23;455(7216):1061-8 [18772890.001]
  • [Cites] Nature. 2008 Nov 6;456(7218):66-72 [18987736.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(Database issue):D387-92 [18931379.001]
  • [Cites] PLoS One. 2009;4(5):e5548 [19440246.001]
  • [Cites] Genome Biol. 2009;10(3):R25 [19261174.001]
  • [Cites] Clin Genet. 2009 Jul;76(1):1-18 [19659756.001]
  • [Cites] Nature. 2009 Sep 10;461(7261):272-6 [19684571.001]
  • [Cites] Genome Res. 2009 Oct;19(10):1843-8 [19635845.001]
  • [Cites] Nature. 2009 Oct 8;461(7265):809-13 [19812674.001]
  • [Cites] PLoS One. 2009;4(12):e8232 [20011588.001]
  • [Cites] PLoS Biol. 2010 Jan;8(1):e1000275 [20052272.001]
  • [Cites] Nature. 2010 Jan 14;463(7278):191-6 [20016485.001]
  • [Cites] Nature. 2010 Jan 14;463(7278):184-90 [20016488.001]
  • [Cites] Nat Methods. 2010 Apr;7(4):248-9 [20354512.001]
  • [Cites] Nat Methods. 2010 Aug;7(8):575-6 [20676075.001]
  • [Cites] Nat Genet. 2010 Oct;42(10):827-9 [20802478.001]
  • [Cites] Nat Genet. 2001 Jun;28(2):184-7 [11381269.001]
  • (PMID = 21203531.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3008745
  •  go-up   go-down


27. Ten Dam GB, Yamada S, Kobayashi F, Purushothaman A, van de Westerlo EM, Bulten J, Malmström A, Sugahara K, Massuger LF, van Kuppevelt TH: Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas. Histochem Cell Biol; 2009 Jul;132(1):117-27
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / metabolism. Antibodies / immunology. Dermatan Sulfate / metabolism. Ovarian Neoplasms / metabolism. Ovary / metabolism

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Opin Struct Biol. 2003 Oct;13(5):612-20 [14568617.001]
  • [Cites] Biochimie. 2006 Sep;88(9):1135-43 [16690200.001]
  • [Cites] Semin Cancer Biol. 2002 Jun;12(3):173-86 [12083848.001]
  • [Cites] J Biol Chem. 2006 Apr 28;281(17):11560-8 [16505484.001]
  • [Cites] Int J Biochem Cell Biol. 2003 Mar;35(3):376-90 [12531251.001]
  • [Cites] Biochim Biophys Acta. 2002 Nov 20;1588(2):165-72 [12385781.001]
  • [Cites] Crit Rev Oncol Hematol. 2004 Mar;49(3):259-68 [15036265.001]
  • [Cites] Glycobiology. 2002 Sep;12(9):117R-25R [12213784.001]
  • [Cites] J Biol Chem. 2000 Jun 16;275(24):18085-92 [10749870.001]
  • [Cites] J Biol Chem. 2006 Feb 24;281(8):4654-62 [16373349.001]
  • [Cites] EMBO J. 1994 Feb 1;13(3):692-8 [7508862.001]
  • [Cites] J Biol Chem. 2003 Oct 31;278(44):43744-54 [12917413.001]
  • [Cites] Biochim Biophys Acta. 2005 Apr 15;1740(1):45-53 [15878740.001]
  • [Cites] Anal Biochem. 1994 Sep;221(2):356-61 [7529008.001]
  • [Cites] J Biol Chem. 2005 Jun 17;280(24):23184-93 [15849184.001]
  • [Cites] Eur J Biochem. 1996 Aug 1;239(3):871-80 [8774738.001]
  • [Cites] Annu Rev Biochem. 1998;67:609-52 [9759499.001]
  • [Cites] J Neurosci. 2000 Jun 1;20(11):4099-111 [10818145.001]
  • [Cites] Matrix Biol. 2006 Sep;25(7):457-61 [16934446.001]
  • [Cites] Biochim Biophys Acta. 2006 Aug;1760(8):1217-25 [16730906.001]
  • [Cites] Int J Cancer. 2003 Nov 10;107(3):359-64 [14506734.001]
  • [Cites] Semin Reprod Med. 2006 Sep;24(4):270-82 [16944424.001]
  • [Cites] Am J Pathol. 2007 Oct;171(4):1324-33 [17717144.001]
  • [Cites] Glycoconj J. 2008 Oct;25(7):603-10 [18368478.001]
  • [Cites] J Histochem Cytochem. 2003 Jun;51(6):727-39 [12754284.001]
  • [Cites] J Biol Chem. 2005 Feb 18;280(7):5300-6 [15563459.001]
  • [Cites] J Cell Physiol. 2000 Oct;185(1):68-79 [10942520.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):10982-6 [11790764.001]
  • [Cites] J Biol Chem. 1995 Dec 29;270(52):31027-36 [8537360.001]
  • [Cites] Glycobiology. 2006 Jun;16(6):502-13 [16489125.001]
  • [Cites] J Biol Chem. 1998 May 22;273(21):12960-6 [9582329.001]
  • [Cites] J Biol Chem. 2005 Mar 11;280(10):9180-91 [15632143.001]
  • [Cites] Clin Cancer Res. 2002 Jun;8(6):1754-60 [12060613.001]
  • (PMID = 19360434.001).
  • [ISSN] 1432-119X
  • [Journal-full-title] Histochemistry and cell biology
  • [ISO-abbreviation] Histochem. Cell Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies; 0 / Epitopes; 24967-94-0 / Dermatan Sulfate
  •  go-up   go-down


28. Midi A, Tecimer T, Bozkurt S, Ozkan N: Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma. Indian J Urol; 2008 Apr;24(2):169-77
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma.
  • AIM: Atypical adenomatous hyperplasia (AAH) is a small glandular proliferation that has histological similarities with Gleason grade 1 and 2 prostatic adenocarcinoma (PACG1,2).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Urology. 1995 Dec;46(6):837-42 [7502426.001]
  • [Cites] Hum Pathol. 1996 Apr;27(4):396-407 [8617484.001]
  • [Cites] Am J Surg Pathol. 1995 Jul;19(7):737-47 [7793471.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1990;417(3):191-6 [1696762.001]
  • [Cites] Indian J Cancer. 2004 Apr-Jun;41(2):60-5 [15318010.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1151-60 [12218571.001]
  • [Cites] Am J Surg Pathol. 2002 Jul;26(7):921-5 [12131160.001]
  • [Cites] Ann N Y Acad Sci. 2002 Jun;963:169-84 [12095942.001]
  • [Cites] Am J Surg Pathol. 2001 Nov;25(11):1397-404 [11684956.001]
  • [Cites] Anal Quant Cytol Histol. 2000 Dec;22(6):438-44 [11147297.001]
  • [Cites] Pathol Res Pract. 1999;195(12):795-9 [10631713.001]
  • [Cites] Br J Cancer. 1994 Jun;69(6):1098-101 [7515262.001]
  • [Cites] Am J Surg Pathol. 1994 Sep;18(9):863-70 [7520673.001]
  • [Cites] Hum Pathol. 1993 Jun;24(6):618-23 [7684998.001]
  • [Cites] Hum Pathol. 1993 Aug;24(8):819-32 [8375853.001]
  • [Cites] Hum Pathol. 1992 Mar;23(3):273-9 [1555838.001]
  • [Cites] Mod Pathol. 1991 Mar;4(2):220-4 [1710806.001]
  • [Cites] Cancer. 1987 Feb 15;59(4):788-94 [2433020.001]
  • [Cites] J Clin Pathol. 1989 Apr;42(4):383-6 [2469700.001]
  • [Cites] J Postgrad Med. 1989 Jul;35(3):157-61 [2483935.001]
  • [Cites] Am J Surg Pathol. 1988 Dec;12(12):897-906 [3202246.001]
  • [Cites] Am J Surg Pathol. 1985 Jan;9(1):53-5 [3970298.001]
  • [Cites] Nat Clin Pract Urol. 2007 Jun;4(6):321-32 [17551536.001]
  • [Cites] Crit Rev Clin Lab Sci. 2007;44(3):243-70 [17453919.001]
  • [Cites] Asian J Androl. 2007 Mar;9(2):229-33 [16751999.001]
  • [Cites] Ann Saudi Med. 1998 Jan-Feb;18(1):22-7 [17341910.001]
  • [Cites] Int J Surg Pathol. 2005 Apr;13(2):167-73 [15864380.001]
  • [Cites] Hum Pathol. 1999 Sep;30(9):1077-86 [10492043.001]
  • [Cites] Am J Pathol. 1999 Sep;155(3):967-71 [10487854.001]
  • [Cites] Mod Pathol. 1999 May;12(5):472-8 [10349984.001]
  • [Cites] Mod Pathol. 1999 May;12(5):443-4 [10349979.001]
  • [Cites] Am J Surg Pathol. 1999 Feb;23(2):147-52 [9989840.001]
  • [Cites] Urology. 1999 Feb;53(2):351-5 [9933053.001]
  • [Cites] Anal Quant Cytol Histol. 1998 Oct;20(5):417-23 [9801760.001]
  • [Cites] Cancer Res. 1998 Feb 1;58(3):389-91 [9458077.001]
  • [Cites] Am J Clin Pathol. 1997 Feb;107(2):219-23 [9024071.001]
  • [Cites] Pathologica. 1997 Jun;89(3):288-300 [9270265.001]
  • [Cites] Cancer. 1997 Mar 15;79(6):1172-9 [9070495.001]
  • [Cites] Mod Pathol. 1996 Jan;9(1):77-81 [8821962.001]
  • [Cites] Cancer. 1996 Jul 15;78(2):330-6 [8674012.001]
  • [Cites] Am J Surg Pathol. 1995 May;19(5):506-18 [7537024.001]
  • (PMID = 19468392.001).
  • [ISSN] 0970-1591
  • [Journal-full-title] Indian journal of urology : IJU : journal of the Urological Society of India
  • [ISO-abbreviation] Indian J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2684265
  • [Keywords] NOTNLM ; Adenosis / cancer / hyperplasia / low grade / proliferations / prostate / small glandular
  •  go-up   go-down


29. Yoshihara T, Kadota Y, Yoshimura Y, Tatano Y, Takeuchi N, Okitsu H, Umemoto A, Yamauchi T, Itoh K: Proteomic alteration in gastic adenocarcinomas from Japanese patients. Mol Cancer; 2006;5:75
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Evaluation of the specific decreases in gene and protein expression of FOV in patients may be utilized as clinical biomarkers for effective diagnosis and assessment of gastric cancer.
  • [MeSH-major] Adenocarcinoma / metabolism. Proteome / analysis. Proteomics / methods. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Jpn J Cancer Res. 2000 May;91(5):459-63 [10835488.001]
  • [Cites] Hepatogastroenterology. 2000 Jul-Aug;47(34):998-1001 [11020863.001]
  • [Cites] Cancer Res. 2001 Feb 15;61(4):1592-7 [11245470.001]
  • [Cites] Int J Oncol. 2001 Oct;19(4):701-7 [11562744.001]
  • [Cites] Electrophoresis. 2001 Aug;22(14):2990-3000 [11565793.001]
  • [Cites] Biochem Biophys Res Commun. 2001 Dec 14;289(4):876-81 [11735128.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jan 25;290(3):948-54 [11798165.001]
  • [Cites] Proteomics. 2002 Mar;2(3):313-24 [11921447.001]
  • [Cites] Electrophoresis. 2002 Aug;23(15):2513-24 [12210210.001]
  • [Cites] Eur J Cancer. 2003 Jun;39(9):1199-215 [12763207.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2003 Aug;285(2):G332-43 [12851218.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2003 Aug;285(2):G344-53 [12851219.001]
  • [Cites] World J Gastroenterol. 2003 Jul;9(7):1398-403 [12854129.001]
  • [Cites] Pathobiology. 2002-2003;70(6):353-60 [12865632.001]
  • [Cites] J Cell Biochem. 2003 Aug 1;89(5):868-86 [12874822.001]
  • [Cites] J Korean Med Sci. 2003 Aug;18(4):505-9 [12923326.001]
  • [Cites] Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R135-44 [12928479.001]
  • [Cites] Annu Rev Biochem. 2003;72:783-812 [14527327.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13537-42 [14573703.001]
  • [Cites] Clin Cancer Res. 2003 Nov 15;9(15):5768-75 [14654562.001]
  • [Cites] J Neurochem. 2004 Feb;88(3):759-68 [14720225.001]
  • [Cites] Biochem J. 2004 Apr 15;379(Pt 2):291-9 [14711373.001]
  • [Cites] J Pathol. 2004 Jul;203(3):789-97 [15221938.001]
  • [Cites] Br J Cancer. 2004 Aug 31;91(5):980-4 [15266315.001]
  • [Cites] Proteomics. 2004 Sep;4(9):2776-88 [15352251.001]
  • [Cites] Proteomics. 2004 Oct;4(10):3276-87 [15378696.001]
  • [Cites] Gastroenterology. 1993 Sep;105(3):820-6 [8359652.001]
  • [Cites] Anticancer Res. 1995 Sep-Oct;15(5B):2055-64 [8572602.001]
  • [Cites] Int J Cancer. 1997 Feb 20;74(1):1-6 [9036861.001]
  • [Cites] Br J Cancer. 1997;75(7):969-77 [9083331.001]
  • [Cites] Am J Pathol. 1998 Jul;153(1):1-4 [9665457.001]
  • [Cites] J Biochem Biophys Methods. 1998 Nov 18;37(3):105-16 [9870185.001]
  • [Cites] J Surg Oncol. 2004 Nov 1;88(2):86-99 [15499602.001]
  • [Cites] Cancer Res. 2004 Dec 15;64(24):9093-100 [15604278.001]
  • [Cites] Mol Cell Proteomics. 2005 Feb;4(2):144-55 [15608340.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):409-18 [15684407.001]
  • [Cites] Biochemistry. 2005 Jun 7;44(22):7967-75 [15924415.001]
  • [Cites] J Proteome Res. 2005 Jul-Aug;4(4):1213-22 [16083271.001]
  • [Cites] Biosci Rep. 2005 Feb-Apr;25(1-2):107-25 [16222423.001]
  • [Cites] Anal Chem. 2000 May 1;72(9):2148-53 [10815978.001]
  • (PMID = 17187689.001).
  • [ISSN] 1476-4598
  • [Journal-full-title] Molecular cancer
  • [ISO-abbreviation] Mol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Proteome; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC1774573
  •  go-up   go-down


30. Nair KS, Naidoo R, Chetty R: Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol; 2005 Apr;58(4):343-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This review provides a brief description of five families of CAMs (cadherins, integrins, CD44, immunoglobulin superfamily, and selectins) and highlights their altered expression in relation both to prognosis and tumour behaviour in squamous cell carcinoma and adenocarcinoma of the oesophagus.
  • [MeSH-minor] Adenocarcinoma / chemistry. Antigens, CD44 / analysis. Cadherins / analysis. Carcinoma, Squamous Cell / chemistry. Humans. Integrins / analysis. Neoplasm Metastasis. Prognosis. Selectins / analysis

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1998 Jan;32(1):7-14 [9522210.001]
  • [Cites] J Cell Physiol. 1998 Sep;176(3):482-94 [9699501.001]
  • [Cites] Cancer. 1998 Sep 1;83(5):858-66 [9731887.001]
  • [Cites] Chest. 1999 Dec;116(6 Suppl):463S-465S [10619509.001]
  • [Cites] Mol Pathol. 1999 Aug;52(4):189-96 [10694938.001]
  • [Cites] Mol Pathol. 1999 Aug;52(4):208-13 [10694941.001]
  • [Cites] Int J Oncol. 2000 Apr;16(4):677-82 [10717234.001]
  • [Cites] Int J Oncol. 2000 Apr;16(4):725-9 [10717240.001]
  • [Cites] Genes Dev. 2000 Aug 1;14(15):1837-51 [10921899.001]
  • [Cites] Br J Surg. 2000 Aug;87(8):992-1005 [10931041.001]
  • [Cites] J Cell Biol. 2000 Aug 7;150(3):567-80 [10931868.001]
  • [Cites] Int J Oncol. 2000 Oct;17(4):701-5 [10995880.001]
  • [Cites] Breast Cancer. 2000 Jan;7(1):19-26 [11029766.001]
  • [Cites] Cell Biol Int. 2001;25(1):61-9 [11237409.001]
  • [Cites] Clin Chem. 2001 Apr;47(4):624-30 [11274010.001]
  • [Cites] Oncol Rep. 2001 Sep-Oct;8(5):981-5 [11496302.001]
  • [Cites] Clin Cancer Res. 2001 Nov;7(11):3519-25 [11705871.001]
  • [Cites] J Clin Invest. 2002 Apr;109(8):999-1006 [11956235.001]
  • [Cites] J Cell Biol. 1991 Sep;114(5):1059-68 [1874786.001]
  • [Cites] Annu Rev Biochem. 1991;60:155-90 [1883195.001]
  • [Cites] J Clin Lab Anal. 1991;5(5):344-66 [1941355.001]
  • [Cites] J Cell Biol. 1991 Dec;115(6):1751-61 [1757472.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2292-6 [1372439.001]
  • [Cites] Cell. 1992 Apr 3;69(1):11-25 [1555235.001]
  • [Cites] Cell. 1992 Apr 17;69(2):225-36 [1568244.001]
  • [Cites] J Pathol. 1992 May;167(1):77-82 [1625062.001]
  • [Cites] J Pathol. 1992 Jun;167(2):187-91 [1378891.001]
  • [Cites] Cell. 1992 Jul 24;70(2):293-301 [1638632.001]
  • [Cites] Lancet. 1992 Oct 31;340(8827):1053-8 [1357452.001]
  • [Cites] Br J Cancer. 1992 Oct;66(4):629-34 [1384639.001]
  • [Cites] J Cell Biol. 1993 Feb;120(3):577-85 [8381117.001]
  • [Cites] Lancet. 1993 Mar 20;341(8847):725-6 [8095628.001]
  • [Cites] Am J Pathol. 1993 Apr;142(4):981-6 [7682766.001]
  • [Cites] Am J Pathol. 1993 Apr;142(4):987-93 [7682767.001]
  • [Cites] J Surg Oncol. 1993 Jun;53(2):78-83 [8501910.001]
  • [Cites] Br J Cancer. 1993 Jul;68(1):122-4 [7686390.001]
  • [Cites] J Cell Biol. 1993 Jul;122(2):431-42 [8320265.001]
  • [Cites] Br J Cancer. 1993 Aug;68(2):428-32 [8347502.001]
  • [Cites] Cancer Res. 1993 Sep 15;53(18):4197-203 [7689929.001]
  • [Cites] J Biol Chem. 1993 Oct 25;268(30):22883-94 [8226797.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):630-1 [7505052.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):695-8 [7505053.001]
  • [Cites] Cancer Res. 1994 Jan 1;54(1):291-6 [8261454.001]
  • [Cites] Cell. 1994 Jan 28;76(2):301-14 [7507411.001]
  • [Cites] J Cell Biol. 1994 Feb;124(4):589-600 [8106556.001]
  • [Cites] Cancer. 1994 Mar 1;73(5):1324-31 [7906606.001]
  • [Cites] Cancer Res. 1994 Jun 1;54(11):3007-10 [8187090.001]
  • [Cites] J Cell Biol. 1994 Jun;125(6):1327-40 [8207061.001]
  • [Cites] J Cell Biol. 1994 Jul;126(2):391-401 [7518464.001]
  • [Cites] Semin Oncol. 1994 Aug;21(4):425-30 [8042040.001]
  • [Cites] J Cell Biol. 1994 Aug;126(4):1099-109 [7519619.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8263-7 [8058792.001]
  • [Cites] Blood. 1994 Oct 1;84(7):2068-101 [7522621.001]
  • [Cites] J Biol Chem. 1994 Oct 28;269(43):26602-5 [7929388.001]
  • [Cites] J Cell Physiol. 1997 Oct;173(1):54-63 [9326449.001]
  • [Cites] J Pathol. 1997 Jul;182(3):331-8 [9349237.001]
  • [Cites] Blood. 1997 Nov 15;90(10):4039-45 [9354673.001]
  • [Cites] Int J Cancer. 1997 Dec 19;74(6):582-7 [9421352.001]
  • [Cites] Am J Pathol. 1998 Jan;152(1):135-44 [9422531.001]
  • [Cites] J Cell Biol. 1997 Jun 16;137(6):1421-31 [9182672.001]
  • [Cites] Cancer. 1998 Sep 15;83(6):1074-80 [9740070.001]
  • [Cites] Clin Cancer Res. 1996 Jul;2(7):1097-102 [9816273.001]
  • [Cites] Cell. 1996 Oct 18;87(2):175-85 [8861902.001]
  • [Cites] Science. 1996 Nov 15;274(5290):1123-33 [8895455.001]
  • [Cites] Dev Biol. 1996 Dec 15;180(2):402-12 [8954713.001]
  • [Cites] Br J Surg. 1996 Nov;83(11):1608-14 [9014688.001]
  • [Cites] Clin Cancer Res. 1998 Feb;4(2):407-10 [9516929.001]
  • [Cites] J Clin Invest. 1997 Jul 1;100(1):1-5 [9202049.001]
  • [Cites] EMBO J. 1997 Jul 1;16(13):3797-804 [9233789.001]
  • [Cites] J Pathol. 1998 Sep;186(1):1-2 [9875132.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):139-44 [9874785.001]
  • [Cites] J Cell Biol. 1999 Mar 22;144(6):1311-22 [10087272.001]
  • [Cites] Semin Cancer Biol. 1999 Apr;9(2):67-81 [10202129.001]
  • [Cites] Am J Med. 1999 Apr;106(4):467-76 [10225251.001]
  • [Cites] Am J Pathol. 1999 Apr;154(4):965-73 [10233832.001]
  • [Cites] Hepatogastroenterology. 1999 Mar-Apr;46(26):938-43 [10370643.001]
  • [Cites] Cell Growth Differ. 1999 Jun;10(6):369-76 [10392898.001]
  • [Cites] J Biol Chem. 1999 Jul 23;274(30):21409-15 [10409703.001]
  • [Cites] Curr Opin Cell Biol. 1999 Oct;11(5):591-6 [10508646.001]
  • [Cites] J Exp Med. 1965 Mar 1;121:439-62 [14270243.001]
  • [Cites] Anticancer Res. 2002 May-Jun;22(3):1849-57 [12168881.001]
  • [Cites] J Cell Biol. 2002 Sep 2;158(5):953-65 [12213839.001]
  • [Cites] World J Gastroenterol. 2003 Feb;9(2):225-32 [12532436.001]
  • [Cites] Surgery. 2003 Feb;133(2):162-9 [12605177.001]
  • [Cites] Anticancer Res. 2003 Jan-Feb;23(1A):161-5 [12680208.001]
  • [Cites] J Neurosurg. 2003 May;98(5):1084-93 [12744370.001]
  • [Cites] Anticancer Res. 2003 Nov-Dec;23(6a):4435-42 [14666731.001]
  • [Cites] Cancer Res. 1986 Jan;46(1):1-7 [2998604.001]
  • [Cites] J Cell Biol. 1987 May;104(5):1361-74 [3553211.001]
  • [Cites] J Exp Med. 1987 Oct 1;166(4):1125-31 [3655655.001]
  • [Cites] J Pathol. 1988 Jul;155(3):207-12 [3411381.001]
  • [Cites] Development. 1988 Apr;102(4):639-55 [3048970.001]
  • [Cites] Biochim Biophys Acta. 1988 Nov 15;948(2):175-224 [3052592.001]
  • [Cites] Cell. 1989 Apr 21;57(2):327-34 [2702691.001]
  • [Cites] Science. 1989 Dec 8;246(4935):1303-6 [2588007.001]
  • [Cites] Science. 1990 Jan 5;247(4938):49-56 [2294591.001]
  • [Cites] Cancer Res. 1990 Feb 15;50(4):1271-8 [1967552.001]
  • [Cites] J Cell Biol. 1990 Feb;110(2):349-57 [2153683.001]
  • [Cites] Cell. 1990 Feb 23;60(4):577-84 [1689216.001]
  • [Cites] Cancer Metastasis Rev. 1989 Dec;8(3):263-80 [2697474.001]
  • [Cites] Science. 1990 Mar 9;247(4947):1219-22 [1690453.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jun;87(11):4246-50 [2349235.001]
  • [Cites] Cell. 1990 Jun 29;61(7):1303-13 [1694723.001]
  • [Cites] Nature. 1990 Aug 2;346(6283):425-34 [1974032.001]
  • [Cites] FASEB J. 1990 Aug;4(11):2868-80 [2199285.001]
  • [Cites] Lab Invest. 1990 Dec;63(6):780-91 [1979361.001]
  • [Cites] Cell. 1991 May 31;65(5):849-57 [1904011.001]
  • [Cites] Cell. 1991 Jul 12;66(1):107-19 [2070412.001]
  • [Cites] Cancer Res. 1994 Dec 1;54(23):6282-7 [7954478.001]
  • [Cites] Gut. 1994 Oct;35(10):1343-7 [7959182.001]
  • [Cites] J Cell Biol. 1994 Dec;127(6 Pt 2):2061-9 [7806582.001]
  • [Cites] Curr Opin Cell Biol. 1994 Oct;6(5):663-73 [7530461.001]
  • [Cites] Cell. 1995 Feb 10;80(3):413-22 [7532110.001]
  • [Cites] Nature. 1995 Mar 23;374(6520):327-37 [7885471.001]
  • [Cites] J Biol Chem. 1995 Mar 10;270(10):5549-55 [7890674.001]
  • [Cites] J Cell Biol. 1995 Jul;130(1):67-77 [7790378.001]
  • [Cites] FASEB J. 1995 Jul;9(10):866-73 [7542213.001]
  • [Cites] J Cell Biol. 1995 Jul;130(2):451-60 [7542249.001]
  • [Cites] Mol Biol Cell. 1995 Apr;6(4):419-31 [7542940.001]
  • [Cites] J Clin Pathol. 1995 Jun;48(6):539-44 [7665697.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8813-7 [7568023.001]
  • [Cites] J Pathol. 1995 Sep;177(1):11-20 [7472774.001]
  • [Cites] Am J Pathol. 1995 Dec;147(6):1823-39 [7495306.001]
  • [Cites] Curr Opin Cell Biol. 1995 Oct;7(5):634-40 [8573337.001]
  • [Cites] Science. 1996 Apr 5;272(5258):60-6 [8600538.001]
  • [Cites] Cancer Lett. 1996 Apr 19;102(1-2):183-91 [8603368.001]
  • [Cites] Br J Surg. 1996 May;83(5):588-601 [8689199.001]
  • [Cites] Oncology. 1997 Mar-Apr;54(2):158-65 [9075789.001]
  • [Cites] Trends Genet. 1997 Apr;13(4):157-62 [9097727.001]
  • [Cites] Proc Soc Exp Biol Med. 1999 Nov;222(2):124-38 [10564536.001]
  • [Cites] Gut. 2000 Jan;46(1):14-9 [10601048.001]
  • (PMID = 15790695.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Cadherins; 0 / Cell Adhesion Molecules; 0 / Integrins; 0 / Selectins
  • [Number-of-references] 132
  • [Other-IDs] NLM/ PMC1770622
  •  go-up   go-down


31. Alam SM, Fujimoto J, Jahan I, Sato E, Tamaya T: Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. Br J Cancer; 2008 Feb 26;98(4):845-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma, Clear Cell / genetics. Adenocarcinoma, Clear Cell / metabolism. Adenocarcinoma, Clear Cell / pathology. Adenocarcinoma, Mucinous / genetics. Adenocarcinoma, Mucinous / metabolism. Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Papillary / genetics. Adenocarcinoma, Papillary / metabolism. Adenocarcinoma, Papillary / pathology. Aged. Cystadenocarcinoma, Serous / genetics. Cystadenocarcinoma, Serous / metabolism. Cystadenocarcinoma, Serous / pathology. Endometrial Neoplasms / genetics. Endometrial Neoplasms / metabolism. Endometrial Neoplasms / pathology. Female. Humans. Immunoenzyme Techniques. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Prognosis. RNA, Messenger / genetics. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Survival Rate

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Prostate. 1999 Dec 1;41(4):275-80 [10544301.001]
  • [Cites] Ann Oncol. 2007 Mar;18(3):485-90 [17108150.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10936-41 [10984508.001]
  • [Cites] Melanoma Res. 2000 Oct;10(5):401-11 [11095400.001]
  • [Cites] Oncogene. 2000 Nov 20;19(49):5614-9 [11114742.001]
  • [Cites] Cancer Res. 2001 Mar 1;61(5):2301-6 [11280802.001]
  • [Cites] Surg Oncol Clin N Am. 2001 Apr;10(2):271-88, viii [11382587.001]
  • [Cites] J Cell Sci. 2002 Mar 1;115(Pt 5):1059-72 [11870224.001]
  • [Cites] Microsc Res Tech. 2002 Oct 1;59(1):58-67 [12242697.001]
  • [Cites] Oncogene. 2002 Oct 10;21(46):7011-26 [12370823.001]
  • [Cites] Int J Cancer. 2003 Feb 20;103(5):657-63 [12494475.001]
  • [Cites] Mol Cancer Res. 2002 Nov;1(1):2-11 [12496364.001]
  • [Cites] Eur J Cancer. 2002 Sep;38 Suppl 5:S3-10 [12528767.001]
  • [Cites] Clin Cancer Res. 2003 Feb;9(2):613-8 [12576426.001]
  • [Cites] J Cell Sci. 2003 Jun 15;116(Pt 12):2461-70 [12734395.001]
  • [Cites] Ear Nose Throat J. 2003 Nov;82(11):866, 869-70, 887 [14661437.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5583-8 [15067119.001]
  • [Cites] Arch Pathol Lab Med. 1985 Aug;109(8):716-21 [3893381.001]
  • [Cites] Anal Biochem. 1987 Apr;162(1):156-9 [2440339.001]
  • [Cites] Science. 1987 Dec 18;238(4834):1717-20 [2825356.001]
  • [Cites] Oncogene. 1990 Mar;5(3):445-7 [2314900.001]
  • [Cites] Cold Spring Harb Symp Quant Biol. 1992;57:25-41 [1339664.001]
  • [Cites] Cancer Res. 1994 Jul 15;54(14):3645-50 [8033077.001]
  • [Cites] Science. 1994 Nov 4;266(5186):816-9 [7973638.001]
  • [Cites] Cancer Res. 1995 Jun 15;55(12):2528-32 [7780963.001]
  • [Cites] EMBO J. 1995 Jul 3;14(13):3116-26 [7621826.001]
  • [Cites] Neuron. 1996 Jul;17(1):9-19 [8755474.001]
  • [Cites] Oncogene. 1996 Aug 15;13(4):813-22 [8761303.001]
  • [Cites] Cell. 1997 Aug 8;90(3):403-4 [9267020.001]
  • [Cites] Cell Tissue Res. 1997 Nov;290(2):227-41 [9321684.001]
  • [Cites] Curr Opin Cell Biol. 1997 Oct;9(5):608-15 [9330863.001]
  • [Cites] Am J Physiol. 1997 Oct;273(4 Pt 1):G824-32 [9357823.001]
  • [Cites] Clin Cancer Res. 1998 Mar;4(3):791-7 [9533549.001]
  • [Cites] Curr Opin Genet Dev. 1999 Aug;9(4):455-60 [10449346.001]
  • [Cites] Int J Cancer. 1999 Oct 22;84(5):494-501 [10502726.001]
  • [Cites] Cell Growth Differ. 1999 Sep;10(9):629-38 [10511313.001]
  • [Cites] Mol Cell. 1999 Sep;4(3):403-14 [10518221.001]
  • [Cites] Hum Pathol. 2006 Jul;37(7):883-9 [16784989.001]
  • [Cites] BMC Cancer. 2006;6:144 [16737551.001]
  • [Cites] Cancer Res. 2006 Nov 15;66(22):10709-19 [17090524.001]
  • [Cites] Biochemistry. 1999 Oct 26;38(43):14396-408 [10572014.001]
  • (PMID = 18231102.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ephrin-B2; 0 / RNA, Messenger; EC 2.7.10.1 / Receptor, EphB4
  • [Other-IDs] NLM/ PMC2259170
  •  go-up   go-down


32. Niu D, Murata S, Kondo T, Nakazawa T, Kawasaki T, Ma D, Yamane T, Nakamura N, Katoh R: Involvement of centrosomes in nuclear irregularity of thyroid carcinoma cells. Virchows Arch; 2009 Aug;455(2):149-57
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Carcinoma, Papillary / pathology. Cell Nucleus / pathology. Centrosome / physiology. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ultrastruct Pathol. 1998 May-Jun;22(3):185-97 [9793200.001]
  • [Cites] J Cell Sci. 1996 Apr;109 ( Pt 4):713-26 [8718663.001]
  • [Cites] Endocrinol Jpn. 1991 Dec;38(6):627-32 [1823030.001]
  • [Cites] J Cell Biol. 2007 Sep 10;178(6):897-904 [17785515.001]
  • [Cites] Histol Histopathol. 2001 Jan;16(1):1-14 [11193183.001]
  • [Cites] Diagn Cytopathol. 1987 Dec;3(4):307-10 [3428064.001]
  • [Cites] Histol Histopathol. 1999 Apr;14(2):501-9 [10212812.001]
  • [Cites] Virchows Arch. 2004 Apr;444(4):350-5 [14758551.001]
  • [Cites] Annu Rev Cell Dev Biol. 1997;13:83-117 [9442869.001]
  • [Cites] J Cell Sci. 2004 Jan 15;117(Pt 2):133-41 [14676269.001]
  • [Cites] Am J Surg Pathol. 1979 Feb;3(1):31-8 [534382.001]
  • [Cites] Diagn Cytopathol. 2005 May;32(5):264-8 [15830362.001]
  • [Cites] Virchows Arch. 2005 Jul;447(1):61-5 [15928943.001]
  • [Cites] Hum Pathol. 2007 Dec;38(12):1810-8 [17714762.001]
  • [Cites] J Cell Biol. 2005 Dec 5;171(5):799-810 [16330710.001]
  • [Cites] Cytometry. 2002 Nov 1;49(3):91-5 [12442308.001]
  • [Cites] Microsc Res Tech. 2003 Aug 1;61(5):457-62 [12845572.001]
  • [Cites] Cell Tissue Res. 1998 Dec;294(3):525-35 [9799469.001]
  • [Cites] Cell Mol Life Sci. 2006 Feb;63(3):316-32 [16389459.001]
  • [Cites] Oncogene. 2002 Sep 9;21(40):6146-53 [12214243.001]
  • [Cites] Curr Biol. 1999 May 6;9(9):R315-7 [10322119.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Aug;85(8):2889-96 [10946899.001]
  • [Cites] Am J Surg Pathol. 1986 Oct;10(10):672-9 [3766846.001]
  • [Cites] Anal Quant Cytol Histol. 2005 Apr;27(2):83-94 [15913201.001]
  • [Cites] Mol Biosyst. 2007 Sep;3(9):583-9 [17700857.001]
  • (PMID = 19588164.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Tubulin
  •  go-up   go-down


33. Osaki M, Inoue T, Yamaguchi S, Inaba A, Tokuyasu N, Jeang KT, Oshimura M, Ito H: MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach. Virchows Arch; 2007 Oct;451(4):771-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / genetics. Adenoma / genetics. Cell Cycle Proteins / genetics. Genes, Tumor Suppressor. Nuclear Proteins / genetics. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Biol. 2004 Jun 8;14(11):942-52 [15182667.001]
  • [Cites] EMBO J. 2001 Nov 15;20(22):6371-82 [11707408.001]
  • [Cites] J Biol Chem. 2002 Aug 23;277(34):31005-13 [12042300.001]
  • [Cites] Cancer Genet Cytogenet. 2005 May;159(1):10-7 [15860351.001]
  • [Cites] Pathol Res Pract. 2001;197(4):223-9 [11358006.001]
  • [Cites] J Histochem Cytochem. 1981 Apr;29(4):577-80 [6166661.001]
  • [Cites] Oncogene. 2007 Feb 15;26(7):945-57 [16909107.001]
  • [Cites] Anal Quant Cytol Histol. 1999 Apr;21(2):161-5 [10560486.001]
  • [Cites] Oncogene. 2001 May 31;20(25):3301-5 [11423979.001]
  • [Cites] J Cell Biol. 1995 Jun;129(5):1195-204 [7775567.001]
  • [Cites] Cancer Res. 1999 Mar 1;59(5):1090-5 [10070967.001]
  • [Cites] Int J Cancer. 1999 Oct 29;83(3):309-13 [10495421.001]
  • [Cites] Hepatogastroenterology. 2001 Nov-Dec;48(42):1793-6 [11813626.001]
  • [Cites] N Engl J Med. 1995 Jul 6;333(1):32-41 [7776992.001]
  • [Cites] Nat Rev Cancer. 2002 Nov;2(11):815-25 [12415252.001]
  • [Cites] Curr Opin Genet Dev. 2001 Feb;11(1):83-90 [11163156.001]
  • [Cites] Mol Cell Biol. 1994 Dec;14(12):8282-91 [7969164.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Aug;40(4):329-33 [15188456.001]
  • [Cites] Cell. 1991 Aug 9;66(3):507-17 [1651171.001]
  • [Cites] Cancer Res. 2007 Jan 1;67(1):160-6 [17210695.001]
  • [Cites] Cell. 1998 Apr 3;93(1):81-91 [9546394.001]
  • [Cites] Jpn J Cancer Res. 2002 Aug;93(8):857-60 [12716461.001]
  • [Cites] Hum Pathol. 2004 May;35(5):587-93 [15138934.001]
  • [Cites] Oncogene. 2005 Jun 16;24(26):4301-10 [15782113.001]
  • [Cites] Gastric Cancer. 1998 Dec;1(1):10-24 [11957040.001]
  • [Cites] Proteomics. 2005 Aug;5(12):3205-13 [16003825.001]
  • [Cites] Mol Biol Cell. 1999 Aug;10(8):2607-18 [10436016.001]
  • [Cites] Cancer Lett. 2005 Dec 8;230(1):6-19 [16253756.001]
  • [Cites] World J Gastroenterol. 2006 May 21;12(19):2979-90 [16718776.001]
  • [Cites] Apoptosis. 1998 Dec;3(6):431-7 [14646476.001]
  • [Cites] J Korean Med Sci. 2000 Apr;15(2):159-66 [10803691.001]
  • [Cites] Trends Cell Biol. 2005 Nov;15(11):589-98 [16214339.001]
  • [Cites] Science. 2002 Sep 27;297(5590):2267-70 [12351790.001]
  • [Cites] Br J Cancer. 2001 Jul 20;85(2):199-203 [11461076.001]
  • [Cites] Histol Histopathol. 2003 Apr;18(2):665-77 [12647816.001]
  • [Cites] Mol Cell. 2002 May;9(5):931-43 [12049731.001]
  • [Cites] J Cell Biol. 2003 Dec 22;163(6):1231-42 [14691134.001]
  • [Cites] Cell. 2002 Apr 5;109(1):113-24 [11955451.001]
  • [Cites] Cancer Res. 2001 Apr 1;61(7):2847-51 [11306456.001]
  • [Cites] Mol Cell. 2002 Jan;9(1):59-71 [11804586.001]
  • [Cites] Nat Genet. 1999 Jan;21(1):103-7 [9916800.001]
  • (PMID = 17674037.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / MAD1L1 protein, human; 0 / Nuclear Proteins
  •  go-up   go-down


34. Freeman HJ, Perry T, Webber DL, Chang SD, Loh MY: Mucinous carcinoma in Crohn's disease originating in a fistulous tract. World J Gastrointest Oncol; 2010 Jul 15;2(7):307-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous carcinoma in Crohn's disease originating in a fistulous tract.
  • Malignant disease, including mucinous carcinomas of the colorectum, may complicate long-standing Crohn's disease.
  • An 18-year-old male with extensive small and large bowel involvement with Crohn's disease developed recurrent peri-rectal fistulous disease that persisted for more than a decade despite pharmacological and surgical therapy as well as later therapy with biological agents.
  • Eventually, an extensive and difficult-to-detect mucinous carcinoma developed in the fistulous tract.
  • Although fistula cancer is rarely described in Crohn's disease, use of immunosuppressant and biological agents may play an initiating or exacerbating role in its development or progression.
  • As potent biological agents are frequently used, often to avoid surgical treatment, clinicians should have an increasingly high index of suspicion for this potential complication, especially if fistulous drainage persists and remains refractory to medical therapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21160662.001).
  • [ISSN] 1948-5204
  • [Journal-full-title] World journal of gastrointestinal oncology
  • [ISO-abbreviation] World J Gastrointest Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2999135
  • [Keywords] NOTNLM ; Adalimumab / Anal fistula / Anorectal adenocarcinoma / Crohn’s disease / Fistula carcinoma / Infliximab / Tumor necrosis factor antibodies
  •  go-up   go-down


35. Tan J, Wang B, Zhu L: DNA binding and oxidative DNA damage induced by a quercetin copper(II) complex: potential mechanism of its antitumor properties. J Biol Inorg Chem; 2009 Jun;14(5):727-39
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Antineoplastic Agents / chemistry. Antineoplastic Agents / pharmacology. Antineoplastic Agents / toxicity. Caspase 3 / metabolism. Cell Line, Tumor. Cell Survival / drug effects. DNA / metabolism. Gene Expression Regulation, Neoplastic / drug effects. Humans. Inhibitor of Apoptosis Proteins. Lung Neoplasms / drug therapy. Microtubule-Associated Proteins / genetics. Oxidation-Reduction. Reactive Oxygen Species / metabolism. Spectrometry, Fluorescence. Spectrophotometry. Viscosity / drug effects

  • Hazardous Substances Data Bank. QUERCETIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Basic Life Sci. 1984;29 Pt A:229-44 [6085260.001]
  • [Cites] Mol Genet Metab. 1999 Dec;68(4):468-72 [10607476.001]
  • [Cites] Free Radic Biol Med. 2004 Aug 1;37(3):287-303 [15223063.001]
  • [Cites] Chem Res Toxicol. 1997 Apr;10(4):386-92 [9114974.001]
  • [Cites] J Biol Inorg Chem. 2006 Sep;11(6):791-801 [16821038.001]
  • [Cites] Cancer Cell. 2008 May;13(5):385-93 [18455122.001]
  • [Cites] Biophys Chem. 2004 Dec 1;112(1):69-76 [15501577.001]
  • [Cites] Free Radic Biol Med. 2006 Dec 15;41(12):1807-16 [17157183.001]
  • [Cites] FEBS Lett. 2006 Jan 23;580(2):533-8 [16412432.001]
  • [Cites] Mutat Res. 1999 Mar 10;425(1):107-15 [10082921.001]
  • [Cites] Bioorg Med Chem. 2009 Jan 15;17(2):614-20 [19097913.001]
  • [Cites] Free Radic Res Commun. 1986;1(6):349-53 [2851502.001]
  • [Cites] Free Radic Biol Med. 1987;3(2):97-105 [2822548.001]
  • [Cites] Free Radic Biol Med. 1992;12(2):101-6 [1559614.001]
  • [Cites] J Biol Chem. 2005 Mar 11;280(10):9745-51 [15637054.001]
  • [Cites] Bioorg Med Chem Lett. 2007 Mar 1;17(5):1197-9 [17189687.001]
  • [Cites] Chem Biol Interact. 1998 Sep 4;115(2):141-51 [9826946.001]
  • [Cites] J Biol Chem. 1989 Sep 15;264(26):15435-40 [2549063.001]
  • [Cites] J Immunol Methods. 1983 Dec 16;65(1-2):55-63 [6606682.001]
  • [Cites] Arch Biochem Biophys. 1993 Jul;304(1):102-9 [8323275.001]
  • [Cites] IUBMB Life. 2000 Sep;50(3):167-71 [11142343.001]
  • [Cites] Int J Cancer. 1992 May 28;51(3):425-32 [1592533.001]
  • [Cites] Colloids Surf B Biointerfaces. 2007 Apr 1;55(2):149-52 [17234390.001]
  • [Cites] Cell Biol Toxicol. 2000;16(2):91-8 [10917564.001]
  • [Cites] Biochemistry. 1992 Oct 6;31(39):9319-24 [1390718.001]
  • [Cites] J Inorg Biochem. 2005 May;99(5):1205-19 [15833344.001]
  • [Cites] Cancer Lett. 2008 May 8;263(1):77-88 [18242825.001]
  • [Cites] Carcinogenesis. 1990 Nov;11(11):2001-3 [2225332.001]
  • [Cites] Redox Rep. 2004;9(2):97-104 [15231064.001]
  • [Cites] Chem Res Toxicol. 1998 May;11(5):420-7 [9585472.001]
  • [Cites] Crit Rev Oncol Hematol. 2002 Apr;42(1):93-103 [11923071.001]
  • [Cites] Anal Chim Acta. 2007 Feb 12;584(1):19-27 [17386580.001]
  • (PMID = 19259707.001).
  • [ISSN] 1432-1327
  • [Journal-full-title] Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
  • [ISO-abbreviation] J. Biol. Inorg. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / (Cu(4-methylcoumarin-6,7-dioxactetate)(phenanthroline)2); 0 / Antineoplastic Agents; 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; 0 / Organometallic Compounds; 0 / Reactive Oxygen Species; 9007-49-2 / DNA; 9IKM0I5T1E / Quercetin; EC 3.4.22.- / Caspase 3
  •  go-up   go-down


36. Wilson PM, Fazzone W, LaBonte MJ, Deng J, Neamati N, Ladner RD: Novel opportunities for thymidylate metabolism as a therapeutic target. Mol Cancer Ther; 2008 Sep;7(9):3029-37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Novel opportunities for thymidylate metabolism as a therapeutic target.
  • For over 40 years, the fluoropyrimidine 5-fluorouracil (5-FU) has remained the central agent in therapeutic regimens employed in the treatment of colorectal cancer and is frequently combined with the DNA-damaging agents oxaliplatin and irinotecan, increasing response rates and improving overall survival.
  • However, many patients will derive little or no benefit from treatment, highlighting the need to identify novel therapeutic targets to improve the efficacy of current 5-FU-based chemotherapeutic strategies. dUTP nucleotidohydrolase (dUTPase) catalyzes the hydrolysis of dUTP to dUMP and PPi, providing substrate for thymidylate synthase (TS) and DNA synthesis and repair.
  • Although dUTP is a normal intermediate in DNA synthesis, its accumulation and misincorporation into DNA as uracil is lethal.
  • Importantly, uracil misincorporation represents an important mechanism of cytotoxicity induced by the TS-targeted class of chemotherapeutic agents including 5-FU.
  • A growing body of evidence suggests that dUTPase is an important mediator of response to TS-targeted agents.
  • In this article, we present further evidence showing that elevated expression of dUTPase can protect breast cancer cells from the expansion of the intracellular uracil pool, translating to reduced growth inhibition following treatment with 5-FU.
  • We therefore report the implementation of in silico drug development techniques to identify and develop small-molecule inhibitors of dUTPase.
  • As 5-FU and the oral 5-FU prodrug capecitabine remain central agents in the treatment of a variety of malignancies, the clinical utility of a small-molecule inhibitor to dUTPase represents a viable strategy to improve the clinical efficacy of these mainstay chemotherapeutic agents.

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2000 Sep;83(6):792-9 [10952785.001]
  • [Cites] Cancer Res. 2000 Jul 1;60(13):3493-503 [10910061.001]
  • [Cites] Pharmacogenomics J. 2001;1(1):65-70 [11913730.001]
  • [Cites] J Clin Oncol. 2002 Apr 1;20(7):1721-8 [11919227.001]
  • [Cites] Curr Top Med Chem. 2002 Mar;2(3):211-27 [11944817.001]
  • [Cites] Cancer Res. 2002 Sep 1;62(17):4909-15 [12208740.001]
  • [Cites] Nat Rev Cancer. 2003 May;3(5):330-8 [12724731.001]
  • [Cites] Cancer Res. 2003 Jun 1;63(11):2898-904 [12782596.001]
  • [Cites] J Clin Oncol. 2004 Jan 15;22(2):229-37 [14657227.001]
  • [Cites] J Clin Oncol. 2004 Feb 1;22(3):529-36 [14752076.001]
  • [Cites] Pharmacogenetics. 2004 May;14(5):319-27 [15115918.001]
  • [Cites] N Engl J Med. 2004 Jun 3;350(23):2335-42 [15175435.001]
  • [Cites] Mol Pharmacol. 2004 Sep;66(3):620-6 [15322254.001]
  • [Cites] Mol Pharmacol. 1980 Nov;18(3):513-20 [6110169.001]
  • [Cites] Mol Pharmacol. 1982 Jan;21(1):211-6 [6215571.001]
  • [Cites] J Bacteriol. 1988 Mar;170(3):1069-75 [2830228.001]
  • [Cites] Clin Pharmacokinet. 1989 Apr;16(4):215-37 [2656050.001]
  • [Cites] Anal Biochem. 1989 Aug 1;180(2):222-6 [2554751.001]
  • [Cites] Cancer Res. 1991 May 1;51(9):2346-52 [2015598.001]
  • [Cites] Cancer Res. 1994 May 1;54(9):2296-8 [8162567.001]
  • [Cites] Cancer Res. 1995 Apr 1;55(7):1407-12 [7882343.001]
  • [Cites] Structure. 1996 Sep 15;4(9):1077-92 [8805593.001]
  • [Cites] Nucleic Acids Symp Ser. 1995;(34):77-8 [8841560.001]
  • [Cites] J Mol Biol. 1997 Apr 4;267(3):727-48 [9126849.001]
  • [Cites] Biochem Pharmacol. 1997 Sep 1;54(5):635-8 [9337081.001]
  • [Cites] Clin Cancer Res. 1998 May;4(5):1243-50 [9607583.001]
  • [Cites] Eur J Cancer. 1998 Jul;34(8):1274-81 [9849491.001]
  • [Cites] J Clin Oncol. 1999 Mar;17(3):1061-70 [10071301.001]
  • [Cites] Nature. 1957 Mar 30;179(4561):663-6 [13418758.001]
  • [Cites] N Engl J Med. 2006 Dec 28;355(26):2733-43 [17192538.001]
  • [Cites] Clin Colorectal Cancer. 2006 Nov;6(4):261-4 [17241510.001]
  • [Cites] Cancer Res. 2007 Feb 1;67(3):940-5 [17283124.001]
  • [Cites] J Clin Oncol. 2007 Nov 20;25(33):5210-7 [17968020.001]
  • [Cites] Int J Cancer. 1999 Dec 22;84(6):614-7 [10567908.001]
  • [Cites] J Clin Oncol. 2000 Jan;18(1):136-47 [10623704.001]
  • [Cites] Lancet. 2000 Mar 25;355(9209):1041-7 [10744089.001]
  • [Cites] Clin Cancer Res. 2000 Apr;6(4):1322-7 [10778957.001]
  • [Cites] J Clin Oncol. 2001 Nov 1;19(21):4097-106 [11689577.001]
  • (PMID = 18790783.001).
  • [ISSN] 1535-7163
  • [Journal-full-title] Molecular cancer therapeutics
  • [ISO-abbreviation] Mol. Cancer Ther.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA104796-03; United States / NCI NIH HHS / CA / R21 CA104796; United States / NCI NIH HHS / CA / 5R21CA104796-3; United States / NCI NIH HHS / CA / R21 CA104796-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; EC 3.6.1.- / Pyrophosphatases; EC 3.6.1.23 / dUTP pyrophosphatase; U3P01618RT / Fluorouracil; VC2W18DGKR / Thymidine
  • [Other-IDs] NLM/ NIHMS68743; NLM/ PMC2597111
  •  go-up   go-down


37. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA, Fearon KC: Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer; 2006 Dec 4;95(11):1568-75
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / metabolism. Esophageal Neoplasms / metabolism. Esophagogastric Junction / metabolism. Inflammation / pathology. Interleukin-1beta / metabolism. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pathol. 1999 Dec;189(4):487-95 [10629548.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2005 May;17(5):547-57 [15827446.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Nov;162(5):1957-63 [11069840.001]
  • [Cites] Clin Cancer Res. 2005 Aug 15;11(16):5802-8 [16115919.001]
  • [Cites] Br J Cancer. 2006 Mar 13;94(5):637-41 [16479253.001]
  • [Cites] Am J Surg. 2001 Aug;182(2):197-201 [11574097.001]
  • [Cites] Nutr Cancer. 2001;41(1-2):64-9 [12094630.001]
  • [Cites] Oncogene. 2002 Sep 5;21(39):6071-81 [12203119.001]
  • [Cites] Int J Oncol. 2002 Oct;21(4):881-6 [12239630.001]
  • [Cites] Br J Surg. 2003 Feb;90(2):215-9 [12555298.001]
  • [Cites] Mod Pathol. 2003 Jul;16(7):641-51 [12861059.001]
  • [Cites] Br J Cancer. 2003 Sep 15;89(6):1028-30 [12966420.001]
  • [Cites] Anticancer Res. 2003 Nov-Dec;23(6D):5015-22 [14981961.001]
  • [Cites] Clin Cancer Res. 2004 Mar 15;10(6):2020-8 [15041721.001]
  • [Cites] Clin Exp Immunol. 2004 Jul;137(1):65-73 [15196245.001]
  • [Cites] Am J Gastroenterol. 2004 Sep;99(9):1667-74 [15330899.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Br J Cancer. 1982 Mar;45(3):390-4 [6896153.001]
  • [Cites] J Clin Pathol. 1986 Jun;39(6):585-9 [3722412.001]
  • [Cites] Cancer. 1987 Feb 1;59(3):501-5 [3539313.001]
  • [Cites] J Cancer Res Clin Oncol. 1987;113(6):567-72 [3316241.001]
  • [Cites] Cancer Res. 1991 Jan 1;51(1):415-21 [1703040.001]
  • [Cites] J Immunol. 1993 Mar 15;150(6):2341-5 [8450216.001]
  • [Cites] J Clin Invest. 1993 Nov;92(5):2152-9 [8227330.001]
  • [Cites] Ann Surg. 1994 Apr;219(4):325-31 [7512810.001]
  • [Cites] Cancer Res. 1995 Feb 15;55(4):921-7 [7850809.001]
  • [Cites] Cancer. 1995 Apr 15;75(8):2077-82 [7535184.001]
  • [Cites] Br J Cancer. 1996 Sep;74(5):766-72 [8795580.001]
  • [Cites] Br J Cancer. 1984 Mar;49(3):375-7 [6704315.001]
  • [Cites] Science. 1996 Nov 8;274(5289):998-1001 [8875945.001]
  • [Cites] Cancer Res. 1997 Jan 1;57(1):94-9 [8988047.001]
  • [Cites] Br J Surg. 1998 Nov;85(11):1457-9 [9823902.001]
  • [Cites] Clin Sci (Lond). 1999 Jan;96(1):83-7 [9857110.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1999 Jan;82(1):107-10 [10192497.001]
  • [Cites] APMIS. 1999 May;107(5):514-22 [10335956.001]
  • [Cites] Int J Oncol. 1999 Oct;15(4):823-7 [10493968.001]
  • [Cites] Anticancer Res. 2004 Sep-Oct;24(5C):3335-42 [15515429.001]
  • [Cites] Cancer. 2004 Dec 15;101(12):2779-87 [15546137.001]
  • [Cites] J Clin Oncol. 2005 Feb 10;23(5):953-64 [15598976.001]
  • [Cites] J Mol Endocrinol. 2000 Oct;25(2):169-93 [11013345.001]
  • (PMID = 17088911.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Acute-Phase Proteins; 0 / Biomarkers, Tumor; 0 / Cytokines; 0 / Interleukin-1beta; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC2360731
  •  go-up   go-down


38. Belshaw NJ, Elliott GO, Foxall RJ, Dainty JR, Pal N, Coupe A, Garg D, Bradburn DM, Mathers JC, Johnson IT: Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa. Br J Cancer; 2008 Jul 8;99(1):136-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa.
  • Aberrant CpG island (CGI) methylation occurs early in colorectal neoplasia.
  • Quantitative methylation-specific PCR profiling applied to biopsies was used to quantify low levels of CGI methylation of 18 genes in the morphologically normal colonic mucosa of neoplasia-free subjects, adenomatous polyp patients, cancer patients and their tumours.
  • Multivariate statistical analyses distinguished tumour from mucosa with a sensitivity of 78.9% and a specificity of 100% (P=3 x 10(-7)).
  • In morphologically normal mucosa, age-dependent CGI methylation was observed for APC, AXIN2, DKK1, HPP1, N33, p16, SFRP1, SFRP2 and SFRP4 genes, and significant differences in CGI methylation levels were detected between groups.
  • Multinomial logistic regression models based on the CGI methylation profiles from normal mucosa correctly identified 78.9% of cancer patients and 87.9% of non-cancer (neoplasia-free+polyp) patients (P=4.93 x 10(-7)) using APC, HPP1, p16, SFRP4, WIF1 and ESR1 methylation as the most informative variables.
  • Similarly, CGI methylation of SFRP4, SFRP5 and WIF1 correctly identified 61.5% of polyp patients and 78.9% of neoplasia-free subjects (P=0.0167).
  • The apparently normal mucosal field of patients presenting with neoplasia has evidently undergone significant epigenetic modification.
  • Methylation of the genes selected by the models may play a role in the earliest stages of the development of colorectal neoplasia.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):265-70 [11120884.001]
  • [Cites] Cancer Sci. 2007 Sep;98(9):1454-60 [17640302.001]
  • [Cites] Hematol Oncol Clin North Am. 2002 Aug;16(4):775-810 [12418049.001]
  • [Cites] Cancer Res. 2002 Dec 1;62(23):6820-2 [12460892.001]
  • [Cites] Biochim Biophys Acta. 2003 Jun 5;1653(1):1-24 [12781368.001]
  • [Cites] Cancer Res. 2003 Jul 1;63(13):3819-25 [12839979.001]
  • [Cites] Adv Exp Med Biol. 2003;532:39-49 [12908548.001]
  • [Cites] Cancer Lett. 2004 Mar 31;206(1):107-13 [15019166.001]
  • [Cites] Nat Genet. 2004 Apr;36(4):417-22 [15034581.001]
  • [Cites] Cancer Res. 2004 Jul 1;64(13):4442-52 [15231653.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1495-501 [15342451.001]
  • [Cites] Clin Cancer Res. 2004 Sep 1;10(17):5969-70; author reply 5970 [15355931.001]
  • [Cites] Nat Genet. 1994 Aug;7(4):536-40 [7951326.001]
  • [Cites] Anal Biochem. 1995 Mar 20;226(1):161-6 [7785768.001]
  • [Cites] Nucleic Acids Res. 1997 Nov 1;25(21):4422-6 [9336479.001]
  • [Cites] Nature. 1999 Apr 1;398(6726):431-6 [10201374.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6 [10411935.001]
  • [Cites] Cancer. 1953 Sep;6(5):963-8 [13094644.001]
  • [Cites] Nat Rev Cancer. 2004 Dec;4(12):988-93 [15573120.001]
  • [Cites] J Clin Pathol. 2005 May;58(5):515-9 [15858124.001]
  • [Cites] Oncogene. 2005 Jun 9;24(25):4138-48 [15824739.001]
  • [Cites] Biochem Soc Trans. 2005 Aug;33(Pt 4):709-11 [16042580.001]
  • [Cites] Gastroenterology. 2005 Aug;129(2):626-38 [16083717.001]
  • [Cites] J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8 [16174854.001]
  • [Cites] Oncogene. 2005 Nov 24;24(53):7946-52 [16007117.001]
  • [Cites] Oncogene. 2006 Jan 5;25(1):139-46 [16247484.001]
  • [Cites] Nat Rev Cancer. 2006 Feb;6(2):107-16 [16491070.001]
  • [Cites] Br J Cancer. 2006 Feb 27;94(4):593-8 [16421593.001]
  • [Cites] Diagn Mol Pathol. 2006 Mar;15(1):17-23 [16531764.001]
  • [Cites] J Mol Diagn. 2006 May;8(2):209-17 [16645207.001]
  • [Cites] Gut. 2006 Jul;55(7):1000-6 [16407376.001]
  • [Cites] Nat Genet. 2006 Jul;38(7):787-93 [16804544.001]
  • [Cites] Cancer Res. 2006 Jul 1;66(13):6553-62 [16818627.001]
  • [Cites] Oncol Rep. 2006 Aug;16(2):429-35 [16820927.001]
  • [Cites] Anal Biochem. 2006 Aug 1;355(1):117-24 [16756932.001]
  • [Cites] Curr Mol Med. 2006 Jun;6(4):401-8 [16900663.001]
  • [Cites] Gut. 2006 Oct;55(10):1467-74 [16469793.001]
  • [Cites] Am J Clin Nutr. 2007 Oct;86(4):1064-72 [17921385.001]
  • [Cites] Nat Rev Genet. 2002 Jun;3(6):415-28 [12042769.001]
  • (PMID = 18542073.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] ENG
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2453007
  •  go-up   go-down


39. Milano F, Guarriera M, Rygiel AM, Krishnadath KK: Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery. PLoS One; 2010 Aug 26;5(8):e12424
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery.
  • BACKGROUND: Esophageal adenocarcinoma (EAC) is a highly aggressive disease with poor prognosis, which frequently exhibits HER-2 gene amplification.
  • [MeSH-major] ATP-Binding Cassette Transporters / immunology. Adenocarcinoma / immunology. Antibodies, Monoclonal / pharmacology. Antigen Presentation / drug effects. Esophageal Neoplasms / immunology. Gene Expression / drug effects. Receptor, ErbB-2 / genetics. T-Lymphocytes / immunology

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • Hazardous Substances Data Bank. Trastuzumab .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Chest Surg Clin N Am. 2000 Aug;10(3):441-50 [10967749.001]
  • [Cites] J Natl Cancer Inst. 2010 Feb 24;102(4):271-4 [20075370.001]
  • [Cites] N Engl J Med. 2001 Mar 15;344(11):783-92 [11248153.001]
  • [Cites] Int J Oncol. 2001 Dec;19(6):1211-20 [11713591.001]
  • [Cites] Cancer Res. 2001 Dec 15;61(24):8647-50 [11751378.001]
  • [Cites] Cancer Immunol Immunother. 2002 Jan;50(11):615-24 [11807625.001]
  • [Cites] Lancet Oncol. 2002 Mar;3(3):137-44 [11902499.001]
  • [Cites] Cancer Res. 2002 Apr 15;62(8):2244-7 [11956077.001]
  • [Cites] Am J Clin Pathol. 2002 Jul;118(1):60-6 [12109857.001]
  • [Cites] Cancer Res. 2002 Oct 15;62(20):5813-7 [12384543.001]
  • [Cites] Clin Cancer Res. 2002 Nov;8(11):3394-400 [12429626.001]
  • [Cites] Clin Cancer Res. 2002 Nov;8(11):3407-18 [12429628.001]
  • [Cites] Clin Cancer Res. 2003 Aug 15;9(9):3448-53 [12960136.001]
  • [Cites] World J Surg. 2003 Sep;27(9):999-1008; discussion 1006-8 [12917764.001]
  • [Cites] J Neurooncol. 2004 Jan;66(1-2):1-8 [15015764.001]
  • [Cites] J Clin Oncol. 2004 Mar 15;22(6):1063-70 [15020607.001]
  • [Cites] Ann Thorac Surg. 2004 Apr;77(4):1193-8; discussion 1198-9 [15063233.001]
  • [Cites] Clin Cancer Res. 2004 Apr 1;10(7):2538-44 [15073134.001]
  • [Cites] Int J Oncol. 2004 Aug;25(2):487-91 [15254748.001]
  • [Cites] Ann Thorac Surg. 2004 Nov;78(5):1790-800 [15511476.001]
  • [Cites] Hum Pathol. 1993 Oct;24(10):1127-34 [8104858.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3353-7 [7724565.001]
  • [Cites] N Engl J Med. 1997 Jul 17;337(3):161-7 [9219702.001]
  • [Cites] Semin Oncol. 1999 Aug;26(4 Suppl 12):51-9 [10482194.001]
  • [Cites] Clin Cancer Res. 2005 Apr 1;11(7):2552-60 [15814633.001]
  • [Cites] Clin Cancer Res. 2005 Jul 1;11(13):4898-904 [16000588.001]
  • [Cites] Cancer Immunol Immunother. 2006 Jan;55(1):85-95 [15948002.001]
  • [Cites] J Immunother. 2006 Jan-Feb;29(1):53-60 [16365600.001]
  • [Cites] J Immunol. 2006 Mar 15;176(6):3402-9 [16517708.001]
  • [Cites] Cancer Res. 2006 May 15;66(10):5452-60 [16707474.001]
  • [Cites] Clin Cancer Res. 2006 Aug 15;12(16):4925-32 [16914581.001]
  • [Cites] Mod Pathol. 2007 Jan;20(1):120-9 [17143264.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):405-9 [17097832.001]
  • [Cites] J Immunol Methods. 2007 Apr 10;321(1-2):94-106 [17336322.001]
  • [Cites] Cancer. 2007 May 15;109(10):1980-8 [17385213.001]
  • [Cites] Cancer Immunol Immunother. 2007 Dec;56(12):1967-77 [17564704.001]
  • [Cites] Cancer Immunol Immunother. 2008 Feb;57(2):197-206 [17622526.001]
  • [Cites] Cancer Immunol Immunother. 2008 Nov;57(11):1719-26 [18408926.001]
  • [Cites] Anal Cell Pathol. 2000;20(1):25-32 [11007435.001]
  • (PMID = 20865050.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ATP-Binding Cassette Transporters; 0 / ATP-Binding Cassette, Sub-Family B, Member 3; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 145892-13-3 / TAP2 protein, human; EC 2.7.10.1 / Receptor, ErbB-2; P188ANX8CK / Trastuzumab
  • [Other-IDs] NLM/ PMC2928738
  •  go-up   go-down


40. Kähler D, Alexander C, Schultz H, Abdullah M, Branscheid D, Lindner B, Zabel P, Vollmer E, Goldmann T: Proteomics out of the archive: Two-dimensional electrophoresis and mass spectrometry using HOPE-fixed, paraffin-embedded tissues. J Histochem Cytochem; 2010 Mar;58(3):221-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / chemistry. Biomarkers, Tumor / analysis. Carcinoma, Non-Small-Cell Lung / chemistry. Carcinoma, Squamous Cell / chemistry. Lung Neoplasms / chemistry. Proteome / analysis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Biospecimen Research Database. Biospecimen Research Database .
  • Hazardous Substances Data Bank. FORMALDEHYDE .
  • Hazardous Substances Data Bank. ETHANOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Histochem. 2000 Feb;102(1):5-14 [10726160.001]
  • [Cites] J Histochem Cytochem. 2009 Sep;57(9):849-60 [19471015.001]
  • [Cites] Pathol Res Pract. 2001;197(12):823-6 [11795830.001]
  • [Cites] Proteomics. 2001 Nov;1(11):1359-63 [11922595.001]
  • [Cites] Pathol Res Pract. 2002;198(2):91-5 [11928870.001]
  • [Cites] Pathol Int. 2002 Apr;52(4):286-93 [12031084.001]
  • [Cites] Am J Pathol. 2002 Dec;161(6):1961-71 [12466110.001]
  • [Cites] Pathol Res Pract. 2002;198(11):735-40 [12530576.001]
  • [Cites] Histochem Cell Biol. 2003 Feb;119(2):103-8 [12610729.001]
  • [Cites] Proteomics. 2003 Apr;3(4):413-21 [12687609.001]
  • [Cites] J Histochem Cytochem. 2003 Jul;51(7):977-80 [12810849.001]
  • [Cites] Pathol Res Pract. 2003;199(9):619-23 [14621198.001]
  • [Cites] Am J Pathol. 2003 Dec;163(6):2638-40 [14633636.001]
  • [Cites] Pathol Res Pract. 2004;200(6):469-72 [15310150.001]
  • [Cites] Pathol Res Pract. 2004;200(7-8):511-5 [15462498.001]
  • [Cites] Cell. 1982 Nov;31(1):11-24 [6186379.001]
  • [Cites] Cancer Res. 1988 May 15;48(10):2724-9 [2452011.001]
  • [Cites] Anal Chem. 1996 Mar 1;68(5):850-8 [8779443.001]
  • [Cites] Cancer Lett. 1997 Dec 16;121(1):31-7 [9459171.001]
  • [Cites] Diagn Mol Pathol. 2006 Jun;15(2):115-23 [16778593.001]
  • [Cites] J Mol Med (Berl). 2007 Aug;85(8):863-75 [17318615.001]
  • [Cites] Cesk Patol. 1999 Jul;35(3):80-4 [11038661.001]
  • (PMID = 19995946.001).
  • [ISSN] 1551-5044
  • [Journal-full-title] The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
  • [ISO-abbreviation] J. Histochem. Cytochem.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Fixatives; 0 / Proteome; 1HG84L3525 / Formaldehyde; 3K9958V90M / Ethanol
  • [Other-IDs] NLM/ PMC2825487
  •  go-up   go-down


41. Petersen S, Hellmich G, von Mildenstein K, Porse G, Ludwig K: Is surgery-only the adequate treatment approach for T2N0 rectal cancer? J Surg Oncol; 2006 Apr 1;93(5):350-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: To evaluate the results of patients with curative resected T2N0 rectal carcinoma, we reviewed data of 164 consecutive patients with adenocarcinoma of the rectum between 1981 and 2003 in our department.
  • In addition, patient characteristics were stratified according to the position of the rectal tumor with respect to the anal verge.
  • [MeSH-major] Adenocarcinoma / surgery. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16550556.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Beumer JH, Garner RC, Cohen MB, Galbraith S, Duncan GF, Griffin T, Beijnen JH, Schellens JH: Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry. Invest New Drugs; 2007 Aug;25(4):327-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / metabolism. Carcinoma, Non-Small-Cell Lung / metabolism. Carcinoma, Squamous Cell / metabolism. Chromatography, Liquid / methods. Colonic Neoplasms / metabolism. Feces / chemistry. Female. Humans. Lung Neoplasms / metabolism. Male. Middle Aged. Ovarian Neoplasms / metabolism. Pancreatic Neoplasms / metabolism. Sigmoid Neoplasms / metabolism. Tandem Mass Spectrometry / methods

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Ixabepilone .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1997 Jul 4;272(27):17118-25 [9202030.001]
  • [Cites] Annu Rev Med. 1997;48:353-74 [9046968.001]
  • [Cites] Cancer Res. 1995 Jun 1;55(11):2325-33 [7757983.001]
  • [Cites] Science. 2004 Aug 6;305(5685):866-9 [15297674.001]
  • [Cites] Methods Find Exp Clin Pharmacol. 2004 Jan-Feb;26(1):53-84 [14988742.001]
  • [Cites] Clin Cancer Res. 2004 Feb 15;10(4):1289-98 [14977827.001]
  • [Cites] J Clin Oncol. 2003 May 1;21(9):1866-73 [12721265.001]
  • [Cites] Nat Rev Drug Discov. 2003 Mar;2(3):233-40 [12612650.001]
  • [Cites] Suppl Tumori. 2002 Jul-Aug;1(4):S17-8 [12415808.001]
  • [Cites] Curr Pharm Des. 2002;8(19):1707-12 [12171542.001]
  • [Cites] Clin Cancer Res. 2002 Jul;8(7):2035-43 [12114401.001]
  • [Cites] Drug Metab Dispos. 2002 Jul;30(7):823-30 [12065441.001]
  • [Cites] Chembiochem. 2000 Jul 3;1(1):67-70 [11828400.001]
  • [Cites] Curr Drug Metab. 2000 Sep;1(2):205-13 [11465084.001]
  • [Cites] Clin Pharmacokinet. 2000 Dec;39(6):429-43 [11192475.001]
  • [Cites] J Pharm Biomed Anal. 2000 Dec 15;24(2):197-209 [11130199.001]
  • [Cites] Mutat Res. 2000 Dec 20;472(1-2):119-27 [11113704.001]
  • [Cites] Expert Opin Investig Drugs. 2006 Jun;15(6):691-702 [16732719.001]
  • [Cites] Mutat Res. 1998 Jun 18;402(1-2):67-75 [9675247.001]
  • [Cites] J Clin Oncol. 2007 Mar 20;25(9):1082-8 [17261851.001]
  • [Cites] Clin Pharmacokinet. 2006;45(1):33-58 [16430310.001]
  • [Cites] Int J Cancer. 1999 Feb 9;80(4):539-45 [9935154.001]
  • (PMID = 17347871.001).
  • [ISSN] 0167-6997
  • [Journal-full-title] Investigational new drugs
  • [ISO-abbreviation] Invest New Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Epothilones; K27005NP0A / ixabepilone
  • [Other-IDs] NLM/ PMC1915607
  •  go-up   go-down


43. Li L, Wang X, Chen J, Ding H, Zhang Y, Hu TC, Hu LH, Jiang HL, Shen X: The natural product Aristolactam AIIIa as a new ligand targeting the polo-box domain of polo-like kinase 1 potently inhibits cancer cell proliferation. Acta Pharmacol Sin; 2009 Oct;30(10):1443-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / enzymology. Animals. Apoptosis / drug effects. Catalytic Domain / genetics. Cell Division / drug effects. Cell Line, Tumor. Colonic Neoplasms / drug therapy. Colonic Neoplasms / enzymology. Dose-Response Relationship, Drug. HT29 Cells. HeLa Cells. Humans. Indole Alkaloids. Inhibitory Concentration 50. Lactams. Leukemia L1210 / drug therapy. Leukemia L1210 / enzymology. Ligands. Lung Neoplasms / drug therapy. Lung Neoplasms / enzymology. Mice. Molecular Structure. Protein Structure, Tertiary / genetics. Spindle Apparatus / drug effects. Stomach Neoplasms / drug therapy. Stomach Neoplasms / enzymology. Surface Plasmon Resonance. Two-Hybrid System Techniques

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6388-92 [8022793.001]
  • [Cites] Chem Biol. 2008 May;15(5):459-66 [18482698.001]
  • [Cites] J Cell Biol. 1996 Dec;135(6 Pt 2):1701-13 [8991084.001]
  • [Cites] Biochem Biophys Res Commun. 1997 May 19;234(2):397-405 [9177283.001]
  • [Cites] J Biol Chem. 1997 Nov 7;272(45):28646-51 [9353331.001]
  • [Cites] J Nat Prod. 2000 Aug;63(8):1160-3 [10978218.001]
  • [Cites] Cell Signal. 2000 Jun;12(6):405-11 [11202906.001]
  • [Cites] Cell Growth Differ. 2000 Dec;11(12):615-23 [11149596.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1984-9 [11854496.001]
  • [Cites] Inflamm Res. 2002 Feb;51(2):112-4 [11926312.001]
  • [Cites] Mol Cell. 2002 Mar;9(3):515-25 [11931760.001]
  • [Cites] Oncogene. 2002 May 9;21(20):3162-71 [12082631.001]
  • [Cites] Apoptosis. 2002 Aug;7(4):321-8 [12101391.001]
  • [Cites] J Pharmacol Exp Ther. 2002 Nov;303(2):858-66 [12388673.001]
  • [Cites] Bioorg Med Chem Lett. 2002 Dec 16;12(24):3557-9 [12443775.001]
  • [Cites] Oncogene. 2003 Jan 9;22(1):69-80 [12527909.001]
  • [Cites] Anal Biochem. 2003 May 15;316(2):171-4 [12711337.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5789-94 [12732729.001]
  • [Cites] Dev Cell. 2003 Jul;5(1):127-38 [12852857.001]
  • [Cites] Cell. 2003 Oct 3;115(1):83-95 [14532005.001]
  • [Cites] Nat Prod Rep. 2003 Dec;20(6):565-83 [14700200.001]
  • [Cites] Curr Biol. 2004 Oct 5;14(19):1712-22 [15458642.001]
  • [Cites] J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12 [2359136.001]
  • [Cites] Mol Cell Biol. 1992 Sep;12(9):4164-9 [1508211.001]
  • [Cites] Cell Growth Differ. 1994 Mar;5(3):249-57 [8018557.001]
  • [Cites] Mol Cell. 1998 Feb;1(3):371-80 [9660921.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9301-6 [9689075.001]
  • [Cites] Genes Dev. 1998 Dec 15;12(24):3777-87 [9869630.001]
  • [Cites] Cancer Cell. 2005 Mar;7(3):275-86 [15766665.001]
  • [Cites] Nat Rev Cancer. 2006 Apr;6(4):321-30 [16557283.001]
  • [Cites] Curr Biol. 2007 Feb 20;17(4):316-22 [17291758.001]
  • [Cites] J Biol Chem. 1995 Apr 28;270(17):10351-7 [7730342.001]
  • (PMID = 19801998.001).
  • [ISSN] 1745-7254
  • [Journal-full-title] Acta pharmacologica Sinica
  • [ISO-abbreviation] Acta Pharmacol. Sin.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Aristolactam AIIIa; 0 / Cell Cycle Proteins; 0 / Enzyme Inhibitors; 0 / Indole Alkaloids; 0 / Lactams; 0 / Ligands; 0 / Proto-Oncogene Proteins; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / polo-like kinase 1
  • [Other-IDs] NLM/ PMC4007328
  •  go-up   go-down


44. Ono M, Matsubara J, Honda K, Sakuma T, Hashiguchi T, Nose H, Nakamori S, Okusaka T, Kosuge T, Sata N, Nagai H, Ioka T, Tanaka S, Tsuchida A, Aoki T, Shimahara M, Yasunami Y, Itoi T, Moriyasu F, Negishi A, Kuwabara H, Shoji A, Hirohashi S, Yamada T: Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics. J Biol Chem; 2009 Oct 16;284(42):29041-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / blood. Case-Control Studies. Cell Line, Tumor. Chromatography, Liquid / methods. Enzyme-Linked Immunosorbent Assay / methods. Humans. Image Processing, Computer-Assisted. Mass Spectrometry / methods. Pancreatic Neoplasms / blood. Proteome. RNA Interference

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2000 Apr 1;95(7):2321-8 [10733502.001]
  • [Cites] Science. 2001 Apr 20;292(5516):468-72 [11292861.001]
  • [Cites] Ann N Y Acad Sci. 2001;936:1-10 [11460464.001]
  • [Cites] Ann N Y Acad Sci. 2001;936:580-93 [11460517.001]
  • [Cites] Mol Cell Proteomics. 2002 May;1(5):376-86 [12118079.001]
  • [Cites] Matrix Biol. 2003 Mar;22(1):15-24 [12714038.001]
  • [Cites] J Nutr. 2003 Jun;133(6 Suppl 1):2090S-2096S [12771371.001]
  • [Cites] J Biol Chem. 2003 Nov 28;278(48):47685-93 [14500733.001]
  • [Cites] J Proteome Res. 2003 Nov-Dec;2(6):643-9 [14692458.001]
  • [Cites] Glycoconj J. 2004;20(1):71-8 [14993838.001]
  • [Cites] Anal Chem. 2004 Jul 15;76(14):4193-201 [15253663.001]
  • [Cites] J Biochem. 1975 Oct;78(4):687-96 [1213987.001]
  • [Cites] Adv Cancer Res. 1989;52:257-331 [2662714.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Jun 18;247(2):514-7 [9642161.001]
  • [Cites] EMBO J. 1999 Jan 15;18(2):306-12 [9889187.001]
  • [Cites] Nat Biotechnol. 1999 Oct;17(10):994-9 [10504701.001]
  • [Cites] Mol Cell Proteomics. 2005 Feb;4(2):144-55 [15608340.001]
  • [Cites] J Immunol. 2005 Apr 15;174(8):4485-94 [15814669.001]
  • [Cites] J Proteome Res. 2005 Mar-Apr;4(2):377-86 [15822913.001]
  • [Cites] J Chromatogr A. 2005 Mar 4;1067(1-2):73-83 [15844511.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10852-7 [16043703.001]
  • [Cites] Mol Cell Proteomics. 2005 Sep;4(9):1265-72 [15958392.001]
  • [Cites] Gastroenterology. 2005 Oct;129(4):1225-36 [16230076.001]
  • [Cites] Cancer Res. 2005 Nov 15;65(22):10613-22 [16288055.001]
  • [Cites] Nat Biotechnol. 2006 Mar;24(3):333-8 [16525410.001]
  • [Cites] Mol Cell Proteomics. 2006 Jul;5(7):1338-47 [16552026.001]
  • [Cites] Gastroenterology. 2007 Nov;133(5):1569-78 [17983804.001]
  • [Cites] J Proteome Res. 2008 Jan;7(1):51-61 [18173218.001]
  • [Cites] Gastroenterology. 2008 Jun;134(7):1961-71, 1971.e1-4 [18439914.001]
  • [Cites] Nature. 2008 Sep 18;455(7211):421-4 [18690212.001]
  • [Cites] Cancer Sci. 2009 Mar;100(3):514-9 [19154406.001]
  • [Cites] J Clin Oncol. 2009 May 1;27(13):2261-8 [19289617.001]
  • (PMID = 19696023.001).
  • [ISSN] 1083-351X
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Blood Proteins; 0 / Proteome; 9001-32-5 / Fibrinogen; EC 1.14.11.2 / Procollagen-Proline Dioxygenase
  • [Other-IDs] NLM/ PMC2781450
  •  go-up   go-down


45. de Noo ME, Tollenaar RA, Deelder AM, Bouwman LH: Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears. World J Gastroenterol; 2006 Nov 7;12(41):6594-601
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Colorectal adenocarcinoma (CRC) is the third most common type of cancer and the fourth most frequent cause of death due to cancer worldwide.
  • Given the natural history of CRC, early diagnosis appears to be the most appropriate tool to reduce disease-related mortality.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colorectal Neoplasms / diagnosis. Proteomics / methods

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Pathol Lab Med. 2002 Dec;126(12):1518-26 [12456215.001]
  • [Cites] Proteomics. 2003 Jan;3(1):56-63 [12548634.001]
  • [Cites] Clin Chem. 2006 Jun;52(6):1045-53 [16574760.001]
  • [Cites] Semin Oncol. 2005 Feb;32(1):24-34 [15726503.001]
  • [Cites] Nature. 2003 Mar 13;422(6928):233-7 [12634797.001]
  • [Cites] J Natl Cancer Inst. 2003 Mar 19;95(6):489-90; author reply 490-1 [12644546.001]
  • [Cites] Eur J Cancer. 2003 Apr;39(6):718-27 [12651195.001]
  • [Cites] Nat Rev Cancer. 2003 Apr;3(4):243-52 [12671663.001]
  • [Cites] Nat Rev Cancer. 2003 Apr;3(4):267-75 [12671665.001]
  • [Cites] J Am Coll Surg. 2003 May;196(5):722-8 [12742204.001]
  • [Cites] J Mammary Gland Biol Neoplasia. 2002 Oct;7(4):433-40 [12882527.001]
  • [Cites] Bioinformatics. 2003 Aug 12;19(12):1484-91 [12912828.001]
  • [Cites] Clin Cancer Res. 2003 Aug 1;9(8):2904-11 [12912935.001]
  • [Cites] Gastroenterology. 2003 Feb;124(2):544-60 [12557158.001]
  • [Cites] Trends Biotechnol. 2002 Dec;20(12 Suppl):S30-4 [12570157.001]
  • [Cites] Technol Cancer Res Treat. 2002 Aug;1(4):297-304 [12625789.001]
  • [Cites] Anal Chem. 2005 Nov 15;77(22):7232-41 [16285670.001]
  • [Cites] Clin Chem. 2005 Dec;51(12):2229-35 [16223889.001]
  • [Cites] Nat Rev Cancer. 2005 Nov;5(11):845-56 [16239904.001]
  • [Cites] J Clin Invest. 2006 Jan;116(1):26-30 [16395400.001]
  • [Cites] J Clin Invest. 2006 Jan;116(1):271-84 [16395409.001]
  • [Cites] J Pathol. 2006 Apr;208(5):595-606 [16518808.001]
  • [Cites] Proteomics. 2006 Apr;6(7):2095-100 [16502467.001]
  • [Cites] World J Gastroenterol. 2006 Mar 14;12(10):1536-44 [16570345.001]
  • [Cites] Eur J Cancer. 2006 May;42(8):1068-76 [16603345.001]
  • [Cites] Biostatistics. 2003 Jul;4(3):449-63 [12925511.001]
  • [Cites] Lancet. 2003 Aug 9;362(9382):433-9 [12927430.001]
  • [Cites] J Proteome Res. 2003 Jul-Aug;2(4):361-72 [12938926.001]
  • [Cites] Proteomics. 2003 Sep;3(9):1667-72 [12973722.001]
  • [Cites] Cancer Res. 2003 Oct 1;63(19):6105-9 [14559785.001]
  • [Cites] BMC Bioinformatics. 2003 Jun 9;4:24 [12795817.001]
  • [Cites] CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29 [14974761.001]
  • [Cites] J Natl Cancer Inst. 2004 Mar 3;96(5):353-6 [14996856.001]
  • [Cites] Anal Chem. 2004 Mar 15;76(6):1560-70 [15018552.001]
  • [Cites] Bioinformatics. 2004 Mar 22;20(5):777-85 [14751995.001]
  • [Cites] Nat Rev Cancer. 2004 Apr;4(4):309-14 [15057290.001]
  • [Cites] Gastroenterology. 2004 May;126(5):1448-53 [15131804.001]
  • [Cites] N Engl J Med. 2004 Jun 3;350(23):2375-82 [15175439.001]
  • [Cites] World J Gastroenterol. 2004 Nov 1;10(21):3127-31 [15457557.001]
  • [Cites] Ann Intern Med. 1997 May 15;126(10):811-22 [9148658.001]
  • [Cites] Eur J Cancer. 2004 Nov;40(17):2613-22 [15541962.001]
  • [Cites] Ann Oncol. 2005 Jan;16(1):16-22 [15598930.001]
  • [Cites] J Clin Oncol. 2005 Jan 10;23(2):378-91 [15637400.001]
  • [Cites] Lancet. 2005 Jan 8-14;365(9454):153-65 [15639298.001]
  • [Cites] Clin Cancer Res. 2005 Feb 1;11(3):963-5 [15709159.001]
  • [Cites] Clin Cancer Res. 2005 Feb 1;11(3):1110-8 [15709178.001]
  • [Cites] Nat Biotechnol. 2005 Mar;23(3):291-2 [15765078.001]
  • [Cites] BMC Bioinformatics. 2005;6:68 [15788095.001]
  • [Cites] Brief Funct Genomic Proteomic. 2005 Feb;3(4):322-31 [15814023.001]
  • [Cites] Clin Sci (Lond). 2005 May;108(5):369-83 [15831087.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1685-95 [15887159.001]
  • [Cites] Clin Chem. 2005 Jun;51(6):973-80 [15845803.001]
  • [Cites] Am J Gastroenterol. 2005 Jun;100(6):1393-403 [15929776.001]
  • [Cites] Rapid Commun Mass Spectrom. 2005;19(12):1624-36 [15915451.001]
  • [Cites] J Proteome Res. 2005 May-Jun;4(3):972-81 [15952745.001]
  • [Cites] Anal Chem. 2005 Aug 15;77(16):5114-23 [16097747.001]
  • [Cites] Dig Surg. 2005;22(4):276-81 [16174984.001]
  • [Cites] Adv Exp Med Biol. 2000;477:349-78 [10849763.001]
  • [Cites] J Pathol. 2000 Nov;192(3):280-8 [11054709.001]
  • [Cites] Lancet. 2002 Feb 16;359(9306):572-7 [11867112.001]
  • [Cites] Gastrointest Endosc Clin N Am. 2002 Jan;12(1):53-63 [11916161.001]
  • [Cites] Eur J Cancer. 2002 May;38(7):872-9 [11978511.001]
  • [Cites] Cancer Res. 2002 Jul 1;62(13):3609-14 [12097261.001]
  • [Cites] Ann Intern Med. 2002 Jul 16;137(2):132-41 [12118972.001]
  • [Cites] Lancet. 2002 Jul 13;360(9327):170; author reply 170-1 [12126845.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1160-9 [12142368.001]
  • (PMID = 17075970.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 69
  • [Other-IDs] NLM/ PMC4125662
  •  go-up   go-down


46. Maw MK, Fujimoto J, Tamaya T: Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers. Br J Cancer; 2008 Nov 18;99(10):1557-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / metabolism. Carcinoma, Squamous Cell / metabolism. Inhibitor of Differentiation Protein 1 / biosynthesis. Neovascularization, Pathologic / metabolism. Uterine Cervical Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Adv Cancer Res. 1985;43:175-203 [2581424.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12718-23 [14555767.001]
  • [Cites] Anal Biochem. 1987 Apr;162(1):156-9 [2440339.001]
  • [Cites] Nucleic Acids Res. 1994 Mar 11;22(5):749-55 [8139914.001]
  • [Cites] Cancer Res. 1994 Dec 1;54(23):6065-8 [7954447.001]
  • [Cites] Cell Growth Differ. 1995 Jul;6(7):837-43 [7547505.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13543-8 [14578451.001]
  • [Cites] Cancer J. 2004 Jan-Feb;10(1):27-32 [15000492.001]
  • [Cites] Br J Cancer. 2004 Mar 22;90(6):1198-203 [15026801.001]
  • [Cites] Br J Cancer. 1996 Apr;73(8):884-8 [8611421.001]
  • [Cites] Mol Cell Biol. 1997 Dec;17(12):7317-27 [9372963.001]
  • [Cites] Mol Cell Biol. 1998 Apr;18(4):2371-81 [9528806.001]
  • [Cites] Mol Cell Biol. 1998 Aug;18(8):4577-88 [9671467.001]
  • [Cites] Trends Cell Biol. 1998 Feb;8(2):58-65 [9695810.001]
  • [Cites] EMBO J. 1999 Feb 15;18(4):968-76 [10022839.001]
  • [Cites] Br J Cancer. 1999 Mar;79(7-8):1249-54 [10098767.001]
  • [Cites] Br J Cancer. 1999 May;80(5-6):827-33 [10360662.001]
  • [Cites] Cancer Res. 1999 Jul 1;59(13):3041-4 [10397240.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9637-41 [10449746.001]
  • [Cites] Am J Pathol. 1999 Sep;155(3):815-22 [10487839.001]
  • [Cites] Br J Cancer. 2005 Oct 17;93(8):933-8 [16189525.001]
  • [Cites] Gynecol Oncol. 2006 Oct;103(1):186-9 [16595146.001]
  • [Cites] Cancer Lett. 2006 Dec 8;244(2):203-10 [16469432.001]
  • [Cites] Arch Pathol Lab Med. 1985 Aug;109(8):716-21 [3893381.001]
  • [Cites] Nature. 1999 Oct 14;401(6754):670-7 [10537105.001]
  • [Cites] Cancer Res. 2000 Mar 1;60(5):1332-40 [10728695.001]
  • [Cites] Cancer Res. 2000 Jul 1;60(13):3662-5 [10910083.001]
  • [Cites] Nature. 2000 Oct 5;407(6804):592-8 [11034201.001]
  • [Cites] J Cell Sci. 2000 Nov;113 ( Pt 22):3897-905 [11058077.001]
  • [Cites] Cancer Res. 2000 Nov 1;60(21):5929-33 [11085505.001]
  • [Cites] Nature. 2001 Feb 22;409(6823):1067-70 [11234019.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7812-6 [11427735.001]
  • [Cites] Cancer Res. 2001 Aug 1;61(15):5703-6 [11479201.001]
  • [Cites] Cancer Res. 2001 Aug 15;61(16):6008-11 [11507043.001]
  • [Cites] Nat Med. 2001 Nov;7(11):1194-201 [11689883.001]
  • [Cites] Cancer. 2001 Nov 15;92(10):2569-77 [11745191.001]
  • [Cites] Oncogene. 2002 Mar 14;21(12):1812-22 [11896613.001]
  • [Cites] J Urol. 2002 Jun;167(6):2598-602 [11992094.001]
  • [Cites] Carcinogenesis. 2002 May;23(5):721-5 [12016143.001]
  • [Cites] Mol Carcinog. 2002 Sep;35(1):42-9 [12203366.001]
  • [Cites] Ann Oncol. 2002 Oct;13(10):1598-604 [12377648.001]
  • [Cites] Cancer Cell. 2002 Dec;2(6):473-83 [12498716.001]
  • [Cites] Clin Cancer Res. 2003 Feb;9(2):779-85 [12576450.001]
  • [Cites] Int J Cancer. 2003 May 10;104(6):677-82 [12640673.001]
  • [Cites] Oncogene. 2003 Jul 17;22(29):4498-508 [12881706.001]
  • [Cites] J Pathol. 2003 Aug;200(5):561-7 [12898591.001]
  • [ErratumIn] Br J Cancer. 2009 Jul 21;101(2):377-8
  • (PMID = 19002177.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Angiogenesis Modulating Agents; 0 / Biomarkers, Tumor; 0 / Inhibitor of Differentiation Protein 1; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC2584935
  •  go-up   go-down


47. Dunn JM, Mackenzie GD, Oukrif D, Mosse CA, Banks MR, Thorpe S, Sasieni P, Bown SG, Novelli MR, Rabinovitch PS, Lovat LB: Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy. Br J Cancer; 2010 May 25;102(11):1608-17
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy.
  • [MeSH-major] Adenocarcinoma / diagnosis. Barrett Esophagus / diagnosis. Barrett Esophagus / drug therapy. Chromosome Aberrations. Esophagus / pathology. Image Cytometry. Photochemotherapy
  • [MeSH-minor] Aged. Case-Control Studies. Cytogenetic Analysis / methods. DNA, Neoplasm / genetics. Female. Flow Cytometry / methods. Humans. Hyperplasia / diagnosis. Hyperplasia / drug therapy. Hyperplasia / genetics. Male. Middle Aged. Neoplasm Staging. Ploidies. Prognosis. Recurrence. Time Factors

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Gastroenterol. 1999 Dec;94(12):3413-9 [10606296.001]
  • [Cites] N Engl J Med. 2009 May 28;360(22):2277-88 [19474425.001]
  • [Cites] Gastroenterology. 1989 May;96(5 Pt 1):1249-56 [2703113.001]
  • [Cites] Anal Cell Pathol. 1995 Jan;8(1):67-74 [7734413.001]
  • [Cites] Lasers Med Sci. 2008 Apr;23(2):203-10 [17610005.001]
  • [Cites] J Histochem Cytochem. 1983 Nov;31(11):1333-5 [6619538.001]
  • [Cites] Am J Gastroenterol. 2001 Nov;96(11):3071-83 [11721752.001]
  • [Cites] Gastroenterology. 2001 Jun;120(7):1630-9 [11375945.001]
  • [Cites] Crit Rev Clin Lab Sci. 1994;31(1):1-34 [8049032.001]
  • [Cites] Cytometry. 1994 Dec 15;18(4):218-22 [7895528.001]
  • [Cites] Am J Gastroenterol. 2000 Jul;95(7):1669-76 [10925966.001]
  • [Cites] Gut. 2008 Aug;57(8):1041-8 [18305067.001]
  • [Cites] Cytometry. 1992;13(6):577-85 [1451590.001]
  • [Cites] Am J Gastroenterol. 2000 Nov;95(11):3089-96 [11095322.001]
  • [Cites] Cytometry. 1992;13(3):314-21 [1576895.001]
  • [Cites] Br J Surg. 1988 Aug;75(8):760-3 [3167523.001]
  • [Cites] Cytometry. 1995 Sep 15;22(3):181-9 [8556949.001]
  • [Cites] Arch Intern Med. 1991 Nov;151(11):2212-6 [1953225.001]
  • [Cites] Br J Obstet Gynaecol. 1994 Jul;101(7):621-5 [8043542.001]
  • [Cites] Gastrointest Endosc. 2007 Sep;66(3):460-8 [17643436.001]
  • [Cites] Hum Pathol. 2001 Apr;32(4):379-88 [11331954.001]
  • [Cites] Lasers Med Sci. 2009 Sep;24(5):729-34 [19057983.001]
  • [Cites] Cancer. 1994 Mar 15;73(6):1595-607 [8156486.001]
  • [Cites] BMC Clin Pathol. 2008 May 30;8:5 [18513411.001]
  • [Cites] N Engl J Med. 1985 Oct 3;313(14):857-9 [4033716.001]
  • [Cites] Mod Pathol. 1991 Mar;4(2):178-82 [2047381.001]
  • [Cites] Cancer. 2008 Aug 1;113(3):470-6 [18553366.001]
  • [Cites] Methods Cell Biol. 1994;41:263-96 [7861967.001]
  • (PMID = 20461081.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Grant] United Kingdom / Cancer Research UK / / A9022
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  • [Other-IDs] NLM/ PMC2883155
  •  go-up   go-down


48. Sørby LA, Andersen SN, Bukholm IR, Jacobsen MB: Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer. J Exp Clin Cancer Res; 2010;29:144
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / genetics. Colonic Neoplasms / genetics. Gene Expression Profiling / standards. Oligonucleotide Array Sequence Analysis / standards. RNA, Messenger / analysis. Reverse Transcriptase Polymerase Chain Reaction / standards

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Oncol Clin N Am. 2000 Oct;9(4):655-60; discussion 661-3 [11008229.001]
  • [Cites] BMC Mol Biol. 2010;11:74 [20858237.001]
  • [Cites] Anal Biochem. 2001 Aug 1;295(1):17-21 [11476540.001]
  • [Cites] Anal Biochem. 2002 Apr 15;303(2):209-14 [11950223.001]
  • [Cites] Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 [12184808.001]
  • [Cites] Anal Biochem. 2002 Oct 15;309(2):293-300 [12413463.001]
  • [Cites] Nat Genet. 2003 Jan;33(1):49-54 [12469122.001]
  • [Cites] Kidney Int. 2003 Jul;64(1):356-60 [12787429.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jan 23;313(4):856-62 [14706621.001]
  • [Cites] Biotechnol Lett. 2004 Mar;26(6):509-15 [15127793.001]
  • [Cites] Scand J Immunol. 2004 Jun;59(6):566-73 [15182252.001]
  • [Cites] Biotechniques. 2004 Jul;37(1):112-4, 116, 118-9 [15283208.001]
  • [Cites] Cancer Res. 2004 Aug 1;64(15):5245-50 [15289330.001]
  • [Cites] J Biomol Tech. 2004 Sep;15(3):155-66 [15331581.001]
  • [Cites] Cell. 1990 Jun 1;61(5):759-67 [2188735.001]
  • [Cites] Dis Colon Rectum. 1998 Sep;41(9):1116-26 [9749495.001]
  • [Cites] Anal Biochem. 2004 Dec 1;335(1):1-9 [15519565.001]
  • [Cites] Lab Invest. 2005 Jan;85(1):154-9 [15543203.001]
  • [Cites] Mol Cell Probes. 2005 Apr;19(2):101-9 [15680211.001]
  • [Cites] Genes Immun. 2005 Jun;6(4):279-84 [15815687.001]
  • [Cites] Biotechniques. 2005 May;38(5):785-92 [15945375.001]
  • [Cites] J Mol Diagn. 2006 Feb;8(1):76-83 [16436637.001]
  • [Cites] Mol Aspects Med. 2006 Apr-Jun;27(2-3):192-223 [16445974.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G1067-74 [16399877.001]
  • [Cites] Neurosci Lett. 2006 Dec 1;409(2):112-7 [17034947.001]
  • [Cites] Brain Res. 2007 Feb 9;1132(1):20-8 [17188656.001]
  • [Cites] Int J Oncol. 2007 Aug;31(2):303-12 [17611686.001]
  • [Cites] Clin Chim Acta. 2008 Mar;389(1-2):146-51 [18179774.001]
  • [Cites] J Dermatol Sci. 2008 Mar;49(3):217-25 [18061409.001]
  • [Cites] Dis Colon Rectum. 2008 Sep;51(9):1395-402 [18607552.001]
  • [Cites] Anal Biochem. 2009 Aug 15;391(2):91-7 [19464249.001]
  • [Cites] BMC Mol Biol. 2010;11:12 [20122155.001]
  • [Cites] Mol Cell Probes. 2010 Apr;24(2):87-92 [19837153.001]
  • [Cites] Anal Biochem. 2010 Apr 15;399(2):211-7 [20036209.001]
  • [Cites] Br J Cancer. 2010 Mar 16;102(6):1037-43 [20179706.001]
  • [Cites] Ups J Med Sci. 2010 Aug;115(3):169-75 [20230186.001]
  • [Cites] J Pathol. 2010 Sep;222(1):1-15 [20681009.001]
  • [Cites] J Biochem Biophys Methods. 2000 Nov 20;46(1-2):69-81 [11086195.001]
  • (PMID = 21059236.001).
  • [ISSN] 1756-9966
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC2988724
  •  go-up   go-down


49. Ulaş M, Neşşar G, Bostanoğlu A, Aydoğ G, Kayaalp C, Ozoğul Y, Seven C: Development of two cancers in the same patient after ileorectal and ileal pouch anal anastomosis for familial adenomatous polyposis. Med Princ Pract; 2006;15(1):83-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of two cancers in the same patient after ileorectal and ileal pouch anal anastomosis for familial adenomatous polyposis.
  • After 19 years, in situ adenocarcinoma was detected in the rectal stump.
  • Completion proctectomy, mucosectomy, and hand-sewn ileal pouch anal anastomosis with protective ileostomy were performed.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Adenomatous Polyposis Coli / surgery. Anal Canal / surgery. Carcinoma, Squamous Cell / diagnosis. Colonic Neoplasms / complications. Ileostomy

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • Genetic Alliance. consumer health - Familial Polyposis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16340235.001).
  • [ISSN] 1011-7571
  • [Journal-full-title] Medical principles and practice : international journal of the Kuwait University, Health Science Centre
  • [ISO-abbreviation] Med Princ Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


50. Teoh CM, Gunasegaram T, Chan KY, Sukumar N, Sagap I: Review of risk factors associated with the anastomosis leakage in anterior resection in Hospital Universiti Kebangsaan Malaysia. Med J Malaysia; 2005 Aug;60(3):275-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was a significant difference (p=0.03) of anastomosis leakage in those patients with very distal tumour of < 4cm from anal verge (42%), when compare to those patients with proximal tumor of > 15cm from anal verge (4.3%).
  • [MeSH-major] Adenocarcinoma / epidemiology. Adenocarcinoma / surgery. Anastomosis, Surgical / adverse effects. Colorectal Neoplasms / epidemiology. Colorectal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16379179.001).
  • [ISSN] 0300-5283
  • [Journal-full-title] The Medical journal of Malaysia
  • [ISO-abbreviation] Med. J. Malaysia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Malaysia
  •  go-up   go-down


51. Maggio-Price L, Treuting P, Bielefeldt-Ohmann H, Seamons A, Drivdahl R, Zeng W, Lai L, Huycke M, Phelps S, Brabb T, Iritani BM: Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer. Am J Pathol; 2009 Jan;174(1):317-29
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter-infected Smad3/Rag2-double knockout (DKO) mice had more diffuse inflammation and increased incidence of adenocarcinoma compared with Helicobacter-infected Smad3(-/-) or Rag2(-/-) mice alone.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13180-5 [10557294.001]
  • [Cites] Mol Cell Biol. 1999 Apr;19(4):2495-504 [10082515.001]
  • [Cites] EMBO J. 2000 Apr 17;19(8):1745-54 [10775259.001]
  • [Cites] J Med Microbiol. 2000 Jun;49(6):525-34 [10847206.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2000 Sep;279(3):G492-9 [10960347.001]
  • [Cites] Immunogenetics. 2000 Aug;51(10):869-72 [10970103.001]
  • [Cites] J Intern Med. 2000 Sep;248(3):171-83 [10971784.001]
  • [Cites] Curr Opin Microbiol. 2005 Feb;8(1):83-91 [15694861.001]
  • [Cites] J Exp Med. 2005 Mar 7;201(5):737-46 [15753207.001]
  • [Cites] Immunol Rev. 2005 Apr;204:184-94 [15790359.001]
  • [Cites] Nat Rev Microbiol. 2005 Apr;3(4):343-9 [15806096.001]
  • [Cites] J Exp Med. 2005 Apr 4;201(7):1061-7 [15809351.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4):891-906 [15825073.001]
  • [Cites] Cell Cycle. 2005 Feb;4(2):217-20 [15655344.001]
  • [Cites] Cancer Res. 2005 May 15;65(10):3998-4004 [15899788.001]
  • [Cites] Am J Pathol. 2005 Jun;166(6):1793-806 [15920164.001]
  • [Cites] Nat Rev Microbiol. 2005 Aug;3(8):621-31 [16064054.001]
  • [Cites] Oncogene. 2005 Aug 29;24(37):5701-12 [16123803.001]
  • [Cites] Nat Rev Cancer. 2006 Jan;6(1):24-37 [16397525.001]
  • [Cites] Cancer Res. 2006 Jan 15;66(2):828-38 [16424015.001]
  • [Cites] World J Gastroenterol. 2006 Apr 21;12(15):2455-8 [16688844.001]
  • [Cites] Mol Carcinog. 2006 Jun;45(6):355-61 [16673382.001]
  • [Cites] Nature. 2006 May 25;441(7092):431-6 [16724054.001]
  • [Cites] Nature. 2006 Jun 22;441(7096):1015-9 [16791201.001]
  • [Cites] Science. 2006 Oct 13;314(5797):268-74 [16959974.001]
  • [Cites] PLoS Pathog. 2006 Nov;2(11):e115 [17121462.001]
  • [Cites] Cancer Res. 2006 Dec 15;66(24):11565-70 [17178846.001]
  • [Cites] J Gastroenterol Hepatol. 2007 Jan;22(1):51-9 [17201881.001]
  • [Cites] Curr Opin Microbiol. 2007 Feb;10(1):76-81 [17208515.001]
  • [Cites] Ann Oncol. 2007 Aug;18(8):1376-81 [17496310.001]
  • [Cites] Prostate. 2008 Mar 1;68(4):400-7 [18196539.001]
  • [Cites] Am J Gastroenterol. 2008 Feb;103(2):407-15 [18289203.001]
  • [Cites] J Clin Oncol. 2008 Mar 20;26(9):1544-52 [18285605.001]
  • [Cites] Vopr Onkol. 2007;53(6):664-7 [18416134.001]
  • [Cites] Nat Immunol. 2008 Jun;9(6):632-40 [18438410.001]
  • [Cites] Cell. 2004 Aug 6;118(3):285-96 [15294155.001]
  • [Cites] Gut. 2001 Aug;49(2):190-8 [11454793.001]
  • [Cites] Adv Exp Med Biol. 2001;490:21-32 [11505971.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G764-78 [11518689.001]
  • [Cites] Nature. 2001 Jul 5;412(6842):99 [11808612.001]
  • [Cites] Am J Pathol. 2002 Feb;160(2):739-51 [11839595.001]
  • [Cites] Clin Immunol. 2002 Feb;102(2):169-78 [11846459.001]
  • [Cites] Carcinogenesis. 2002 Mar;23(3):529-36 [11895869.001]
  • [Cites] Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:115-27 [11966532.001]
  • [Cites] Am J Pathol. 2002 Jun;160(6):2253-7 [12057927.001]
  • [Cites] Trends Microbiol. 2002 Jun;10(6):293-9 [12088666.001]
  • [Cites] Cancer Res. 2002 Nov 15;62(22):6362-6 [12438215.001]
  • [Cites] Am J Pathol. 2003 Feb;162(2):691-702 [12547727.001]
  • [Cites] Gastroenterology. 2003 Mar;124(3):762-77 [12612914.001]
  • [Cites] Dig Dis Sci. 2003 Feb;48(2):408-14 [12643623.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7901-6 [12810954.001]
  • [Cites] J Surg Oncol. 2003 Aug;83(4):222-6 [12884234.001]
  • [Cites] Cancer Res. 2003 Sep 15;63(18):6042-50 [14522933.001]
  • [Cites] Nat Rev Cancer. 2003 Nov;3(11):807-21 [14557817.001]
  • [Cites] Oncogene. 2004 Mar 11;23(10):1902-10 [14661063.001]
  • [Cites] J Clin Invest. 2004 May;113(9):1296-306 [15124021.001]
  • [Cites] Cell. 2004 Sep 17;118(6):671-4 [15369667.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):461-6 [15329734.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):405-6 [15385993.001]
  • [Cites] Anal Biochem. 1986 Apr;154(1):138-43 [2422981.001]
  • [Cites] Cell. 1998 Sep 18;94(6):703-14 [9753318.001]
  • [Cites] Trends Genet. 1998 Sep;14(9):364-7 [9769732.001]
  • [Cites] Cancer Lett. 2000 Apr 3;151(1):31-8 [10766420.001]
  • (PMID = 19119184.001).
  • [ISSN] 1525-2191
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] ENG
  • [Grant] United States / NCRR NIH HHS / RR / RR024462-02; United States / NCRR NIH HHS / RR / RR024462-03; United States / NCRR NIH HHS / RR / RR024462-01A1; United States / NCRR NIH HHS / RR / K26 RR024462-01A1; United States / NCRR NIH HHS / RR / RR024462-05; United States / NCRR NIH HHS / RR / K26 RR024462; United States / NCRR NIH HHS / RR / RR024462-04; United States / NCRR NIH HHS / RR / K26 RR024462-05; United States / NCRR NIH HHS / RR / K26 RR024462-02; United States / NIAID NIH HHS / AI / 1R01AI053568; United States / NIAID NIH HHS / AI / R01 AI053568; United States / NCRR NIH HHS / RR / K26 RR024462-03; United States / NCI NIH HHS / CA / R01 CA068328; United States / NCI NIH HHS / CA / 2R01CA68328; United States / NCRR NIH HHS / RR / K26 RR024462-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Rag2 protein, mouse; 0 / Smad3 Protein; 0 / Smad3 protein, mouse; 0 / Transforming Growth Factor beta
  • [Other-IDs] NLM/ PMC2631344
  •  go-up   go-down


52. Zhou M, Magi-Galluzzi C, Epstein JI: Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall. Anal Quant Cytol Histol; 2006 Jun;28(3):125-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Prostate basal cell lesions can have architectural and cytologic atypia that mimic prostate adenocarcinoma.
  • Immunohistochemical stains for basal cell markers are most helpful in the differential diagnosis.
  • All of the published studies show basal cell lesions are positive for basal cell keratins, whereas adenocarcinoma is negative for both.
  • RESULTS: Histologically, both cases were highly suspicious for prostate adenocarcinoma with infiltrative growth pattern and significant nuclear atypia.
  • However, both lesions were positive for another basal cell marker, p63, confirming that they were basal cells in origin, rather than prostate adenocarcinoma.
  • CONCLUSION: Prostate basal cell lesions can occasionally be negative for basal cell keratins by immunohistochemistry and therefore may be misdiagnosed as prostate adenocarcinoma.

  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16786721.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CKAP4 protein, human; 0 / Membrane Proteins; 68238-35-7 / Keratins
  •  go-up   go-down


53. Peng Y, Jiang Y, Chuang ST, Yang XJ: Computer-aided detection of prostate cancer on tissue sections. Appl Immunohistochem Mol Morphol; 2009 Oct;17(5):442-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These results show that the novel automated computer technique can accurately identify prostatic adenocarcinoma in the triple-antibody cocktail-stained prostate sections.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 2001 Sep;220(3):781-6 [11526282.001]
  • [Cites] Am J Surg Pathol. 2001 Nov;25(11):1397-404 [11684956.001]
  • [Cites] JAMA. 2002 Apr 3;287(13):1662-70 [11926890.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1151-60 [12218571.001]
  • [Cites] Am J Surg Pathol. 2003 Mar;27(3):365-71 [12604893.001]
  • [Cites] Hum Pathol. 2004 Sep;35(9):1121-31 [15343515.001]
  • [Cites] Am J Clin Pathol. 2004 Oct;122(4):517-23 [15487448.001]
  • [Cites] Am J Surg Pathol. 1995 Mar;19(3):251-60 [7532918.001]
  • [Cites] Anal Quant Cytol Histol. 1995 Oct;17(5):314-22 [8534334.001]
  • [Cites] Pathol Res Pract. 1995 Sep;191(9):935-44 [8606876.001]
  • [Cites] Radiology. 1996 Jun;199(3):843-8 [8638015.001]
  • [Cites] Acad Radiol. 1999 Jan;6(1):22-33 [9891149.001]
  • [Cites] Abdom Imaging. 2005 Jan-Feb;30(1):26-41 [15647868.001]
  • [Cites] Am J Clin Pathol. 2005 Feb;123(2):231-6 [15842047.001]
  • [Cites] Anal Quant Cytol Histol. 2006 Feb;28(1):1-13 [16566275.001]
  • [Cites] Histopathology. 2006 May;48(6):668-73 [16681682.001]
  • [Cites] Am J Clin Pathol. 2007 Feb;127(2):248-53 [17210521.001]
  • [Cites] Nat Clin Pract Urol. 2007 Jan;4(1):39-45 [17211424.001]
  • [Cites] N Engl J Med. 2007 Apr 5;356(14):1399-409 [17409321.001]
  • [Cites] N Engl J Med. 2007 Jul 5;357(1):84; author reply 85 [17615628.001]
  • [Cites] N Engl J Med. 2007 Jul 5;357(1):84; author reply 85 [17615630.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Am J Surg Pathol. 2008 Mar;32(3):461-7 [18300803.001]
  • [Cites] AJR Am J Roentgenol. 2008 Apr;190(4):854-9 [18356428.001]
  • (PMID = 19417626.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Grant] United States / NIBIB NIH HHS / EB / R21 EB006466; United States / NCI NIH HHS / CA / R21 CA97308; United States / NCI NIH HHS / CA / R21 CA097308-01; United States / NCI NIH HHS / CA / CA097308-02; United States / NCI NIH HHS / CA / R01 CA092361; United States / NCI NIH HHS / CA / CA097308-01; United States / NIBIB NIH HHS / EB / EB006466-02; United States / NIBIB NIH HHS / EB / EB006466-01A1; United States / NIBIB NIH HHS / EB / R21 EB006466-01A1; United States / NIBIB NIH HHS / EB / R21 EB006466-02; United States / NCI NIH HHS / CA / R21 CA097308; United States / NCI NIH HHS / CA / R21 CA097308-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS100571; NLM/ PMC2836393
  •  go-up   go-down


54. Lemos C, Peters GJ, Jansen G, Martel F, Calhau C: Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur J Nutr; 2007 Sep;46(6):329-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds.

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • MedlinePlus Health Information. consumer health - Folic Acid.
  • Hazardous Substances Data Bank. TRITIUM, RADIOACTIVE .
  • Hazardous Substances Data Bank. FOLIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Pharmacol. 2006 Dec 3;551(1-3):19-26 [17034785.001]
  • [Cites] Am J Clin Nutr. 2001 Oct;74(4):418-25 [11566638.001]
  • [Cites] J Nutr. 2000 Feb;130(2):129-32 [10720158.001]
  • [Cites] Pharmacol Rev. 2000 Dec;52(4):673-751 [11121513.001]
  • [Cites] Am J Clin Nutr. 2000 Aug;72(2):324-32 [10919921.001]
  • [Cites] Mol Genet Metab. 2000 Sep-Oct;71(1-2):121-38 [11001804.001]
  • [Cites] Annu Rev Physiol. 2004;66:419-46 [14977409.001]
  • [Cites] J Agric Food Chem. 2001 Dec;49(12):5736-42 [11743756.001]
  • [Cites] Am J Physiol Cell Physiol. 2006 Jul;291(1):C189-93 [16495369.001]
  • [Cites] Am J Physiol. 1987 Feb;252(2 Pt 1):G229-36 [3826350.001]
  • [Cites] Eur J Intern Med. 2001 Dec;12(6):484-9 [11711270.001]
  • [Cites] Eur J Cancer. 2005 Sep;41(13):1941-54 [15953717.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):147-52 [16193318.001]
  • [Cites] Mol Cancer Ther. 2002 Sep;1(11):959-69 [12481418.001]
  • [Cites] J Cell Physiol. 2003 Aug;196(2):403-8 [12811835.001]
  • [Cites] Free Radic Biol Med. 2002 Feb 15;32(4):314-8 [11841921.001]
  • [Cites] Br J Haematol. 2000 Sep;110(4):791-800 [11054060.001]
  • [Cites] J Biol Chem. 1981 May 10;256(9):4489-93 [7217093.001]
  • [Cites] Arch Neurol. 1998 Nov;55(11):1449-55 [9823829.001]
  • [Cites] Am J Clin Nutr. 2000 Jun;71(6 Suppl):1698S-702S; discussion 1703S-4S [10837321.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 2002;42:25-54 [11807163.001]
  • [Cites] Vitam Horm. 2003;66:403-56 [12852262.001]
  • [Cites] Crit Rev Ther Drug Carrier Syst. 1997;14(3):221-86 [9282267.001]
  • [Cites] J Nutr. 2002 Aug;132(8 Suppl):2367S-2372S [12163694.001]
  • [Cites] Annu Rev Nutr. 2000;20:561-93 [10940346.001]
  • [Cites] Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1083-8 [15571207.001]
  • [Cites] J Lab Clin Med. 1986 May;107(5):420-4 [3701189.001]
  • [Cites] Am J Physiol. 1997 Feb;272(2 Pt 1):C729-36 [9124317.001]
  • [Cites] Annu Rev Nutr. 2000;20:395-430 [10940340.001]
  • [Cites] Alcohol Clin Exp Res. 2005 Apr;29(4):664-71 [15834233.001]
  • [Cites] Exp Biol Med (Maywood). 2001 Apr;226(4):243-70 [11368417.001]
  • [Cites] Eur J Clin Nutr. 1997 Jan;51 Suppl 1:S54-9 [9023482.001]
  • [Cites] Nutr Rev. 2004 Jun;62(6 Pt 2):S3-12; discussion S13 [15298442.001]
  • [Cites] Am J Clin Nutr. 1999 Oct;70(4):495-501 [10500018.001]
  • [Cites] Phytochemistry. 2004 May;65(10):1317-30 [15231405.001]
  • [Cites] Biochem Pharmacol. 1997 Jan 24;53(2):223-31 [9037255.001]
  • [Cites] J Biol Chem. 1997 Apr 25;272(17 ):11165-70 [9111015.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2003 Aug;17(4):575-92 [12828956.001]
  • [Cites] J Clin Lab Anal. 1997;11(5):287-313 [9292395.001]
  • [Cites] Curr Pharm Des. 2003;9(31):2593-613 [14529544.001]
  • [Cites] Biochim Biophys Acta. 2001 Jul 2;1513(1):49-54 [11427193.001]
  • [Cites] Life Sci. 2005 Apr 8;76(21):2483-96 [15763079.001]
  • (PMID = 17712586.001).
  • [ISSN] 1436-6207
  • [Journal-full-title] European journal of nutrition
  • [ISO-abbreviation] Eur J Nutr
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Flavonoids; 0 / Folic Acid Antagonists; 0 / Phenols; 0 / Polyphenols; 0 / Tea; 10028-17-8 / Tritium; 935E97BOY8 / Folic Acid
  •  go-up   go-down


55. Mittal R, Perakath B, Chase S, Jesudason MR, Nayak S: Transanal excision of anorectal lesions--a single centre experience. Trop Gastroenterol; 2010 Jan-Mar;31(1):65-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seventeen patients with adenocarcinoma, two with melanoma and one with verrucous carcinoma underwent curative resection.
  • Four patients with malignant melanoma and one with adenocarcinoma underwent palliative resection.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Anal Canal / surgery. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Palliative Care. Postoperative Complications. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20860237.001).
  • [ISSN] 0250-636X
  • [Journal-full-title] Tropical gastroenterology : official journal of the Digestive Diseases Foundation
  • [ISO-abbreviation] Trop Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


56. Simeonov R, Simeonova G: Computer-assisted nuclear morphometry in relation to metastasis to regional lymph nodes in canine hepatoid adenocarcinomas. Anal Quant Cytol Histol; 2008 Dec;30(6):343-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Computer-assisted nuclear morphometry in relation to metastasis to regional lymph nodes in canine hepatoid adenocarcinomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19160703.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Letter
  • [Publication-country] United States
  •  go-up   go-down


57. Cohen SJ, Engstrom PF, Lewis NL, Langer CJ, McLaughlin S, Beard M, Weiner LM, Meropol NJ: Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors. Am J Clin Oncol; 2008 Feb;31(1):1-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Three objective tumor responses were noted (squamous cell of anus, adenocarcinoma of unknown primary, adenocarcinoma of rectum).

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. BORTEZOMIB .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18376220.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA006927
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Boronic Acids; 0 / Organoplatinum Compounds; 0 / Pyrazines; 04ZR38536J / oxaliplatin; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; 69G8BD63PP / Bortezomib; U3P01618RT / Fluorouracil
  •  go-up   go-down


58. Donigan M, Loh BD, Norcross LS, Li S, Williamson PR, DeJesus S, Ferrara A, Gallagher JT, Baker CH: A metastatic colon cancer model using nonoperative transanal rectal injection. Surg Endosc; 2010 Mar;24(3):642-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: For this study, 60 Balb/c mice were anesthetized and subjected to gentle anal dilation using blunt-tipped forceps at the anal opening.
  • Two mice (3.3%) from the 2.5 x 10(4) CT26-luc group showed metastatic colonic adenocarcinoma to the liver on postinjection day 50.
  • [MeSH-minor] Anal Canal. Animals. Cell Line, Tumor. Disease Models, Animal. Injections / methods. Mice. Mice, Inbred BALB C

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2004 May 13;350(20):2050-9 [15141043.001]
  • [Cites] Dig Surg. 2005;22(1-2):16-25 [15838167.001]
  • [Cites] Int J Cancer. 1989 Jul 15;44(1):177-81 [2744889.001]
  • [Cites] J Surg Res. 2009 Jun 15;154(2):299-303 [19101690.001]
  • [Cites] Cancer Res. 1975 Sep;35(9):2434-9 [1149045.001]
  • [Cites] Am J Pathol. 2007 Mar;170(3):1077-85 [17322390.001]
  • [Cites] Cancer Res. 1988 Apr 1;48(7):1943-8 [3349467.001]
  • [Cites] Arch Surg. 1995 Jun;130(6):649-53 [7763175.001]
  • [Cites] Surg Endosc. 2003 Jun;17(6):972-8 [12640542.001]
  • [Cites] Surg Endosc. 1998 Aug;12 (8):1092-5 [9685551.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Cancer Sci. 2004 Jun;95(6):514-9 [15182433.001]
  • [Cites] Eur J Surg Oncol. 2008 Apr;34(4):476-81 [17698312.001]
  • [Cites] Surg Oncol. 1992 Jun;1(3):251-6 [1341258.001]
  • [Cites] Int J Oncol. 2005 Jul;27(1):113-20 [15942650.001]
  • [Cites] Clin Cancer Res. 2000 Jun;6(6):2556-61 [10873112.001]
  • (PMID = 19688392.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


59. Serra Aracil X: [Transanal endoscopic microsurgery and cancer of the rectum: reality or chimera?]. Cir Esp; 2007 Nov;82(5):251-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Microcirugía endoscópica transanal y cáncer de recto: realidad o quimera.
  • [MeSH-major] Adenocarcinoma / surgery. Adenoma / surgery. Microsurgery. Proctoscopy. Rectal Neoplasms / surgery
  • [MeSH-minor] Anal Canal. Combined Modality Therapy. Humans. Lymphatic Metastasis. Multivariate Analysis. Neoplasm Recurrence, Local. Neoplasm Staging. Rectum / pathology. Risk Factors. Survival Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18021622.001).
  • [ISSN] 0009-739X
  • [Journal-full-title] Cirugía española
  • [ISO-abbreviation] Cir Esp
  • [Language] spa
  • [Publication-type] Editorial
  • [Publication-country] Spain
  •  go-up   go-down


60. Zhao AG, Li T, You SF, Zhao HL, Gu Y, Tang LD, Yang JK: Effects of Wei Chang An on expression of multiple genes in human gastric cancer grafted onto nude mice. World J Gastroenterol; 2008 Feb 7;14(5):693-700
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A human gastric adenocarcinoma cell line SGC-7901 grafted onto nude mice was used as the animal model.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / genetics. Drugs, Chinese Herbal / pharmacology. Stomach Neoplasms / drug therapy. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anal Biochem. 2000 Oct 15;285(2):194-204 [11017702.001]
  • [Cites] Expert Opin Pharmacother. 2007 Apr;8(6):797-808 [17425475.001]
  • [Cites] FEBS Lett. 2002 Aug 14;525(1-3):131-4 [12163175.001]
  • [Cites] World J Gastroenterol. 2002 Oct;8(5):792-6 [12378617.001]
  • [Cites] Gastroenterology. 2002 Dec;123(6):2052-63 [12454861.001]
  • [Cites] Oncogene. 2003 Jan 30;22(4):548-54 [12555068.001]
  • [Cites] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Aug;23(8):580-2 [14503054.001]
  • [Cites] Cancer Lett. 2003 Nov 10;201(1):107-16 [14580692.001]
  • [Cites] Curr Oncol Rep. 2004 May;6(3):192-8 [15066230.001]
  • [Cites] Oncogene. 2004 Jun 17;23(28):4921-9 [15077160.001]
  • [Cites] DNA Res. 2004 Jun 30;11(3):205-18 [15368895.001]
  • [Cites] Oncol Rep. 2004 Oct;12(4):933-8 [15375525.001]
  • [Cites] Cell Death Differ. 1999 Feb;6(2):99-104 [10200555.001]
  • [Cites] Mol Cell Biol. 1999 May;19(5):3829-41 [10207106.001]
  • [Cites] Gan To Kagaku Ryoho. 2005 Jan;32(1):19-23 [15675576.001]
  • [Cites] Clin Cancer Res. 2005 Feb 15;11(4):1386-93 [15746037.001]
  • [Cites] Eukaryot Cell. 2005 Apr;4(4):755-64 [15821135.001]
  • [Cites] Zhong Xi Yi Jie He Xue Bao. 2005 Sep;3(5):378-81 [16159573.001]
  • [Cites] Biochem J. 2005 Dec 1;392(Pt 2):335-44 [16048438.001]
  • [Cites] Chemotherapy. 2006;52(5):264-70 [16873996.001]
  • [Cites] J Clin Oncol. 2006 Nov 1;24(31):4991-7 [17075117.001]
  • [Cites] Curr Opin Struct Biol. 2000 Dec;10(6):649-55 [11114501.001]
  • (PMID = 18205257.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Drugs, Chinese Herbal
  • [Other-IDs] NLM/ PMC2683994
  •  go-up   go-down


61. Palanivelu C, Rangarajan M, Jategaonkar PA, Anand NV: An innovative technique for colorectal specimen retrieval: a new era of "natural orifice specimen extraction" (N.O.S.E). Dis Colon Rectum; 2008 Jul;51(7):1120-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The indication for surgery was familial polyposis coexisting with adenocarcinoma of the upper rectum.
  • A totally laparoscopic proctocolectomy with ileal pouch-anal anastomosis was successfully performed for all cases.
  • [MeSH-major] Adenocarcinoma / surgery. Adenomatous Polyposis Coli / surgery. Proctocolectomy, Restorative / methods. Rectal Neoplasms / surgery. Vagina / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Dis Colon Rectum. 2010 Apr;53(4):502-3; author reply 503 [20305453.001]
  • (PMID = 18481149.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Onal C, Topkan E, Efe E, Yavuz M, Sonmez S, Yavuz A: Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis. Radiat Oncol; 2009;4:14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Clinical and dosimetric data were evaluated for 94 patients who received a total dose 3DCRT of 70 Gy, and rectal doses were compared in four different rectal contouring techniques: the prostate-containing CT sections (method 1); 1 cm above and below the planning target volume (PTV) (method 2); 110 mm starting from the anal verge (method 3); and from the anal verge to the sigmoid flexure (method 4).
  • [MeSH-major] Adenocarcinoma / radiotherapy. Prostatic Neoplasms / radiotherapy. Radiotherapy / adverse effects. Radiotherapy Planning, Computer-Assisted / methods. Rectum / radiation effects. Rectum / radiography

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiother Oncol. 2002 Aug;64(2):209-14 [12242132.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):427-35 [12243818.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1314-21 [12459352.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):71-7 [12504038.001]
  • [Cites] Med Dosim. 2003 Fall;28(3):189-92 [14563439.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):953-62 [14575825.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1072-82 [15001247.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1343-51 [15275719.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1991 Sep;21(4):935-9 [1917622.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):3-11 [9054871.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):83-92 [9588921.001]
  • [Cites] Urology. 1998 Jun;51(6):991-7 [9609638.001]
  • [Cites] Cancer. 1999 Jun 1;85(11):2460-8 [10357419.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1056-65 [15519775.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34 [15752881.001]
  • [Cites] Strahlenther Onkol. 2006 May;182(5):277-82 [16673061.001]
  • [Cites] Br J Radiol. 2008 Apr;81(964):327-32 [18344276.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1028-33 [18280056.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):391-402 [10661346.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):507-12 [10974469.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):635-42 [11020558.001]
  • [Cites] Radiother Oncol. 2002 Jul;64(1):1-12 [12208568.001]
  • [Cites] Radiother Oncol. 2002 Jun;63(3):249-55 [12142088.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105 [12128107.001]
  • [Cites] Br J Radiol. 2002 Feb;75(890):151-61 [11893639.001]
  • [Cites] Strahlenther Onkol. 2000 Apr;176(4):168-72 [10812389.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1280-4 [14630262.001]
  • (PMID = 19432953.001).
  • [ISSN] 1748-717X
  • [Journal-full-title] Radiation oncology (London, England)
  • [ISO-abbreviation] Radiat Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2684071
  •  go-up   go-down


63. Ceni E, Mello T, Tarocchi M, Crabb DW, Caldini A, Invernizzi P, Surrenti C, Milani S, Galli A: Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells. World J Gastroenterol; 2005 Feb 28;11(8):1122-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we analyzed the mechanism by which TZD inhibit growth of human pancreatic carcinoma cell lines in order to evaluate the potential therapeutic use of these drugs in pancreatic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma. Apoptosis / drug effects. Hypoglycemic Agents / pharmacology. Pancreatic Neoplasms. Thiazolidinediones / pharmacology

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Diabetes Medicines.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15754392.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Hypoglycemic Agents; 0 / PPAR gamma; 0 / Thiazolidinediones
  • [Other-IDs] NLM/ PMC4250701
  •  go-up   go-down


64. Schweitzer A: [Giant anal tumor. The patient is not bothered by it]. MMW Fortschr Med; 2008 Apr 17;150(16):5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant anal tumor. The patient is not bothered by it].
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Adenoma / diagnosis. Anus Neoplasms / diagnosis. Rectal Neoplasms / diagnosis
  • [MeSH-minor] Aged, 80 and over. Cell Transformation, Neoplastic / pathology. Diagnosis, Differential. Female. Humans. Rectum / pathology

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18557104.001).
  • [ISSN] 1438-3276
  • [Journal-full-title] MMW Fortschritte der Medizin
  • [ISO-abbreviation] MMW Fortschr Med
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


65. Zykova TA, Zhu F, Zhai X, Ma WY, Ermakova SP, Lee KW, Bode AM, Dong Z: Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog; 2008 Oct;47(10):797-805
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report herein that RSVL directly binds with COX-2 and this binding is absolutely required for RSVL's inhibition of the ability of human colon adenocarcinoma HT-29 cells to form colonies in soft agar.
  • HT-29 human colon adenocarcinoma cells express high levels of COX-2 and either RSVL or RSVL-2, but not RSVL-3, suppressed anchorage independent growth of these cells in soft agar.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. RESVERATROL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2003 Jun 13;278(24):21336-43 [12649276.001]
  • [Cites] Int J Oncol. 2003 Jul;23(1):17-28 [12792772.001]
  • [Cites] Lancet Oncol. 2003 Oct;4(10):605-15 [14554238.001]
  • [Cites] Biochem Pharmacol. 2004 Apr 1;67(7):1399-410 [15013856.001]
  • [Cites] Bioorg Med Chem. 2004 Nov 1;12(21):5571-8 [15465334.001]
  • [Cites] Mutat Res. 2004 Nov 2;555(1-2):33-51 [15476850.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Cancer Res. 1995 Sep 1;55(17):3785-9 [7641194.001]
  • [Cites] Science. 1997 Jan 10;275(5297):218-20 [8985016.001]
  • [Cites] Cancer Res. 1998 Jan 15;58(2):362-6 [9443418.001]
  • [Cites] J Biol Chem. 1998 Aug 21;273(34):21875-82 [9705326.001]
  • [Cites] Carcinogenesis. 1999 Feb;20(2):237-42 [10069459.001]
  • [Cites] J Nutr Biochem. 2005 Jan;16(1):1-8 [15629234.001]
  • [Cites] Oncol Rep. 2005 Apr;13(4):559-83 [15756426.001]
  • [Cites] J Clin Oncol. 2005 Apr 20;23(12):2840-55 [15837998.001]
  • [Cites] Biochem Pharmacol. 2005 Oct 1;70(7):1048-55 [16102733.001]
  • [Cites] Carcinogenesis. 2006 May;27(5):1038-46 [16338953.001]
  • [Cites] Mol Cancer Ther. 2006 Aug;5(8):2034-42 [16928824.001]
  • [Cites] Biochem Pharmacol. 2006 Nov 30;72(11):1506-15 [16999939.001]
  • [Cites] Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83 [17306316.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9759-64 [10944235.001]
  • [Cites] Cancer Res. 2001 Feb 15;61(4):1604-10 [11245472.001]
  • [Cites] Carcinogenesis. 2001 Aug;22(8):1111-7 [11470738.001]
  • [Cites] FASEB J. 2001 Oct;15(12):2057-72 [11641233.001]
  • [Cites] J Nutr. 2002 Feb;132(2):298-302 [11823594.001]
  • [Cites] Biol Pharm Bull. 2002 Jan;25(1):147-8 [11824549.001]
  • [Cites] Lancet Oncol. 2001 Sep;2(9):544-51 [11905709.001]
  • [Cites] Mol Carcinog. 2002 Apr;33(4):244-50 [11933078.001]
  • [Cites] Cancer Control. 2002 Mar-Apr;9(2 Suppl):28-35 [11965228.001]
  • [Cites] Biomed Pharmacother. 2002 Mar;56(2):84-7 [12000139.001]
  • [Cites] Oncology (Williston Park). 2002 Apr;16(4 Suppl 3):17-21 [12014863.001]
  • [Cites] Ann N Y Acad Sci. 2002 May;957:210-29 [12074974.001]
  • [Cites] Curr Med Chem Anticancer Agents. 2003 Mar;3(2):77-93 [12678904.001]
  • [Cites] Oncogene. 2003 Apr 10;22(14):2143-50 [12687016.001]
  • [Cites] J Agric Food Chem. 1999 Oct;47(10):3974-7 [10552752.001]
  • [Cites] Eur J Cancer Prev. 2003 Oct;12(5):417-25 [14512807.001]
  • (PMID = 18381589.001).
  • [ISSN] 1098-2744
  • [Journal-full-title] Molecular carcinogenesis
  • [ISO-abbreviation] Mol. Carcinog.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA111356-03; United States / NCI NIH HHS / CA / R01 CA111356; United States / NCI NIH HHS / CA / CA81064; United States / NCI NIH HHS / CA / R37 CA081064; United States / NCI NIH HHS / CA / CA11536; United States / NCI NIH HHS / CA / R01 CA081064-08; United States / NCI NIH HHS / CA / CA120386; United States / NCI NIH HHS / CA / R01 CA120386; United States / NCI NIH HHS / CA / R01 CA120388; United States / NCI NIH HHS / CA / CA111356-03; United States / NCI NIH HHS / CA / R01 CA120388-03; United States / NCI NIH HHS / CA / CA120388-03; United States / NCI NIH HHS / CA / R01 CA081064
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Stilbenes; EC 1.14.99.1 / Cyclooxygenase 2; Q369O8926L / resveratrol
  • [Other-IDs] NLM/ NIHMS44114; NLM/ PMC2562941
  •  go-up   go-down


71. Arora R, El-Hameed AA, Ahmad MS: Fine needle aspiration cytology and immunocytochemistry of a case of mucinous carcinoma of the breast with neuroendocrine differentiation. Anal Quant Cytol Histol; 2008 Oct;30(5):306-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration cytology and immunocytochemistry of a case of mucinous carcinoma of the breast with neuroendocrine differentiation.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18980163.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


72. Jin Z, Yin L, Xue L, Lin M, Zheng Q: Anorectal functional results after transanal endoscopic microsurgery in benign and early malignant tumors. World J Surg; 2010 May;34(5):1128-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Anorectal manometric values showed the mean anal resting pressure (ARP) decrease from 45 +/- 6 mmHg to 29 +/- 4 mmHg (p < 0.05) and the maximum tolerable volume (MTV) decrease from 175 +/- 21 ml to 90 +/- 15 ml (p < 0.05) at the third month after TEM.
  • Endosonography demonstrated internal anal sphincter (IAS) rupture in five patients, and full integrity of the external anal sphincter (EAS) in all patients.
  • [MeSH-major] Adenocarcinoma / surgery. Adenoma, Villous / surgery. Anal Canal / physiopathology. Anus Neoplasms / surgery. Rectal Neoplasms / surgery. Rectum / physiopathology